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Abstract 
 The briarane diterpenoids are a large class of natural products derived from 
gorgonians and other corals from throughout the world.  Despite the extremely large 
number of briaranes that have been isolated, along with the potent and diverse range of 
biological activities that have been observed, the total synthesis of the briaranes remains 
underexplored.  A facile synthetic route to the briarane diterpenoids will aid in the 
further exploration of these molecules.  Herein, we will describe a number of synthetic 
approaches that were evaluated to access a key fragment of the briarane diterpenoids.  
A key feature of all routes involves the use of 2,5-cyclohexadienone substrates as a 
diverse platform for the launching of the synthesis.  Chapter 1 will provide background 
information on 2,5-cyclohexadienones.  Methods for their synthesis, a survey of their 
diverse reactivity, and selected examples of their use in natural product synthesis will 
all be described.  Emphasis will be given to reactivity patterns which aided us in our 
research.  Chapter 2 will provide a brief survey of the briarane diterpenoids as well as 
some of the major biologically active families.  Previous synthetic efforts used to access 
these molecules will also be described.  Chapter 3 will describe our efforts to synthesize 
a key fragment of the briarane diterpenoids (referred to as the briarane stereotetrad) 
utilizing intermediates containing a bicyclic lactone.  Chapter 4 will describe our 
successful efforts to access the briarane stereotetrad using monocyclic intermediates.  
The important influence of torsional strain in key steps, as well as a successful route to 
access the briarane stereotetrad will be described.  Chapter 5 will report the results of a 
separate research project in which an iodine(III) promoted cyclization of N-allylamides 
to form oxazolines was studied.  The development of optimum reaction conditions and 
the evaluation of the substrate scope will be described.  Key results that suggest novel 
mechanistic details for this electrophilic oxidative cyclization will also be described. 
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Chapter 1 
2,5-Cyclohexadienones: Synthesis, 
Reactivity & Applications in             
Organic Synthesis 
1.1 Synthesis of 2,5-Cyclohexadienones 
 2,5-Cyclohexadienones (Figure 1.1) are a synthetic motif that has seen 
increasing use in the synthesis of complex, organic molecules.1, 2  They are most 
commonly accessed through the oxidative dearomatization of phenols, though other 
methods also exist.  It is possible to form the 2,4-regioisomer in addition to the 2,5-
regioisomer (Figure 1.1), though the 2,4 regioisomer is often difficult to isolate due to 
its propensity to undergo Diels-Alder dimerization.  The regiochemical outcome can 
often be controlled by the substitution pattern on the parent phenol, though judicious 
choice of oxidant can also enable selective formation.1 
Figure 1.1: Cyclohexadienone regioisomers 
 
 The use of 2,5-cyclohexadienones as synthons in organic synthesis has several 
advantages. Some advantages include the ready availability of phenols, the wide variety 
of available reaction conditions on the resulting substrates, and the introduction of a 
stereogenic carbon atom from an achiral precursor leading to opportunities for 
stereoselective synthesis.  While there are a wide variety of methods to oxidize phenols, 
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many such oxidants such as electrochemical oxidation and transition metal salts such 
as Ag2O
3, MnO2
4, and Tl(NO3)3
5
 are either inefficient, irreproducible, or highly toxic.  
However, three major methods have emerged to forge the cyclohexadienone core in a 
more selective and efficient manner. 
1.1.1 Singlet Oxygen Methods 
 Endo and Hikino reported the oxidative dearomatization of a phenol with singlet 
oxygen in 1988 (Scheme 1.1).6  In a series of experiments directed toward the synthesis 
of the natural product rengyol, the authors needed to perform the oxidation of 1.5.  
Using p-cresol as a model system, the authors irradiated the substrate in the presence of 
bubbling O2 with rose-bengal as a sensitizer.  They observed a mixture of hydroperoxide 
12, quinol 13, and side-product 1.4.  The hydroperoxide could be reduced to 1.3 using 
Me2S.  Further experiments revealed that the oxidation was highly dependent on the 
solvent, with methanol giving the best results.  This method could be applied to the 
more complex substrate 1.5 in excellent yield. 
Scheme 1.1: Endo's photosensitized dearomatization 
 
Later, Carreño and Urbano published a highly improved method to dearomatize 
phenols to form 2,5-cyclohexadienones with singlet oxygen (Scheme 1.2).7  The 
authors used oxone and NaHCO3 to form the hydroperoxide substrate 1.8 from phenol 
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1.7.  Compound 18 could be reduced to quinol 1.9 by quenching the reaction mixture 
with Na2S2O3.  The reaction was found to be general for a number of substrates and 
furnished either the hydroperoxides or quinols in good to excellent yields.  
Mechanistically, the oxone and base serves as a source singlet oxygen, which forms 
1,4-endoperoxide 1.17.  Subsequent attack by water opens the endoperoxide to give 
peroxyquinol 1.18. 
Scheme 1.2: (A) Carreño & Urbano's 1O2 dearomatization with selected scope; (B) Proposed 
mechanism 
 
 1.1.2. Ru/Rh-Catalyzed Methods 
 Transition metal-catalyzed oxidative dearomatizations have also been reported.  
Murahashi disclosed a highly efficient synthesis of mixed-peroxide products 1.19 with 
t-BuOOH catalyzed by Ru complexes (Scheme 1.3).8  A screen of Ru sources found 
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RuCl2(PPh)3 to be the ideal catalyst, though simpler systems such as RuCl3·H2O were 
also viable.  The reaction furnished a wide variety of cyclohexadienone substrates in 
high to very high yields for a variety of electron deficient and electron rich substrates.  
The authors proposed a mechanism in which Ru-complex 1.26 initiates a single electron 
transfer (SET) to give phenoxyl radical 1.27, which rapidly undergoes a subsequent 
SET to give phenoxenium ion 1.28 that is trapped by a second equivalent of t-BuOOH 
to give the product.  They proposed that the rapid second oxidation explains the lack of 
observed radical-coupling products 
Scheme 1.3: (A) Murahashi's Ru-catalyzed dearomatization; (B) Proposed mechanism 
 
 Doyle and coworkers further extended this methodology using Rh2(cap)4 as a 
catalyst (Scheme 1.4).9  The use of these conditions allowed the reaction to be 
performed with the more stable and less expensive T-HYDRO (aqueous t-BuOOH) 
oxidant.  The analogous yields were high for a variety of products, often with catalyst 
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loadings of as low as 0.05%.  In contrast to the mechanistic proposal by Murahashi, the 
authors proposed that the reaction occurs through a radical mechanism, with the 
Rh2(cap)4 serving to decompose the T-HYDRO into the t-butyl-peroxy radicals 
(Scheme 1.4B).  The authors based this hypothesis on the lack of quinol products that 
should form in the presence of a phenoxenium ion and the aqueous T-HYDRO reagent.  
A radical mechanism could also explain the high yields for electron-deficient phenols, 
which would not as easily undergo a cationic pathway. 
Scheme 1.4: (A) Doyle's Rh-catalyzed dearomatization; (B) Doyle’s revised mechanistic 
proposal 
 
1.1.3. Hypervalent Iodine Mediated Methods 
 Perhaps the most commonly used method to synthesize 2,5-cyclohexadienones 
involves the oxidative dearomatization of a phenol with iodine(III)-based oxidants.  
Phenyliodine diacetate (PIDA) and phenyliodine bis-trifluoroacetate (PIFA) are the two 
most commonly used oxidants, and have been applied to an extremely wide variety of 
systems.10  The reactions have been observed to proceed relatively cleanly in both inter- 
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and intra-molecular fashion.  Further investigation by McKillop and Taylor showed that 
the conversion of the phenol to the silyl-ether can increase the yield and reduce the 
formation of side-products (Scheme 1.5).11  The reaction was found to be tolerant of 
alkyl substitution at a number of positions (Table 1.1), though the electron deficient 
ester 1.37e proceeded in lower yield.  
Scheme 1.5: Phenol dearomatization with PIFA 
 
 
Though the mechanistic details have not been fully examined, the reaction is believed 
to proceed through a pathway that exists somewhere between one of the two extremes 
shown in Scheme 1.6.  Either an associative mechanism (Path A) or a dissociative 
mechanism (Path B) are plausible mechanistic pathways.12  Both begin with a ligand 
exchange of the phenol onto the oxidant, giving complex 1.41.  In the associative 
mechanism, a nucleophile attacks at the 4-position, displacing the iodine nucleus in an 
SN2’-like fashion to give the cyclohexadienone directly.  The dissociative mechanism 
involves oxidation of the phenol to give phenoxenium ion 1.42.  This cation is 
subsequently trapped with a nucleophile to yield cyclohexadienone product 1.43.  Early 
evidence indicates that the mechanism most-likely occurs through a dissociative-like 
mechanism.12  However, recent uses of chiral hypervalent iodine reagents (Section 
1.1.1.4) to affect enantioselective dearomatizations indicates a reasonable amount of 
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Table 1.1: Dearomatization of free phenol and TIPS-protected phenol with PIFA 
 
Entry Compound Product Yield (%) 
R6 = H 
Yield (%) 
R6 = TIPS 
1 1.39a 1.40a 48 73 
2 1.39b 1.40b 60 73 
3 1.39c 1.40c 67 75 
4 1.39d 1.40d 67 78 
5 1.39e 1.40e 63 70 
6 1.39f 1.40f 27 59 
 
association in the transition state.  As such, the true mechanism probably lies 
somewhere between the extremes of Path A and Path B, and is likely highly dependent 
on the reaction conditions.  Felpin provided an alternate mechanistic proposal to explain 
the superiority of silyl-ether protected phenols in the dearomatization reaction (Scheme 
1.6).13  His proposal involves initial attack by the oxidant at the 4-position of the 
silylated phenol to give 1.46 followed by nucleophilic displacement to form the 
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cyclohexadienone (1.43).  Further investigation into the mechanism of this 
transformation is warranted. 
Scheme 1.6: Possible mechanistic pathways for iodine(III)-mediated oxidative 
dearomatization 
 
Kita reported the use of µ-oxo-bridged diiodide oxidant 1.49 in the oxidative 
dearomatization of a number of phenol substrates (1.47 for example, Scheme 1.7).14  
The reaction was found to produce superior yields for a variety of nucleophiles 
compared to the more commonly used PIFA.  The authors hypothesize that the longer 
C-OCOCF3 bond, influenced by the trans-bridging oxygen accelerates the ligand 
exchange, increasing the efficiency of the oxidation. 
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Scheme 1.7: Kita's improved dearomatization with 1.49 
 
Kita also reported the dearomatization of phenol 1.50 under catalytic conditions 
(Scheme 1.8).15  Their proposed catalytic cycle involves oxidation of an aryl-iodide to 
an iodine(III) species with a terminal oxidant (Scheme 1.8B).  After oxidative 
dearomatization, the regenerated aryl iodide is reoxidized and enters the cycle again.  A 
screen of aryl iodide sources revealed 4-iodotoluene to be the optimum catalyst.  TFA 
was a necessary additive to achieve high yields and catalytic loadings as low as 5 mol% 
could be used without a decrease in yield.  Of the oxidants screened (CH3CO3H, NaBO3, 
NaIO4, CrO3, m-CPBA) only m-CPBA was successful.  The authors were able to 
perform the dearomatization on a number of phenols under these catalytic conditions, 
further expanding the scope of iodine(III)-mediated dearomatization reactions. 
  
 
 
Chapter 1: 2,5-Cyclohexadienones  | 10 
Scheme 1.8: (A) Iodine(III)-catalyzed phenol dearomatization; (B) Proposed catalytic cycle 
 
Hypervalent iodine-based oxidations are also particularly appealing due to the 
wide variety of available nucleophiles that can be used in the dearomatization with 
oxygen-based nucleophiles being particularly effective (Scheme 1.9).  Intermolecular 
oxygen-based nucleophiles that have been used successfully include water (often with 
MeCN as a cosolvent), alcohols and carboxylic acids.  In most cases, the nucleophile is 
used in solvent quantities to maximize yields.  Intramolecular examples can also be 
achieved if the nucleophile is tethered to the phenol producing lactone and cyclic ether 
products.16 
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Scheme 1.9: Intramolecular dearomatization with oxygen nucleophiles 
 
The use of nitrogen-based nucleophiles are rarer.  In many cases, 
cyclohexadienones with N-substitution are instead produced from organometallic 
addition into iminoketal such as 1.55 (Scheme 1.10).  When PIDA is used as the oxidant 
along with added TFA, nitriles (1.57) can also add into the phenol, giving amide 
products.17  Attempts to furnish spiro-lactams have been met with challenges.  An early 
investigation by Kita found that amide 1.58 proceeded through O-cyclization, giving 
spirolactone 1.59 instead.16  Ciufolini found that sulfonamides perform the cyclization 
more readily than amides due to their enhanced nucleophilicity relative to amides;18 
phenol 1.60 could be dearomatized to form 1.61 in excellent yield 
Scheme 1.10: Dearomatization with nitrogen nucleophiles 
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A variety of carbon nucleophiles such as electron-rich aromatics and allylsilanes 
can also be used as nucleophiles (Scheme 1.11).  In most cases, the nucleophiles are 
tethered to the substrate resulting in spiro products, such as has been reported by Kita.19    
Although a few examples do exist where the carbon nucleophile can be added in an 
intermolecular fashion.  Canesi added veratrole and anisole into 1.64 to give 
cyclohexadienone 1.65a&b.20  The resulting products (1.65a&b) were elaborated to 
access the Amaryllidacae alkaloids.  A similar approach by Canesi utilized 
allyltrimethylsilane to furnish 1.67 in acceptable yields en route to aspidospermine.21 
Scheme 1.11: Dearomatization with carbon nucleophiles 
 
1.1.4. Enantioselective Synthesis of Cyclohexadienones with Chiral 
Hypervalent Iodine Complexes 
The ease of access and diversity of reactions available to cyclohexadienones 
makes them an appealing target for enantioselective synthesis.  However, the synthesis 
of both 2,5 and 2,4-cyclohexadienones in an enantioselective manner is a highly 
challenging problem, as the reaction occurs through a potentially dissociated 
carbocation, meaning that the distance between the chiral oxidant species the 
developing stereocenter might be unacceptably long.  2,5-Cyclohexadienones are an 
even more challenging problem, as the iodine nucleus is associated with the phenolic 
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oxygen while the stereocenter is formed para to the phenol; a long distance even if a 
fully associative mechanism is operative.  While several groups have reported methods 
for the enantioselective synthesis of 2,4-cyclohexadienones, only one report of the 
enantioselective synthesis of 2,5-cyclohexadienones exists.  This has been a significant 
area of research, and several recent reviews are available.22  The following section will 
focus on reports most relevant to our work which is reported in later chapters. 
Early reports in the enantioselective synthesis of 2,4-cyclohexadienones came 
from the labs of Kita and Ishihara (Scheme 1.12).  Kita utilized a novel 
spiroindanyldiiodide 1.69 to affect the enantioselective lactonization of 1.68 to give 
products of type 1.70.23  After optimization, the lactones could be obtained in good 
yields with ee values up to 86%.  The reaction could be performed in catalytic fashion 
using m-CPBA as a terminal oxidant though with a reduced ee of 65%.  Ishihara 
investigated related systems that utilized a far more easily synthesized catalyst, 1.72.24  
The reaction yielded lactone products with ee values up to 86%.  Several groups have 
also reported the use of chiral, iodine(V) reagents to synthesize 2,4-cyclohexadienones 
in enantioenriched form, though this reaction takes place through a different 
mechanism.25, 26 
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Scheme 1.12: (A) Kita's enantioselective dearomatization; (B) Ishihara's enantioselective 
dearomatization 
 
Our group has become interested in the enantioselective synthesis of 2,5-
cyclohexadienone substrates through iodine(III)-mediated oxidative dearomatization 
(Table 1.2). Initial work in our group utilized Ishihara-type catalysts (1.72) in the 
dearomatization of 2,4-dimethylphenol.27  While the initial ee values were low (<25%), 
our work verified that enantioselective induction could be achieved.  The synthesis of 
novel catalysts identified tartrate-derived catalyst 1.74 as a promising structure.  An 
investigation into the substrate scope revealed that ee values could be improved slightly, 
giving values up to 60% (Entry 3).  Work is ongoing to identify conditions to further 
improve the enantioselectivity. 
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Table 1.2: Selected scope of Harned's dearomatization of phenols with 1.74 
 
Entry R1 R2 R3 Temp 
(°C) 
Time 
(h) 
Yield 
(%) 
ee (%) 
1 Me H Me 25 16 52 28 
2 Br H Me 25 16 52 30 
3 TMS H Me 25 16 79 60 
4 H Me Me 25 16 43 0 
5 TBS H i-Pr 25 16 41 26 
 
 1.2. Reactions of 2,5-Cyclohexadienones 
 Despite their small size, 2,5-cyclohexadienones possess a dense array of 
reactive functionality.  On a fragment which only contains six carbons, they possess a 
ketone, two conjugated alkenes (which can often be differentiated if the molecule is not 
symmetric), as well as potential functionality at the 4-position introduced by the 
nucleophile.  As such, 2,5-cyclohexadienones can readily be engaged in diverse 
reactions.  This section will discuss some of the most important reactivity patterns 
available to 2,5-cyclohexadienones.  Key examples, both selective and unselective, will 
be introduced for each reaction type, though the reactions mentioned are by no means 
an exhaustive list. 
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1.2.1. 1,2-Additions 
 The cross-conjugated ketone present in 2,5-cyclohexadienones is well suited to 
undergo 1,2-additions in the presence of an appropriate organometallic reagent.  Such 
reactions present the possibility of introducing an additional stereocenter for further 
elaboration.  Subsequent reductive rearomatization has also proven to be a fruitful 
method for accessing highly-substituted phenols. 
 Wipf has examined the stereoselectivity of 1,2-additions of organometallic 
reagents into 2,5-cyclohexadienones in some detail.28, 29  Inspired by their work towards 
the natural product aranorosin (Scheme 1.13A), they observed that nucleophiles 
preferentially approached 1.75 from the α-face.30  An investigation into the steric biases 
in the molecule revealed little steric differentiation between the two trajectories.  
Intrigued by this result, the authors synthesized a series of cyclohexadienone substrates 
(1.77-1.83) to further investigate the selectivity of 1,2-addition.  Addition of MeMgBr 
revealed that the diastereoselectivity was highly sensitive to substrate and reaction 
conditions, though attack from the α-face was always preferred.  Screening of other 
nucleophiles demonstrated a strong dependence on nucleophile hybridization, 
counterion, and solvent (Table 1.3).   
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Scheme 1.13: (A) Selective nucleophilic addition en route to aranosin; (B) Selectivity of 
MeMgBr addition to cyclohexadienone nucleophiles 
 
 
The intriguing stereoselectivity of these model substrates was not easily 
explained by many of the existing stereoselectivity models such as the Ahn-Eisenstein 
model31, a “vinylogous Cieplak” effect32, or Burgess’ and Liotta’s frontier orbital 
distortion model.33  The authors proposed that the stereoselectivity was instead 
governed primarily by ground-state electrostatic effects arising from the sp3 C-O dipole 
moment (Figure 1.2).  Stronger dipoles would lead to preferred attack from the α-face.  
Calculation of the dipole moments for the substrates that were tested correlated well 
with the observed selectivity. 
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Table 1.3: Scope of selective nucleophilic addition to 1.77a 
 
Entry Nuc Yield 1.81a:1.81b solvent 
1 MeMgBr 86 4.8:1 THF 
2 NaBH4 or LiAlH4 100 1:1 MeOH or 
THF 
3 HC≡CMgBr 70 1:1 THF 
4 H9C4C≡CLi 26 1.1:1 THF 
5 PhMgBr 83 3.6:1 THF 
6 MeLi 87 2.1:1 THF 
7 MeLi 77 3.3:1 Et2O 
8 BnOCH2Li 84 3:1 THF 
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Figure 1.2: Trend in dipole moment and associated selectivity 
 
The authors were further gratified to find that the sense of selectivity could be 
reversed in fluorinated substrate 1.85, which possesses a dipole moment opposite that 
of the previously studied substrates (Scheme 1.14).  To their delight, addition of MeLi 
resulted in preferred β-attack.  The authors were able to use this information to design 
a fluorinated chiral auxiliary to direct the attack of a nucleophile into acetal 1.87.34  In 
the presence of THF and HMPA, compounds 1.88a and 1.88b could be obtained in 
1:2.1 dr. 
Scheme 1.14:(A) Stereochemical selectivity reversal in a fluorinated substrate; (B) Chiral       
auxiliary for selective addition 
 
While Wipf’s study of 1,2-additions into cyclohexadienones remains the most 
extensive study to date, 1,2-additions have also been used in the preparation of other 
molecules.  Parker and coworkers performed an addition of lithiated tetrahydropyrans 
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to give substrate 1.90 as a model study for analogous glycoside additions (Scheme 
1.15A).35  Compound 1.90 could then be rearomatized to furnish arylated glycoside-
like molecules (1.91).   Langlois developed an intriguing base-promoted addition of a 
trifluoromethyl group into dienone 1.3 using CF3H as the nucleophile (1.15B).
36  While 
the diastereoselectivity could be influenced by the identity of the base, the addition 
favored attack from the α-face, in accordance with Wipf’s observations.  Morrow 
performed the addition of an aryllithium into cyclohexadienone ketal 1.89 (Scheme 
1.15C).37 Subsequent treatment with BF3·OEt2 gave substituted phenanthrene 
substrates (1.94). 
Scheme 1.15: (A) Parker's tetrahydropyran addition; (B) Langlois' trifluoromethyl addition; 
(C) Morrow's phenanthrene synthesis 
 
1,2-Additions into cyclohexadienone ketals followed by ketal hydrolysis 
provides a useful strategy to introduce complex groups at the 4-position of 
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cyclohexadienones.  Stevens utilized this strategy to synthesize cyclohexadienones with 
heteroaromatic groups (1.96) at the 4-position from cyclohexadienone 1.89 (Scheme 
1.16A), which were studied for their activities against renal and colon cancer cell-
lines.38    Carreño performed the addition of the anion of an enantioenriched sulfoxide 
into ketal 1.89.  Subsequent removal of the ketal furnished quinol 1.98, which possesses 
a chiral auxiliary that could be used to direct further asymmetric reactions (Section 
1.2.2a).39 
Scheme 1.16: (A) Steven's heteroaromatic addition to 1.89; (B) Carreño's synthesis of 
enantioenriched quinol 1.98 
 
 1.2.2. Conjugate Additions 
 1.2.2.a. Organometallic Nucleophiles 
 Liotta observed that Grignard reagents undergo conjugate addition reactions in 
the presence of  the lithium alkoxide of cyclohexadienone quinols 1.99 (Scheme 
1.17).40  They termed the reaction “Ligand-Assisted Nucleophilic Addition” or LANA.  
The regiochemistry is determined by initial coordination of the organometallic 
nucleophile with the alkoxide followed by intramolecular delivery.   
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Scheme 1.17: Schematic LANA reaction 
 
  In their early studies, the quinol alkoxide 1.99 was generated in situ through 
an initial 1,2-addition of a lithium organometallic reagent into a benzoquinone (Scheme 
1.18), though the lithium alkoxide could also be generated by deprotonating the quinol 
with LDA.  In all of their studies, the LANA reaction occurred with complete 
regioselectivity, with the ligand being delivered syn to the alkoxide.  Further 
investigation revealed that excess reagent and higher temperatures (warming to room 
temperature) were necessary for the reaction to reach completion.41  The presence of 
additives such as HMPA, DMPU, or TMEDA were also necessary to suppress 
competing 1,2-addition.  The additive serves to facilitate the metathesis of the Mg 
counterion with the Li alkoxide.  Attempts to perform a LANA reaction with 
organolithium compounds resulted in isolation of the 1,2-addition products 1.106 as the 
sole product.  When protected quinol 1.107 was used, only 1,2-addition product 1.108 
was isolated after desilylation, confirming the necessity for anionic coordination.  The 
reaction was found to be tolerant of substitution on the cyclohexadiene ring, as well as 
at the 4-position.  A wide variety of sp, sp2 and sp3 nucleophiles participated in the 
conjugate addition. 
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Scheme 1.18: (A) Liotta's LANA reaction with selected scope; (B) Attempt to perform 
LANA reaction with organolithium nucleophile; (C) Attempt to perform LANA reaction on a 
protected quinol 
 
 Liotta undertook an investigation into the mechanism of the LANA reaction 
(Scheme 1.19).  A screen of various additives confirmed the necessity of aggregate-
destabilizing additives to achieve high 1,4 selectivity.  The authors also investigated the 
effect of the alkoxide counterion on the 1,4-selectivity.  Potassium was found to give 
enhanced selectivites relative to Li and Na.  Monitoring the reaction at −78 °C over the 
course of several hours revealed that the reaction stalled at <50% conversion.  Warming 
to room temperature resulted in full conversion.  The authors speculate that only the 
dialkylmagnesium species 1.111 is reactive enough to deliver the ligand at low 
temperature.  Warming the system allows complete organometallic transfer through the 
monoalkylmagnesium 1.110. 
  
 
 
Chapter 1: 2,5-Cyclohexadienones  | 24 
Scheme 1.19: Mechanistic proposal for LANA reaction 
 
 Liotta later noted that the use of higher-order organocuprates resulted in 
conjugate additions on similar substrates with opposite (anti to OH group) selectivity 
(Table 1.4).42  They hypothesized that the use of a coordinatively saturated cuprate 
system did not undergo exchange onto the hydroxyl ligand, leading to primarily anti-
addition product 1.116b.  A screening of different cuprate reagents found that higher-
order cuprates were essential, as lower order cuprates led to substantial rearomatization, 
presumably due to single-electron transfer processes.  This methodology was applicable 
to a wide variety of cuprates with good results, though phenyl cuprates did not add with 
the intended selectivity (Entry 6). 
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Table 1.4: Scope of selective cuprate addition into cyclohexadienones 
 
Entry Organometallic Additive R Yield 1.113a:1.113b 
1 BuMgCl DMPU Bu 83 0:100 
2 Li2Bu(2-thienyl)CuCN BF3·OEt2 Bu 61 95:5 
3 (vinyl)MgCl DMPU vinyl 68 0:100 
4 Li2(vinyl)(2-
thienyl)CuCN 
BF3·OEt2 vinyl 54 95:5 
5 PhMgBr DMPU Ph 81 0:100 
6 LiPh2Cu/Me2S -- Ph 61 10:90 
 
 Swenton found that reagents made from an organometallic (Grignard or 
organolithium) and the MAD reagent (methylaluminum bis(4-bromo-2,6-di-tert-
butylphenoxide)) gave a compound which preferentially performed conjugate additions 
into cyclohexadienones (Scheme 1.20).  The regioselectivity is presumably due to steric 
deactivation of the bulky MAD reagent towards the 1,2-addition pathway.43  A wide 
variety of organometallic reagents could be added into a series of cyclohexadienones.  
When quinone monoketals were used, the 1,4-addition proceeded in high yields with a 
variety of organometallic nucleophiles.  The reaction was tolerant of a variety of 
hybridizations and steric conditions.  Yields were slightly lower, though still good, 
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when a variety of quinol ethers were utilized.  In all cases, the addition occurred syn to 
the oxygen in the quinol ether. 
Scheme 1.20: Swenton's MAD addition to quinone monoketals (A) and quinols (B) 
 
 Carreño reported the diastereoselective addition of organoaluminum reagents to 
quinol 1.122 to give enantioenriched enone 1.123 (Scheme 1.21).44  The reaction was 
observed to proceed with high diastereoselectivity to give the product resulting from 
addition syn to the oxygen.  It was found to be necessary to utilize excess of the 
organoaluminum reagents to achieve high yields.  The authors rationalized this 
observation, along with the observed stereoselectivity, by invoking pre-coordination by 
an organoaluminum reagent with the alkoxide.  The addition then proceed through chair 
like transition-state 1.124.  The authors were able to elaborate these products into 
differentially substituted quinols 1.125 through a multistep sequence. 
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Scheme 1.21: (A) Carreno's diastereoselective organoaluminum addition; (B) Elaboration to 
unsymmetrically substituted quinols 
 
 Iwata and coworkers were able to achieve the enantioselective addition of 
trimethylaluminum into cyclohexadienone 1.126, to give enantioenriched product 
1.127.45  The reaction was found to proceed in the presence of a CuI salts and an 
oxazoline ligand.  Further screening found that the sterically-hindered additive TBSOTf 
improved the enantioselectivity.  A number of ligands were screened, and 1.127 could 
be obtained in 68% ee when ligand 1.128 was used. 
Scheme 1.22: Iwata's enantioselective, copper-catalyzed alkylaluminum addition 
 
 Feringa and coworkers were able to achieve a similar enantioselective addition 
of dialkylzinc reagents into quinone ketal 1.89 (Scheme 1.23).46  The authors found that 
the addition occurred in the presence of a copper catalyst and phosphoramidite ligand 
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1.131 to give ee values of <99%.  The reaction could be extended to cyclohexadienones 
of type 1.77.  The addition proceeded with reasonably high selectivity to give addition 
syn to the oxygen.  The products could be obtained in analogously high yields and ee.  
In a later report, the authors found that the addition occurred under complete catalyst 
control.47  When mono-addition product 1.130a was resubjected to the reaction with 
either enantiomer of the catalyst, either the syn (1.132a) or anti (1.132b) products could 
be obtained depending on which enantiomer of catalyst was used (Figure 1.23B). 
Scheme 1.23: Ferringa's Cu-catalyzed enantioselective Et2Zn addition; (B) Demonstration of   
catalyst control 
 
 Bräse reported a creative application of Ferringa’s methodology (Scheme 
1.24).48  Starting from quinone monoketal 1.89, the authors were able to prepare either 
enantiomer of enone 1.133 through appropriate ligand selection.  The ketone was then 
stereoselectively reduced with either enantiomer of the CBS catalyst followed by acetal 
hydrolysis.  Depending on the stereochemistry used for both the dimethylzinc addition 
  
 
 
Chapter 1: 2,5-Cyclohexadienones  | 29 
and CBS reduction, any of the four possible stereoisomers of 1.134 could be prepared 
in 82-97% ee with low to moderate disastereoselectivity. 
Scheme 1.24: Bräse's application of Ferringa’s methodology 
 
 Thomson and coworkers also reported a Rh-catalyzed addition of arylzinc 
chlorides into quinone monoketal 1.89 (Scheme 1.25).49  A variety of aryl groups could 
be added in the presence of [RhCl((R)-BINAP)]2 to give 1.135 in good yields with ee 
values up to 92%.  The authors were able to utilize this desymmetrization to access 
enantioenriched biaryl compounds.  The enones were subjected to oxidative 
dimerization conditions to give 1.136.  Subsequent rearomatization occurred with 
efficient point to axial chirality transfer to give enantioenriched biaryl substrates 1.137 
in good yield and 98% ee. 
Scheme 1.25: Thompson's enantioselective Rh-catalyzed arylzinc addition 
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 Semmelhack used an acylnickel reagent to add alkyl groups into napthoquinone 
monoketal products (Scheme 1.26).50  Treatment of n-BuLi with Ni(CO)4 followed by 
addition of the reagent into 1.135 followed by trapping of the enolate with allyl iodide 
gave 1.139 in 85% yield.  Despite the effectiveness of this protocol, subsequent uses of 
this methodology have not been reported, likely due to the high toxicity of the Ni(CO)4. 
Scheme 1.26: Semmelhack's acylnickel conjugate addition 
 
 There are also several examples of conjugate additions utilizing Pd-based 
catalysts.  Ferringa reported a Heck reaction involving cyclohexadienone 1.140 
(Scheme 1.27).51  The authors found that when 1.140 was treated with Pd(OAc)2 in the 
presence of TADDOL-derived phosphoramidite 1.142, cyclized product 1.141 was 
obtained.  Optimization of the conditions found the bulky base Cy2MeN produced the 
best results, giving 1.141 in 96% ee. 
Scheme 1.27: Ferringa's enantioselective Heck reaction 
 
 A few authors have also reported palladium-catalyzed cyclizations initiated by 
alkyne acetoxylation reactions.  Harned reported a cascade reaction on 
cyclohexadienone 1.143 involving the palladium-catalyzed trans-acetoxylation of the 
alkyne followed by insertion and protodemetallation to form bicycle 1.144 (Scheme 
1.28A).52  Pyridine-type ligands such as bipy or 1.145 were found to be necessary for 
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the reaction to occur and acetic acid was required as the solvent.  The regioselectivity 
of the reaction was found to be highly dependent on the pattern of substitution on the 
cyclohexadienone core.  Cyclization occurred opposite from 2-substituted enones, 
though the selectivity for 3-substituted enones was less pronounced.  Oxygen, nitrogen, 
and carbon tethers participated in the cyclization, though ester substrates did not.  A 
survey of chiral ligands found that (−)iso-PINDY ligand 1.145 promoted the cyclization 
in up to 62% ee, though the selectivity was highly substrate dependent.  Shortly 
thereafter, Sasai reported a similar acetoxylation-cyclization-oxidation cascade reaction 
(Scheme 1.28B) which yielded products of type 1.147.53  Oxygen was found to be the 
ideal terminal oxidant for the reaction.  When enantioenriched SPRIX ligand 1.148 was 
used in the reaction, 1.147 could be obtained in up to 82% ee. 
Scheme 1.28: (A) Harned's palladium-catalyzed acetoxylation-insertion; (B) Sasai's                
acetoxylation-cyclization-oxidation cascade 
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 Several related alkyne cyclizations using boron-containing organometallic 
reagents and transition-metal catalysts have also been reported.  Lautens reported the 
cyclization of alkyne 1.149 triggered by the rhodium-catalyzed insertion of arylboronic 
acids followed by enone cyclization (Scheme 1.29A).54  Extensive ligand optimization 
found diene ligand 1.151 to be the optimum ligand, giving cyclized products in up to 
90% ee.  Tian and Lin reported a similar cyclization of alkynes triggered by arylboronic 
acid insertion (Scheme 1.29B).55  The authors found that (R)-BINAP was the ideal 
ligand with KHF2 as an additive.  Performing the reaction under optimized conditions 
led to cyclized product 1.153 in excellent yield and up to 99% ee.  Tian and Lin also 
reported a similar cyclization initiated by copper-catalyzed alkyne diboration with 
B2Pin2 (Scheme 1.29C).
56  Phosphoramidite ligand 1.131 was found to yield the 
boronate product 1.155 in good yield and up to 99% ee. 
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Scheme 1.29: Enantioselective boronation/cyclization by Lautens (A) and Tian/Lin (B & C) 
 
  
1.2.2.b. Carbon Nucleophiles 
 Chittimalla studied the conjugate addition of the lithium enolate of 
acetophenone into cyclohexadienone ketal 1.89 to give phenol 1.56a&b after 
rearomatization (Scheme 1.30A).57  Their study focused mainly on 2,4-
cyclohexdinones, though they also reported a few examples of addition into quinone 
monoketal 1.89 to give phenol 1.156a in 60% yield along with 1.156b.  Another early 
example of the application of stabilized carbon nucleophiles was reported by McDonald 
and Dreiding (Scheme 1.30B).58  The authors treated quinone monoketal 1.157 with 
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acetone dicarboxylic acid dimethylester 1.158 and catalytic NaOEt to give tricycle 
1.159 in 86% yield as a mixture of diastereomers. 
Scheme 1.30: (A) Chittimalla's conjugate addition of acetophenone; (B) McDonald & 
Dreiding's double conjugate addition 
 
 Parker and coworkers engaged in one of the first thorough investigations into 
the conjugate addition of malonate anions into cyclohexadienones (Scheme 1.31).59  
The authors added the sodium salt of diethylmalonate into quinone monoketals 1.89.  A 
variety of substrates were amenable to the addition.  An investigation of various bases 
found either catalytic amounts of NaOEt in EtOH or stoichiometric NaH in THF to be 
optimum, depending on the substrate.  The resulting adducts were treated under acidic 
conditions to furnish rearomatized products 1.161 in good yield.  The use of ketoester 
nucleophiles with NaOEt as a base led to the isolation of tricyclic products 1.166, which 
result from initial Michael addition into the cyclohexadienone, followed by 
intramolecular conjugate-addition into the remaining enone.  This methodology was 
applicable to a number of cyclohexadienone and napthoquinone substrates.  Treatment 
of 1.166 with acid led to the isolation of furan product 1.167. 
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Scheme 1.31: (A) Parker's conjugate addition of malonate and (B) ketoester nucleophiles 
 
 Aubé and coworkers reported a similar conjugate addition of carbon 
nucleophiles into electron-deficient quinone monoketals 1.172 (Table 1.5).60  A number 
of nucleophiles were found to add in the presence of catalytic KOt-Bu.  The identity of 
the isolated products depended heavily on the nature of the nucleophile.  
Diethylmalonate led to immediate rearomatization of the unstable substrate, giving 
phenol 1.173.  Ethyl-3-nitropropionate resulted in only monoaddition, giving enol-
substrate 1.174.  The authors noted that the substrate was unstable to chromatographic 
purification; attempts at purification with silica gel led to the isolation of large quantities 
of rearomatized product.  In the presence of stoichiometric base, the resulting enolate 
1.177 could be trapped with MeI, giving enone 1.174 as the major diastereomers 
(Scheme 1.32A).  The use of ethyl acetoacetate and 2-nitroacetone both resulted in 
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isolation of the double-addition products 1.175 and 1.176 respectively.  The authors 
investigated the addition of various nucleophiles into other electron-deficient quinone 
monoketals to give a variety of phenols, mono-addition, and double-addition products 
(Scheme 1.32B).  
Table 1.5: Scope of Aubé's nucleophilic addition to electron deficient cyclohexadienone 
1.172 
 
Entry Nucleophile Product Yield (%) 
1 diethyl malonate 
 
74 
2 ethyl 3-nitro-
propionate 
 
ca. 100 
3 ethyl acetoacetate 
 
84 
4 2-nitroacetone 
 
52 
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Scheme 1.32: (A) One-pot nucleophilic addition/methylation; (B) Scope of 
cyclohexadienones for Aubé's nucleophilic addition 
 
Parker accomplished the double-addition of N-benzylidine glycine methyl ester 
into quinone monoketal 1.184.61  Treatment of 1.184 with 1.188 in the presence of NaH 
and 15-crown-5 gave isoindole 1.185.  Subsequent treatment with acid led to the 
isolation of phenol 1.186.  When the compounds were reacted with KOt-Bu in THF at 
low temperature followed by workup with NH4Cl, bicyclic 1.187 was isolated instead.   
Scheme 1.33: Parker's double addition of N-benzylidine glycine methyl ester 
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 In analogy to the work of Parker, Wang reported an asymmetric [3+2] 
cycloaddition of azo-methine ylides on 1.189 to give tricycle 1.191.62  A screen of 
catalyst conditions found AgOAc and ligand 1.131 to be the ideal catalyst.  The reaction 
could be extended to a variety of substitution patterns, allowing for the isolation of 
products with up to 5 stereocenters. 
Scheme 1.34: Wang's asymmetric [3+2] cycloaddition 
 
  Intramolecular conjugate additions into cyclohexadienones have also been 
reported.  In many cases, these conjugate additions involve enantioselective 
desymmetrization reactions due to the propensity of the intramolecular conjugate 
additions to occur diastereoselectively, simplifying desymmetrization efforts.  An early 
report came from the lab of Hayashi (1.35A).63  They performed an organocatalytic, 
enantioselective addition of cyclohexadienone aldehyde 1.192 to give cyclic substrate 
1.193.  A screen of catalysts found the trifluoroacetate salt 1.194 to be the ideal catalyst, 
giving 1.193 in very good yield, high diastereoselectivity, and up to 95% ee.  
Gaunt reported a similar one-pot dearomatization-Michael addition cascade 
(Scheme 1.35B).64  Phenol aldehyde 1.195 was treated with PIDA in the presence of 
proline-derived catalyst 1.197.  When methanol was used as the nucleophile, enone 
1.196 could be obtained in good yield with ee values of up to 99%. 
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Scheme 1.35: (A) Hiyashi's enantioselective conjugate addition; (B) Gaunt's enantioselective 
dearomatization-conjugate addition cascade 
 
 Harned reported the conjugate-addition of cyclohexadienone-tethered 
malonates promoted by weak bases (Scheme 1.36).65  When 1.198 was treated with 
Cs2CO3 in MeCN, bicycle 1.199 was obtained in good yield.  Further study found that 
asymmetrically-substituted substrates could be cyclized regioselectively, with 
conjugate addition into the more electron deficient enone being preferred.  Cyclization 
on methylated substrates occurred selectively opposite to the methyl group.  The 
regioselectivity was reversed for silylated and brominated substrates.  In the case of 
brominated substrates, the authors were surprised to isolate cyclopropane 1.203 as the 
sole product.  Further investigation revealed that the reaction occurs via an initial 
conjugate-addition followed by isomerization of the bromoketone.  Subsequent 
nucleophilic displacement by the malonate gives the cyclopropane.   
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Scheme 1.36: (A) Harned's regioselective malonate conjugate addition; (B) Formation of 
tricyclic cyclopropane 1.203 
 
 An enantioselective variant of the above reaction was also reported (Scheme 
1.37A).  Cinchona alkaloid-derived phase transfer catalysts 1.207 was screened in the 
reaction.  The reactions were found to proceed with moderate to good selectivity.  The 
reaction was tolerant of different substitution patterns on the substrate, though 
substrates with sterically demanding substituents resulted in higher ee values.  When 
the dibromide was used, cyclopropane 1.206 was obtained in high ee. 
You reported a similar conjugate addition of bis-sulfone 1.208 to form bicycle 
1.209 (Scheme 1.37B).66  A survey of catalysts found cinchona-derived urea 1.211 to 
be the ideal catalyst.  A variety of substrates were screened, giving sulfone products 
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1.209 and 1210 in good yields and ee.  The reaction could also be performed in a one-
pot manner from the phenol, giving 1.209 in 33% yield and 88% ee. 
Scheme 1.37: (A) Harned's enantioselective malonate conjugate addition; (B) You's                  
enantioselective bis-sulfone conjugate addition 
 
 1.2.2.c. Heteroatom Nucleophiles 
 Reports of intermolecular heteroatom conjugate additions are significantly 
rarer.  Rolán reported the conjugate addition of sodium methoxide into 1.89 (Scheme 
1.38).67  The addition resulted in a mixture of monoaddition product 1.212 and bis-
addition product 1.213.  Foster further studied the addition of heteroatom nucleophiles 
into 1.89.  When 1.89 was refluxed in methanol, mono-addition and bis-addition 
products were isolated in an 83:17 ratio of 1.212:1.213.  This ratio appears to reflect the 
thermodynamic product, as it did not change after extended reaction times.  Foster also 
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observed that morpholine added into 1.89 cleanly to give mono-addition product 
1.214.68  Cuifolini studied the scope of this amine addition reaction further.69  He found 
that the conjugate addition occurred regioselectively, with the nucleophile adding to the 
sterically less demanding enone of 1.216.  Numerous primary and secondary amines 
could be added to the substrate (Scheme 1.38B).   
Scheme 1.38: (A) Rolán's addition of sodium methoxide; (B) Foster and Cuifolini's reports of 
amine conjugate addition 
 
 Foster observed that thiol additions occur rapidly to give the bis-addition 
product 1.218 (Scheme 1.39A).68  In a later report, DeMarch found that mono-addition 
product 1.217 could be obtained using a catalytic amount of LiOH in CHCl3.
70  Wang 
reported an intriguing extension of this methodology (Scheme 1.39B).  When 
cyclohexadienone oxindole 1.219 was treated with a thiol in the presence of 
bifunctional thiourea catalyst 1.221, desymmetrized substrate 1.220 could be obtained 
in up to 95% ee.71   
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Scheme 1.39: (A) Foster's double thiol addition; (B) Wang's enantioselective thiol addition 
 
 Several authors have published related approaches to the desymmetrization of 
cyclohexadieones through the use of intramolecular oxa-or aza-Michael additions.  You 
reported an early example of the intramolecular cyclization of 1.22 to give 1.223 
catalyzed by phosphoric acid 1.224 (Scheme 1.40).72  You later published a follow up 
paper disclosing an analogous aza-Michael addition of 1.225 to give 1.226.73  In this 
case, thiourea 1.227 was the ideal catalyst.  Substrates could be synthesized in up to 
99% ee.  Rovis synthesized a series of 1,2,4-trioxane substrates through an 
acetalization-oxo-michael cascade sequence on peroxyquinol 1.2 to give 1.228.74  A 
screen of phosphoric acid catalysts found 1.229 to be ideal.  Substrates could be cyclized 
in up to 98% ee.  Ye was able to achieve a vast improvement in oxo-Michael additions 
to cyclohexadienones.75  He performed an oxo-Michael addition of 1.231 using highly 
simplified catalysts.  When (R,R)-DPEN was utilized as a catalyst along with N-Boc-L-
Pro as an additive, dioxane 1.232 could be obtained in up to 99% ee.  The enantiomer 
of 1.232 could be accessed using 1.234 as the catalyst instead.  The simplicity of these 
catalysts makes them a significant improvement over previous efforts. 
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Scheme 1.40: Examples of enantioselective heteroatom conjugate additions 
 
 1.2.3. Diels-Alder Cycloadditions 
 2,5-Cyclohexadienones also readily undergo Diels-Alder cycloadditions.  These 
reactions are often promoted by a Lewis acid such as Et2AlCl
76 or BF3·OEt2
77, though 
thermal conditions, particularly in the protic solvent CF3CH2OH are also known 
(Scheme 1.41).78  The reactions are known to occur in a highly stereoselective manner, 
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giving almost exclusively the endo product with the approach of the diene syn to the 
oxygen substituent. 
Scheme 1.41: Lewis-acid promoted Diels-Alder cycloadditions 
 
 A particularly useful application of cycloadditions on 2,5-cyclohexadienones 
has been reported by Winterfeldt (Scheme 1.42).79  The Diels-Alder cyclization of 
lactone 182 with chiral diene 1243 under high-pressure conditions led to adduct 1.239 
as a single diastereomer.  The resulting enantioenriched adduct was epoxidized to give 
1.240.  The chiral auxiliary could be removed by flash-vacuum pyrolysis yielding 
1.241, the result of a formal enantioselective epoxidation of 1.82.  This methodology 
has been extended to a variety of other substrates such as ether 1.79, though the retro-
Diels-Alder reaction was not attempted on this substrate.  A particularly striking aspect 
of this methodology is the extremely high syn diastereoselectivity observed in the 
cycloaddition.  Houk studied this effect computationally at the semi-empirical level.80  
The authors posited that the decreased steric demand of the oxygen-substituent relative 
to the alkyl substituent is primarily responsible for the observed level of selectivity. 
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Scheme 1.42: Cycloaddition and elaboration using chiral diene 1.243 
 
A more thorough study into the origin of the so-called “syn-oxygen effect” was 
undertaken by Ohkata and Paquette (Scheme 1.43).78  The authors attempted the 
cycloaddition of a number of cyclohexadienones with cyclopentadiene and spiro[2.4]-
hepta-4,6-diene.  The ratio of syn to anti adducts were studied.  In all cases, the syn 
adduct (1.245a) predominated, often with extremely high selectivity.  Oxygen 
substituents were confirmed to be necessary for achieving high selectivity.  The relative 
insensitivity of the selectivity to steric demands led the authors to further investigate 
this reaction computationally.  Computation at the Hartree-Fock level led the authors to 
conclude that other effects in addition to the steric demands proposed by Houk are 
operative.  Investigation of the frontier orbitals led to the hypothesis that approach syn 
to the oxygen minimizes unfavorable secondary orbital overlap.  Their computational 
results also give credence to a Cieplack-like model, in which hyperconjugative effects 
between the more electron-donating alkyl group and the developing anti-periplanar 
bond stabilizes the developing σ* in the transition state (TS1.1).   
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Scheme 1.43: Investigation into the “syn oxygen effect” in Diels-Alder reactions of                  
cyclohexadienones 
 
Corey has also reported an example of an enantioselective Diels-Alder 
desymmetrization reaction of quinone monoketals 1.246 (Scheme 1.44).81  When 1.246 
was treated with (E)-1,3-pentadiened the Mikami (S)-BINOL-Ti(IV) complex, product 
1.248 could be obtained in high yield and enantioselectivity.  A substrate with a more-
hindered acetal (1.247) was also well-tolerated as was substitution on the alkenes.  A 
wide variety of dienes also participated in the cycloaddition. 
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Scheme 1.44: Corey's enantioselective Diels-Alder cycloaddition 
 
 Liao has reported the intramolecular Diels-Alder cycloaddition of masked p-
benzoquinone ketals 1.253 (Scheme 1.45).82  Dearomatization of phenol 1.252 with 
PIDA in MeOH gave ketal 1.253 which spontaneously underwent an in situ 
cycloaddition to give tricyclic product 1.254 in good yield.  A limited investigation into 
the substrate scope found that some substitution was tolerated on both the phenol and 
the diene portion of the molecule.  In most cases, the expected endo products were 
obtained. 
Scheme 1.45: Liao's intramolecular Diels-Alder cycloaddition 
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Brückner reported a Delongchamps annulation of electron-deficient quinone 
monoketals 1.255a (Scheme 1.46).83  Monoketal 1.255a was treated with Nazarov 
reagent 1.256 in the presence of Cs2CO3.  The resulting product could be treated with 
acid to give diketone 1.258.  Several substituents on the Nazarov reagent were screened 
and resulted in moderate to good yields.  Dienone 1.255b, which possesses a conjugated 
ketone was also amenable to the cyclization. 
Scheme 1.46: Brückner's Delongchamps annulation 
 
1.2.4. Epoxidations 
 A number of groups have successfully engaged 2,5-cyclohexadienone 
substrates in epoxidation reactions.  The majority of examples utilize nucleophilic 
epoxidation methods.  Oxidizing agents include HOOH and t-BuOOH.  Bases such as 
K2CO3, KOH, KOt-Bu, and DBU have been used.  Carreño used this approach to 
transform dienone 1.259, which was obtained through his previously reported 
methodology, into epoxide 1.260.84 
 Porco has also reported an enantioselective epoxidation on cyclohexadienone 
systems (Scheme 1.47).85  The authors found that when TrOOH was used as the 
oxidizing agent in the presence of L-DIPT with n-BuLi as the base, epoxide 1.262a 
could be obtained in good ee.  To their surprise, when NaHMDS was used as the base 
instead, the opposite enantiomer was obtained.  The authors attributed this result to the 
differing stereochemical environments of the substrate-counterion complexes. 
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Scheme 1.47: (A) Representative cyclohexadienone epoxidations; (B) Porco's 
enantioselective cyclohexadienone epoxidation 
 
 
1.3. 2,5-Cyclohexadienones in Natural Product Synthesis 
 The ease with which 2,5-cyclohexadienones can be synthesized, along with the 
wide variety of reactions which they undergo has led them to be used in the synthesis 
of numerous natural products.  Many such synthetic strategies feature a late-stage 
dearomatization on a relatively complex substrate.  The use of 2,5-cyclohexadienones 
as building blocks early in a synthetic sequence is rarer.  Several examples of the early-
stage use of 2,5-cyclohexadienones will be highlighted below. 
 1.3.1. Rubiginones A and C 
 Carreño reported the synthesis of the antibiotic molecules rubiginones A2 and 
C2 (Scheme 1.48).
86  The authors utilized their aforementioned sulfoxide-directed 
trimethylaluminum addition to desymmetrize dienone 1.98.  Subsequent DIBAL-H 
reduction gave alcohol 1.263.  Oxidation to the sulfone followed by alcohol protection 
and sulfone elimination gave ketone 1.264.  The substrate could be further elaborated 
to diene 1.265.  A Diels-Alder reaction with 1.267 followed by aromatization under 
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photolytic conditions gave rubiginone C2 (1.266a), which could be readily converted to 
rubiginone A2 (1.266b). 
Scheme 1.48: Carreño's synthesis of rubiginones A and C 
 
 1.3.2. Desamino Huperzine A 
 Mulzer described the synthesis of the lycopodium alkaloid natural product 
desamino huperzine A (Scheme 1.49).87  The authors began their synthesis with 
quinone monoketal 1.157.  When 1.157 was treated with acetone dicarboxylate 
dimethyl ester, bridged-bicyclic product 1.268 could be obtained.  The material could 
be decarboxylated with LiOH to give 1.269.  Further elaboration gave ketonitrile 1.270, 
which could be cyclized to give the pyridine 1.271.  Deprotection and functional group 
manipulation gave the final desamino huperizine A product 1.272. 
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Scheme 1.49: Mulzer's synthesis of desamino huperizine A 
 
 1.3.3. Sorbicillactone A 
 Harned has utilized an intramolecular Michael addition (Scheme 1.50) in the 
synthesis of the marine natural product sorbicillactone A (1.276).88  The TMS ether of 
phenol 1.273 was dearomatized with PIDA to give cyclohexadienone 1.274.  
Installation of the malonate side-chain followed by cyclization and in situ methylation 
gave lactone 1.199d as a 6.1:1 ratio of diastereomers.  Though the desired diastereomer 
was the minor isomer, enough material could be isolated to complete the synthesis.  The 
amide side-chain was installed through a sequence involving a key Curtius 
rearrangement to give amide 1.275.  Installation of the final side-chain followed by 
deprotection gave the natural product 1.276. 
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Scheme 1.50: Harned's synthesis of sorbicillactone A 
 
 
1.4 Conclusion 
In conclusion, 2,5-cyclohexadienones are a class of substrates that can be easily 
accessed by a variety of methods.  In particular, their ready availability from a wide 
variety of phenols through oxidative dearomatization greatly increases the potential of 
these molecules.  Despite their relative simplicity, the molecules undergo a wide variety 
of reactions with many different substrates.  It is often possible to achieve high regio- 
and stereoselectivity as well, enabling rapid construction of molecular complexity.  
However, their use as building blocks in natural product synthesis is still relatively 
sparse.  Further examples, as well as an expanded arsenal of available reactions will 
increase their synthetic utility.  In future chapters, we will report the use 2,5-
cyclohexadienones as a launching point in the synthesis of the briarane diterpenoids.  In 
the course of our studies, we utilized the impressive array of reactions which 2,5-
cyclohexadienones are known to undergo to evaluate several different routes.  Our 
efforts also took advantage of the often extremely high degree of stereoselectivity 
observed to set key stereocenters.  The versatility and ease of access associated with 
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2,5-cyclohexadienones enabled a highly efficient synthesis of a complex fragment of 
the briarane diterpenoids. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Chapter 2: The briarane diterpenoids                                                               | 55 
 
Chapter 2 
The Briarane Diterpenoids:            
Isolation, Bioactivity & Synthetic 
Approaches 
2.1 Marine Gorgonians and the Briarane Diterpenoids 
 2.1.1 Taxonomy & Natural Product Distribution 
 The marine gorgonians represent a diverse set of octocoral marine organisms which 
dominate coral reefs throughout the world.  While their taxonomy has been a subject of 
significant study, their precise identification has often been difficult.89 The gorgonians can 
be further divided into three orders; Scleraxonia, Holaxonia, and Calaxonia.  Among these 
suborders, multiple families and genuses exist for each.  As a result of the abundance of 
such corals, combined with their wide geographic distribution, the gorgonians have been a 
fruitful area of study for natural products chemists.   
 Diterpenoids represent one of the more important classes of natural products which 
have been isolated from gorgonian sources.  As of 2009, Kerr has noted 40 different 
diterpenoid skeletal structures isolated from gorgonians.89  Figure 2.1 shows the nine most 
common skeletal structures, along with their taxonomic distribution among the gorgonian 
family.  In fact, the chemical makeup of a particular gorgonian sample can often aid as a 
taxonomic marker in gorgonian classsification.90     
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Figure 2.1: (A) Eight most common diterpenoid skeletons isolated from gorgonians;                
(B) Distribution of natural products across the gorgonian familyi 
 
 2.1.2 Overview of the Briarane Diterpenoids 
 The briarane skeletal system represents one of the more common natural product 
families that have been isolated from the gorgonian octocorals.  Briarane-type diterpenoids 
have been isolated from both the Scleraxonia and Calaxonia suborders, but not the 
                                                          
i Image from Nat. Prod. Rep., 2009, 26, 681-710. 
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Holaxonia suborder.  The family Briareidae (suborder Scleraxonia) is by far the most 
plentiful source of briarane diterpenoid compounds.  In addition to gorgonian sources, 
Briaranes have also been found in non-gorgonian sources such as sea-pen corals and 
nudibranchs. 
 The briarane skeleton (Scheme 2.1) consists of a trans-fused 
bicyclo[8.4.0]tetradecane ring system.  Most members also possess a γ-lactone comprising 
the C7-C8-C17-C19 carbons.  Another common feature is a congested set of four, 
contiguous stereogenic centers comprising C1-C2-C10-C14.  Oxidative processing by the 
organism can install oxygenation at nearly every other carbon in the system. 
 The briaranes are hypothesized to be biosynthetically derived from the cembrane 
skeleton, which is another commonly found skeletal structure in marine gorgonian species, 
through cyclization between C3 and C8 followed by oxidative processing.  However, to 
date, no biosynthetic studies have been published.91  
Scheme 2.1: Proposed biosynthesis of the briarane skeleton 
 
2.2. Isolation and Bioactivities of Select Briarane Diterpenoids 
 The wide distribution of gorgonian corals has led to the isolation of an extremely 
large number of briarane-type diterpenoids.  To date, over 600 unique briarane diterpenoids 
have been characterized.91, 92  Several examples have also been reported from non-
gorgonian sources such as the sea pansy R. reniformis,93 the sea pen octocoral S. 
tentaculatum,94, and the Mediterranean nudibranch mollusk Armina maculata.95  Some of 
the key briarane diterpenoid families, along with their relevant bioactivity will be discussed 
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below.  Emphasis will be given to families which either display potent biological activity 
or possess a large number of family members. 
 2.2.1. Briaranes from Briareum abestinum 
 Briareum abestinum is a species of gorgonian octocoral found throughout the 
Caribbean.  In 1977, Cierezco and coworkers isolated the first known briarane diterpenoid 
briarein A (2.1a, Figure 2.2) from this source.96  The structure of briarein A was identified 
through the use of x-ray crystallography.  Later work by Cóbar and coworkers further 
confirmed the structure, as well as the structures of briareins B-L through the use of 
extensive 2D NMR spectroscopy.97  Key features of the briareins include the presence of a 
tertiary oxygen (hydroxyl or acetate) at C11 and a secondary cis alcohol at C12.  The 
briareins also contain either a C3-C4 double-bond or epoxide.  Briareins A-E & G contain 
an exocyclic C5-C16 double bond and a C6-Cl.  The remaining briareins contain an 
endocyclic C5-C6 double bond, which likely arises from singlet-oxygen induced 
rearrangement.  To date, no biological activity of the briareins has been reported. 
Figure 2.2: Select members of the briarein family 
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 Briareum abestinum has also been the source of a particularly unique class of 
briarane diterpenoids known as the briareolate esters (Figure 2.3).  These family members 
are noteworthy in that they possess a C19 methyl ester instead of the more common C7-
C8-C17-C19 lactone moiety.   The first such example, briareolate ester A (2.2a), was 
discovered by Tinto and coworkers from a sample collected off the coast of Tobago.98  
Further isolation studies led to the discovery of related briareolate esters B-K, though the 
C7-C8 double bond geometry of briareolate ester G (2.2e) could not be assigned at the 
time.99  Many of the family members were found to possess weak activity against brine 
shrimp. 
 Some years later, West isolated additional members of the briareolate ester family 
from a sample collected off the coast of Florida.  Most noteworthy among these family 
members was briareolate ester L (2.2h).100  Like briareolate ester G (2.2e), briareolate ester 
L was found to possess an α, β, γ δ unsaturated C9 ketone, though the 1H NMR signals for 
the alkene signified a different geometry than that of the isomeric briareolate ester G.  A 
2D ROESY experiment identified H7 correlations with H2 and H10, indicating that the H7 
proton was placed inside the ring, suggesting a Z configuration at the C5-C6 double bond.  
From this information, the authors also assigned the configuration of the C5-C6 double 
bond in 2.2e to be E.  West would later report the isolation of briareolate esters J & K.101 
 Some members of the briareolate ester family were found to possess activity against 
the human embryonic stem cell (hSEC) line BG02 and the pancreatic cancer cell line 
BxPC-3.  Briareolate ester L (2.2h) was found to possess potent activity against both cell 
lines (Table 2.1).  Interestingly, the double bond isomer 2.2e was found to display no 
inhibitory activity against either cell-line.  Briareolate ester M (2.2i) was also found to 
display some activity, though the activity was much lower than that observed for 2.2h.  The 
other briareolate esters screened by West displayed either little or nonexistent activity 
against either cell line. 
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Figure 2.3: Select members of the briareolate ester family 
 
Table 2.1: Cytotoxicity of the briareolate esters 
Entry Briareolate Ester EC50 BG02 (μM) EC50 BxPC-3 (μM) 
1 B (2.2b) >40 >40 
2 C (2.2d) >40 >40 
3 G (2.2e) >20 >20 
4 J (2.2f) >40 N/Aa 
5 K (2.2g) 40 N/Aa 
6 L (2.2h) 2.4 9.3 
7 M (2.2l) 8.0 13.0 
8 N (2.2c) >40 >40 
   a. No data reported 
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West and coworkers were intrigued by the significant activity of 2.2h over related 
family members.  They hypothesized that this increased activity was due to the 
conformation of the E,Z dienone in 2.2h.  A shorter UV absorption maximum for 2.2h over 
the double-bond isomer 2.2e (284 and 288 nm respectively) suggested that 2.2h might be 
less conjugated, making the dienone ‘spring loaded’ for attack by a Michael donor.  B3LYP 
calculations revealed the Z,Z-dienone to be approximately 29 kcal/mol more stable that the 
E,Z,-isomer 
They investigated this hypothesis by treating 2.2h with a variety of nucleophiles 
(Scheme 2.2). When 2.2h was treated with thiophenol in methanol-d4, 2.2h reacted to form 
Michael adduct 2.3 in 5 minutes.  Compound 2.2h also reacted with cysteine methyl ester, 
though the reaction was significantly slower, and DMAP was required.  Neither Michael 
adduct could be isolated, and experiments with nitrogen and oxygen-based nucleophiles 
failed.  Performing an analogous experiment on 2.2e resulted in no in nucleophilic addition, 
further confirming their hypothesis. 
Scheme 2.2: Nucleophilic additions into briareolate ester L 
 
 2.2.2. Briaranes from Briareum excavatum 
Briareum excavatum is a species of gorgonian coral found in regions of the South 
Pacific such as Taiwan, Indonesia, and Australia.  The species has been a fruitful source of 
bioactive diterpenoids of both the excavatolide and the briaexcavatolide families.102  A few 
members of the brianthein family have also been isolated.103  The excavatolides and 
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briaexcavatolides are a large family of natural products with potent biological activity 
(Figure 2.4).  Over thirty members of these compounds have been isolated.  The members 
do not possess a C11-C12 double bond, though there is significant variation in other 
structural details such as the extent and placement of unsaturation, extent of oxygenation, 
and the presence or absence of an epoxide or chloride.  Many of the family members have 
been screened for biological activity and have been found to be toxic against various cancer 
cell lines (Table 2.2).  Some of the more potent members of the excavatolide and 
briaexcavatolide family include excavatolides C, E, K, M, and briaexcavatolide P. 
Figure 2.4: Select members of the excavatolide and briaexcavatolide families 
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Table 2.2: Cytotoxicity of the excavatolides 
Entry 
Compound IC50 (P-
388) 
(μg/mL) 
IC50 (KB) 
(μg/mL) 
IC50 (A-
549) 
(μg/mL) 
IC50 (HT-
29) 
(μg/mL) 
1 excavatolide C 
(2.4a) 
0.3 1.9 1.9 1.9 
2 excavatolide E 
(2.4b) 
1.6 0.8 1.2 1.6 
3 excavatolide K 
(2.4c) 
0.9 3.3 3.0 1.3 
4 excavatolide M 
(2.4d) 
0.001 1.0 0.1 2.2 
5 briaexcavatolide P 
(2.4e) 
0.9 N/Aa 4.8 3.1 
a. No data reported 
A few cytotoxic members of the brianthein family (briantheins A-C) have also been 
isolated from briareum excavatum.103  Some, but not all, of the briantheins possess 
unsaturation at the C8-C17 and C11-C12 positions.  Briantheins A-C were found to possess 
growth inhibition against the KB 3-1 and the multidrug resistant KB-C2 cell lines (Table 
2.3). 
 
Table 2.3: Growth inhibition by brianthein A-C 
Entry Compound Dose 
(µg/mL) 
Growth Inhibition (%) 
KB 3-1 KB-C2 
1 brianthein A 
(2.5a) 
10 27 ± 5 84 ± 3 
3 11 ± 6 60 ± 2 
2 brianthein B 
(2.5b) 
10 26 ± 4 37 ± 6 
3 5 ± 1 26 ± 4 
3 brianthein C 
(2.5c) 
10 17 ± 6 15 ± 2 
3 11 ± 1 0 ± 0 
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2.2.3. Briaranes from Briareum polyanthes 
Additional members of the brianthein family were isolated from the gorgonian 
Briareum polyanthes, found in the eastern end of the Bermuda archipelago (Figure 2.5).104, 
105  Of the compounds isolated, Brianthein W (2.5d) stands out as one of the simplest 
briaranes isolated to date.  Evaluation of 2.5d against the P-388, KB, A-549, and HT-29 
cell lines showed ED50 values of 0.76, >50, >50, >50 μg/mL respectively.  Interestingly, 
brianthein W was also isolated from the luminescent sea pen coral Funiculina 
quadrangularis in the Vada and Capraia Islands in the Ligurian Sea.104  Briantheins X-Z 
were also isolated from Briareum polyanthes and displayed varied activities.  Brianthein 
Y (2.5f) was found to exhibit viral inhibition against the mouse corona virus assay at a 
concentration of 400 µg/mL.  Brianthein Z (2.5g) exhibited stronger antiviral inhibition at 
80 µg/mL.  Brianthein Z also displayed activity against the herpes-simplex virus at 80 
µg/mL and cytotoxicity against the P-388 cell line at a concentration of 10 µg/mL.106 
Figure 2.5: Select members of the brianthein family 
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2.2.4. Briaranes from Briareum stechi 
Briareum stechi is a species of gorgonian that is found in the shallow waters of the 
Great Barrier Reef.  It has been the source of several classes of briarane diterpenoids.  The 
stecholides are a class of highly oxygenated compounds isolated from Briareum stechi 
(Figure 2.6).107  Some examples such as stecholides A, B, and H have been found to display 
activity against the P-388 cancer cell-line (Table 2.4). 
Figure 2.6: Select members of the stecholide family 
 
Table 2.4: Cytotoxicity of the stecholides 
Entry Compound 
ED50 (P-388) 
(μg/mL) 
1 stecholide A 
(2.6a) 45 
2 stecholide B 
(2.6b) 5.4 
3 stecholide H 
(2.6c) 10 
2.2.5. Briaranes from Briareum spp. 
A number of bioactive briarane diterpenoids were collected from a gorgonian in 
Palau which was originally identified to be Pachyclavularia violaea.  Examination of its 
chemical makeup led to the revision of its order to be an unidentified member of the 
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Briareum order Briareum spp.  From this sample a number of solenolides (solenolide A-F) 
were isolated (Figure 2.7).108  They were found to affect a reduction of edema at a 
concentration range of 15 μg.  Some family members also possess antiviral activity.   
Figure 2.7: Select members of the solenolide family 
 
A number of briareolides were isolated from Briareum sp (Figure 2.8).109 Briareolides 
were reported to display moderate anti-inflammatory activity in a mouse ear assay.  A 
number of violides were also isolated from Briareum sp.110 The violides all possess a C13-
C14 double bond.  Several members were found to have biological activity against the 
Vero and MDCK cell lines (Table 2.5).  Some of the violides also possess rare C2-C3-C4 
oxygenation. Violides K & L (2.10k&l) are the only known briarane-type diterpenoids 
found to possess 5 hydroxyl groups. 
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Figure 2.8: Select members of the brianolide, briareolide and violide families 
 
 
 
2.2.6. Briaranes from other marine organisms 
While briarane diterpenoids are most commonly found in gorgonian sources, they 
have also been isolated from other marine organisms.  The funicolides (A-E) were isolated 
from the luminescent sea pen Funiculina quadranglaris (Figure 2.9).111  The family 
members possess the same substitution pattern, and vary only in oxygen substituents and 
the substitution at C7.  Brianthein W, which is simply the C9 oxidized version of the 
funicolides, was isolated as well.104  No biological data has been reported for the 
funicolides. 
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Table 2.5: Cytotoxicity of the violides 
Entry Product CC50 (Vero) 
(μg/mL) 
CC50 (MDCK) 
(μg/mL) 
1 violide A (2.10a) 1.90 1.90 
2 violide B (2.10b) -- -- 
3 violide C (2.10c) 1.69 1.67 
4 violide D (2.10d) 2.53 3.57 
5 violide E (2.10e) 3.65 4.69 
6 violide F (2.10f) 3.93 4.03 
7 violide G (2.10g) 9.37 11.7 
8 violide H (2.10h) 0.85 0.85 
9 violide I (2.10i) 1.41 1.30 
10 violide J (2.10j) >100 >100 
11 violide K (2.10k) >100 >100 
12 violide L (2.10l) >100 >100 
The renillafoulins (A-C) were isolated from the sea pansy Renilla reniformis.93, 112  
these compounds were found to inhibit the settlement of barnacle larvae with varying 
degrees of potency.  Briaranes have also been isolated from a limited number of non-coral 
organisms.  The verecynamins were isolated from extracts of the nudibranch mollusk 
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Armina maculata, though it is possible that the source of the compound is from the 
nudibranch’s diet, as the same compounds were isolated from the sea-pen coral Veretillum 
cynomouium which is a part of the Armina maculata’s diet.95, 113  Unlike most briaranes, 
the verecynarmins possess a furan instead of the more common lactone.   
Figure 2.9: Select members of the funicolide, renillafoulin and verecynarmin families 
 
2.3. Previous Synthetic Approaches to the Briarane Diterpenoids 
 Despite the wide structural diversity and potent biological activity associated with 
the briaranes, relatively little synthetic effort has been expended in their synthesis.  Only a 
few groups have reported synthetic progress towards any member of the briaranes.  To 
date, no completed total syntheses have been reported; a fact that illustrates the significant 
challenge which the briarane diterpenoids pose. While early reports focus on the synthesis 
of various small or highly simplified fragments of the briaranes, including the ten-
membered ring and various stereogenic elements, later reports focus on the formation of 
the C1-C2-C10-C14 stereotetrad core.  Previous reported efforts toward the briarane 
diterpenoids will be presented in chronological order. 
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 2.3.1. Procter’s Synthesis of Briarane 10-Membered Ring of Solenolide F 
 2.3.1.a. Motivation & Retrosynthesis 
 Procter published the first synthetic approach to a portion of the briaranes.114  The 
authors targeted Solenolide F (2.7f, Figure 2.7), which was isolated from the Indopacific 
gorgonian Solenopodium sp.  Their efforts focused specifically on the efficient formation 
of the ten-membered ring from a substrate that already contained the six-membered ring.  
Bicycle 2.14 was selected as their initial synthetic target, which would be formed through 
a CrII-mediated cyclization of vinyl-iodide 2.15 (Scheme 2.3).  Compound 2.15 could be 
obtained through the connection of three components 2.16, 2.17, and 2.18.  Ketal 2.17 
could undergo organometallic conjugate-addition into enone 2.16.  The resulting enolate 
would then intercept sulfoxide 2.18. 
Scheme 2.3: Procter's retrosynthesis of a solenolide F model system 
 
2.3.1.b. Synthesis of the Ten-Membered Ring 
The authors began by investigating the organometallic addition of Grignard reagent 
2.19 into enone 2.16 (Scheme 2.4).  They found that the conjugate addition proceeded well 
in the presence of a catalytic amount of CuI, but it was necessary to trap the resulting 
enolate as silyl-enol ether 2.20 in order to perform the desired conjugate addition.  
Compound 2.20 could be converted to the lithium enolate by treatment with MeLi followed 
by conjugate addition into 2.18.  After elimination, ketone 2.21 could be obtained in good 
overall yield as a 1:1 mixture of diastereomers.  The ketone and ester moieties in the 
product were reduced with LiAlH4 and the ketal protecting group was removed to give 
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allylic alcohol 2.22.  The allylic alcohol was selectively protected as a TBS-ether and the 
resulting diastereomers 2.23a&b could be separated chromatographically.  The relative 
stereochemistry of 2.23a&b was assigned on the basis of coupling-constant analysis.   
Scheme 2.4: Synthesis of diastereomeric alcohols 2.24a & 2.24b 
 
The authors hypothesized that 2.28 would more readily undergo the required 
cyclization due to the trans-diaxial conformation of 2.28, which would position the 
reacting groups far from each other (Scheme 2.5).  The secondary alcohol of 2.25 was 
converted to a methyl ether and ketone 2.26 was converted to vinyl iodide 2.27 through a 
Takai olefination, giving a 1:1 mixture of inseparable E and Z isomers.  Subsequent 
removal of the TBS-ether followed by allylic oxidation gave the cyclization precursor 2.28.  
After optimization, the authors found that cyclized product 2.29 could be obtained, though 
in low yield, by using a massive excess (200 equivalents) of CrCl2 in DMSO.  Despite their 
best efforts, substantial amounts of uncylized, deiodinated compound 2.30 was also 
isolated.  The authors hypothesized that this product likely results from deiodination of the 
unreactive E-vinyl iodide.  As the product was obtained as a 1:1 mixture of diastereomers, 
the authors performed an allylic oxidation of the substrate to give cross-conjugated ketone 
2.31 in order to simplify spectral analysis.  While they were able to successfully form the 
10-membered ring, the poor diastereoselectivity as well as the use of an extremely large 
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amount of toxic, expensive CrCl2 makes this route intractable towards further optimization.  
No further studies by the Procter lab have since been reported. 
Scheme 2.5: Cyclization of a briarane analogue 
 
2.3.2. Nantz’s Synthesis of Two Fragments of Solenolide F 
 2.3.2.a. Motivation and Retrosynthesis 
 Nantz and coworkers sought to develop a method to synthesize the 10-membered 
ring portion (2.32) of Solenolide F (2.7f) in a highly convergent fashion (Scheme 2.6).115  
They hoped to forge the ten-membered ring through a McMurray coupling of dialdehyde 
2.33.  Inspired by the presence of oxygenation α-to the methyl-containing quaternary 
carbons at C1 and C17, they hypothesized that the skeleton could be broken into three 
fragments, two of which contain the aforementioned quaternary centers.  These two 
fragments could be connected through a C4-C6 fragment capable of undergoing 
nucleophilic addition at both ends (referred to by the authors as a ‘propyne equivalent’). 
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 The authors proposed epoxide 2.34 (Fragment A) and acetal 2.36 (Fragment B) as 
the key fragments to target.  The presence of oxygenation next to the methylated, 
quaternary centers led Nantz to consider regioselective epoxide opening with a methyl 
anion equivalent as a viable method to form both fragments.  Fragment B (2.36) could be 
made through the known addition of a methyl-group into epoxide 2.37 at the less-hindered 
position.  The formation of fragment A (2.34) would be more challenging, as it would 
necessitate the addition of the methyl group into the fully-substituted carbon of epoxide 
2.35; a transformation which had not been previously reported.  Both epoxides 2.35 and 
2.37 could be derived from the diol 2.38. 
Scheme 2.6: Nantz's retrosynthesis of solenolide F 
 
 2.3.2.b. Synthesis of Diol Precursor 2.42a&b 
 The authors began by synthesizing the diol precursor to both 2.34 and 2.36 (Scheme 
2.7).  Commercially available 1,3-dihydroxyacetone was acetylated to give the bis-acetate.  
The resulting ketone was converted to triester 2.40 by means of a HWE olefination.  
Cleavage of the acetate protecting groups under acidic conditions led to spontaneous 
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lactonization.  The lactone was benzylated to give 2.41 in good yield.  The lactone was 
reduced with DIBAL-H followed by mono-silylation of the resulting diol.  After a survey 
of protecting groups, the authors found that the DTS (dimethylthexylsilyl) protecting group 
led selectively to mono-silylated products 2.42a&b which could be chromatographically 
separated and used in subsequent reaction.  Compound 2.42a was used to form fragment 
A and 2.42b was used to form fragment B. 
Scheme 2.7: Synthesis of regioisomeric fragments 2.42a & 2.42b 
 
 2.3.2.c. Synthesis of Fragment A 
Prior to performing the epoxide-opening of fragment 2.42a, the authors 
investigated a similar reaction on a number of model substrates (Scheme 2.8).  Epoxide 
opening of substrate 2.43 with trimethylaluminum proceeded to give desired 2.44 as the 
major product, with diol 2.45, which results from a 1,2 alkyl migration, as a minor product.  
Use of bulkier, benzyl-protected epoxide 2.46 led to 2.47 as the major product, with the 
desired 2.48 as a minor product.  Vinyl epoxide 2.49 resulted primarily in the isolation of 
SN2’ product 2.50 along with the alkyl-migration product 2.51.  Encouragingly, propargylic 
epoxide 2.52 provided the desired product 2.53 as the major product.  The alkyne could 
then be potentially converted to a vinyl group if similar reactivity patterns were observed 
in the actual synthesis. 
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Scheme 2.8: Model studies of epoxide opening 
 
 Having observed promising reactivity in model systems, the authors sought to 
synthesize fragment A from alcohol 2.42a (Scheme 2.9).  Compound 2.42a was subjected 
to a Sharpless asymmetric expoxidation to give epoxide 2.55 in good yield with an 
enantiomeric purity of 90% (as determined by Mosher’s method).  The primary alcohol 
was oxidized under Swern conditions and subjected to Wittig olefination to give vinyl 
epoxide 2.35 after silyl-group removal.  
 The authors were pleased to discover that the addition of trimethylaluminum into 
epoxide 2.35 proceeded to give the desired diol 2.56 as the major product, with products 
2.57 and 2.58 formed as side products in a (1.0:0.3:0.2) ratio.  Unlike the case of model 
substrate 2.49, it appeared that the bulkier, benzyl-protected group in 2.35 discouraged 
SN2’ addition.  They also hypothesize that the adjacent π-system served to enhance the 
addition at C3 relative to migrating-group participation.  The resulting product 2.56 was 
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methylated followed by treatment with KOH to form epoxide fragment A (2.34) in 25% 
yield from 2.56. 
Scheme 2.9: Synthesis of "Fragment A" (2.34) 
 
 2.3.2.d. Synthesis of Fragment B 
 The synthesis of fragment B (2.36) began by performing an analogous Sharpless 
asymmetric epoxidation on substrate 2.42b, to give epoxide 2.37 in 86% yield and 92% ee 
(as assigned by Mosher’s method) (Scheme 2.10).  A methyl group was added into the less 
hindered carbon of the epoxide using Me2CuLi in Et2O.  The resulting diol was protected 
as an acetonide (2.59).  The benzyl protecting group was removed with Li in NH3, followed 
by Swern oxidation to give 2.36 (Fragment B) in good yield.  In summary, the Nantz group 
was able to furnish the two quaternary carbon-containing fragments that could be used in 
the synthesis of Solenolide F.  However, no further work towards solenlide F or any other 
briarane targets using this approach has been reported. 
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Scheme 2.10: Synthesis of "Fragment B" (2.36) 
 
 2.3.3. Ito & Iguchi’s Synthesis of the Stereotetrad Core of Pachyclavulide B 
 2.3.3.a. Motivation & Retrosynthesis 
 Pachuclavulide B (2.60) is a briarane-type diterpenoid isolated by the Iguchi lab 
from the Okinawan soft coral Pachyclavularia violacaea (Scheme 2.11).116  The 
compound was found to exhibit growth-inhibitory activity against the SNB-75 central-
nervous system cancer cell line.  Ito and Iguchi identified core structure 2.61 as an ideal 
initial synthetic goal.117  This stereotetrad core possesses the six-membered ring, along with 
four contiguous C1-C2-C10-C14 stereocenters that are commonly found in the briaranes 
and could be easily converted to many family members.  In examining this potential 
substructure, the authors identified latent symmetry within the molecule which they hoped 
to exploit.  To that end, they postulated that 2.61 could come from epoxide 2.62.  
Compound 2.62 could in turn be made through a desymmetrizing epoxidiation of achiral 
diene 2.63, which is itself available from the birch reduction of 2,6,-methylbenzoic acid. 
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Scheme 2.11: Ito/Iguchi's retrosynthesis of pachyclavulide B 
 
 3.3.3.b. Synthesis of Briarane Stereotetrad 2.61 
 The authors began their synthesis by performing the Birch reduction of 2,6-
dimethylbenzoic acid using Na in NH3 followed by conversion to methyl ester 2.63 
(Scheme 2.12).  After optimization, it was found that the ideal epoxidation conditions 
employed a stoichiometric amount of ᴅ-sorbose-derived catalyst 2.69 with oxone as the 
oxidant.  Under these conditions, epoxide 2.62 could be obtained in 44% yield with 81% 
de and 87% ee.  The ester in 2.62 was reduced with DIBAL-H followed by protection of 
the alcohol to give silyl-ether 2.65.  The enantiopurity could be further improved at this 
stage through recrystallization.  Epoxide 2.65 was converted to allylic alcohol 2.66 by 
treatment with Et2AlTMP.  The alcohol was treated with NIS and ethyl vinyl ether to give 
iodide 2.67 in good yield.  Attempts to cyclize 2.67 using Bu3SnH were met with mediocre 
results.  The desired cyclized acetal 2.68 could only be obtained in a disappointing 32% 
yield, along with deiodinated products and 6-endo cyclized products.  Nevertheless, the 
authors elected to carry the material forward. 
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Scheme 2.12: Synthesis of acetal 2.68 
 
 Acetal 2.68 was oxidized to the lactone using Jones’ reagent to give 2.70 (Scheme 
2.13).  At this point, the authors encountered difficulty achieving the desired α-
hydroxylation.  They speculated that the bulky TBDPS group prevented the reaction from 
occurring.  When the silyl ether was removed, hydroxylation with Davis’ oxaziridine 
proceeded smoothly to give lactone 2.71 after reinstallation of the TBDPS ether.  Lactone 
2.71 was reduced with LiAlH4 followed by oxidative cleavage with NaIO4 to give aldehyde 
2.72.  Addition of vinylmagnesium bromide led to the isolation of diol 2.61 in quantitative 
yield as a single diastereomer.  The authors were able to confirm that the stereochemistry 
through NOE correlations (Scheme 2.13B) of the resulting acetonide.  They postulated that 
coordination of the free hydroxyl group at C14 with Mg leads to rigid metallobicycle, in 
which one face of the aldehyde is effectively blocked by the TBDBS group, leading to 
selective addition of the Grignard reagent from the Si face (Scheme 2.13C).  In summary, 
Ito and Iguchi were able to afford the stereotetrad core of the briarane diterpenoids in 
enantioenriched form in 18 steps from starting material, though no further synthetic efforts 
have been reported. 
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Scheme 2.13: (A) Synthesis of briarane stereotetrad 2.61; (B) Rationalization of stereoselective 
Grignard addition 
 
 2.3.4.  Bates’ Synthesis of the Briarane Stereotetrad 
 2.3.4.a.  Motivation & Retrosynthesis 
 As in the previous report by Ito and Iguchi, Bates identified stereotetrad core 2.74 
(referred to by the authors as the ‘northern hemisphere’) of the briaranes to be a key 
synthetic target (Scheme 2.14).118  Their approach to the stereotetrad core hinged on the 
setting the stereocenter at C1 through a sigmatropic rearrangement, and the formation of 
the six-membered ring 2.75 through a crotonate Diels-Alder reaction using sulfonyl diene 
2.76 and methyl crotonate. 
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Scheme 2.14: Bates' retrosynthesis of brianthein W 
 
 2.3.4.b.  Synthesis of the Briarane Stereotetrad 
 The authors began by synthesizing the sulfonyl diene 2.76 (Scheme 2.15).  Crotyl 
chloride and sodium p-toluenesulfinate were combined under phase-transfer conditions to 
give sulfone 2.79.  Sulfone 2.79 was then treated with n-BuLi followed by the addition of 
formaldehyde to give alcohol 2.80.  Elimination of the alcohol was affected using MsCl 
and excess NEt3.  The resulting diene 2.81 was observed to dimerise spontaneously to give 
cyclohexene 2.84 when stored in neat form.  As such, the diene was kept as a solution in 
DCM and stored at cryogenic temperatures.   
 When diene 2.81 was reacted with methyl crotonate in the presence of AlCl3, the 
Diels-Alder adduct 2.82 was obtained.  Extended reaction times (7 days) were necessary 
to achieve high conversions.  A related sulfoxide diene was also evaluated in the Diels-
Alder reaction.  However, the sulfoxide was not used as the reaction proceeded even more 
slowly and gave an intractable mixture of diastereomers due to the additional stereogenic 
center at sulfur.  The ester in 2.82 was reduced with DIBAL-H to give alcohol 2.83.  The 
relative stereochemistry of 2.83 was confirmed by X-ray crystallography.   
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Scheme 2.15: Synthesis of Diels-Alder adduct 2.83 
 
 The authors found the removal of the sulfone to be quite challenging.  A number of 
oxidative methods were evaluated with little success.  It was discovered that the sulfone 
2.83 could be isomerized by heating in MeOH in the presence of NaOH (Scheme 2.16).  
The resulting allylic-sulfone was protected as the TBS ether 2.86, and the sulfone was 
oxidatively removed by treatment with LDA and MoOPD to give enone 2.87 along with a 
small amount of over-oxidized products. 
 The carbonyl moiety was reduced under Luche conditions to give equatorial alcohol 
2.88.  The authors found the allylic alcohol to be resistant to numerous sigmatropic 
rearrangement conditions.  After extensive screening, they found that an Eschenmoser-
Claisen rearrangement could be performed successfully.  Treatment of the allylic alcohol 
2.88 with dimethylacetamide dimethylacetal in xylene under microwave irradiation gave 
the desired rearranged product 2.89 in acceptable yield.  This material was treated with I2 
in wet THF to perform an iodolactonization reaction to afford iodide 2.90, which 
underwent elimination with DBU.  α-Oxygenation of the lactone with LiHMDS and 
MoOPD gave lactone-alcohol 2.91.  Unfortunately, compound 2.91 possessed the opposite 
relative stereochemistry of the natural products.  The stereochemistry was inverted through 
a two-step sequence involving oxidation with IBX followed by reduction of the ketone 
with NaBH4 to give the isomer 2.92.  Reduction with LiAlH4 gave triol 2.93.  The primary 
alcohol could be selectively converted to an iodide by treatment with I2 and PPh3.  The 
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remainder of the side-chain was installed through a Keck allylation to give the briarane 
stereotetrad 2.74 in 16 steps, though no further progress has been reported. 
Scheme 2.16: Synthesis of briarane stereotetrad 2.74 
 
 2.3.5. Crimmins’ Ireand-Claisen Approach to Brianthein A 
 2.3.5.a.  Motivation & Retrosynthesis 
 In the course of their studies on the dianionic Ireland-Claisen rearrangement, 
Crimmins found that substrates such as 2.98 could be furnished through treatment of 2.99 
with LiHMDS in toluene/THF (Scheme 2.17).119  The authors proposed to utilize this facile 
reaction to set three of the four contiguous stereocenters present in the briarane natural 
product brianthein A (2.5a).  Their retrosynthetic plan involved the formation of brianthein 
A from bicyclic core 2.95.  This in turn would be made from the cyclohexene 2.96 which 
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could come from ring-closing metathesis on substrate 2.79.  Substrate 2.97 in turn would 
be the result of the aforementioned dianionic Ireland-Claisen rearrangement of substrate 
2.98.  The authors expected the rearrangement to proceed through chair-like transition state 
TS2.1A which is favored over TS2.1B.   
Scheme 2.17: (A) Crimmins' retrosynthesis of brianthein A; (B) Stereochemical rationalization 
for dianionic Ireland-Claisen rearrangement 
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2.3.5.b.  Synthesis of the Ireland-Claisen Product 2.98. 
 The authors began with oxazolidineone 2.101, which was stereoselectively 
alkylated followed by auxiliary removal with NaBH4 to give alcohol 2.102 (Scheme 2.18).  
Oxidation of compound 2.102 under Swern conditions gave aldehyde 2.13 which was 
reacted with N-proplthiazolidenthione under aldol conditions to give adduct 2.104 in a 
stereoselective fashion.  Compound 2.105 was converted to the Ireland-Claisen precursor 
2.105 by treatment of 2.104 with alcohol 2.106 under basic conditions.  Treatment of 2.105 
with LiHMDS followed by methylation with CH2N2 gave the product 2.98 as a single 
diastereomer in good yield.  The elaboration of this product into brianthein A is currently 
under investigation. 
Scheme 2.18: Ireland-Claisen rearrangement to form briarane precursor 2.98 
 
2.4 Conclusion 
In conclusion, the briarane diterpenoids are an intriguing class of substrates isolated 
from coral sources from around the world.  While their diverse, and often quite potent, 
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biological activity makes them prime targets for synthesis, little synthetic effort has been 
reported.  Early work utilized highly inefficient and toxic reagents to form a key ring.  Other 
early attempts only furnished very small pieces of the briaranes, and no further reports of 
their use exist.  Later work shifted from the ten-membered ring to the C1-C2-C10-C14 
stereotetrad.  To date, work by Ito/Iguchi and Bates require extended reaction sequences to 
forge the stereotetrad, potentially diminishing the utility of their routes in accessing full 
briarane structures.  Crimmins’ work is a significant improvement, forming three of the 
four stereocenters of the stereotetrad in rapid fashion.  However, their route still requires 
the forging of two ring systems plus functional group manipulation to complete the 
synthesis.  Thus, there is still significant room for the improvement of synthetic routes to 
access the briaranes. 
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Chapter 3 
Bicyclic Approaches to the  
Briarane Diterpenoids 
3.1 The Stereotetrad Core as a Key Synthetic Intermediate 
 Inspired by the work of Ito/Iguchi117 and Bates118, we identified briarane 
stereotetrad fragment 3.5 as our initial target en route to the briarane diterpenoids (Scheme 
3.1).  This fragment contains the congested C1-C2-C10-C14 stereotetrad that presents a 
significant challenge for any synthetic approach to the briaranes.  We believed that a viable 
route to this core structure will be useful as a common launching point in the synthesis of 
numerous briarane family members as well as non-natural analogues.   
 We selected brianthein W (3.1) as our initial target due to its relative simplicity.  A 
successful route to brianthein W could be modified at later stages to access other members 
of the briarane family.  Brianthein W would come from 3.2 after deprotection and 
acylation.  The butenolide in 3.2 would be installed through the oxidation and HWE 
olefination of bicycle 3.3.  The ten-membered ring could come from the ring-closing 
metathesis of 3.4.120  The allyl ketone fragment in 3.4 would be installed through a Grignard 
addition into Weinreb amide 3.5, which contains the key structural components of the 
aforementioned briarane stereotetrad. 
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Scheme 3.1: Retrosynthesis of brianthein W to the briarane stereotetrad 
 
3.2  Initial Synthetic Approach 
 3.2.1. Nucleophilic Cyclopropane Opening 
 Our initial strategy sought to overcome some of the challenges that our group 
encountered in previous investigations related to the briaranes.ii  Previous attempts to 
methylate bicyclic lactone 3.6 proceeded in low yields and low conversion (Scheme 3.2).  
Subsequent attempts at an aldol addition also failed to produce the desired adducts (3.9).  
It was our hope that milder aldol conditions would overcome the inherent instability of 
these substrates and allow for product formation. 
                                                          
ii Work performed by Kyle Kalstabakken 
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Scheme 3.2: Previous efforts towards the briaranes 
 
3.2.2.  Initial Retrosynthetic Proposal 
Our initial retrosynthetic proposal involved the formation of the C14 carbinol 
through a stereoselective reduction.  The trisubstituted double-bond of 3.5 could be 
produced via a zinc-mediated reductive cleavage of the C11 lactone in 3.10.121  We planned 
to set the all-carbon quaternary center at C1 through a sulfone Reformatsky reaction of 
methylated β-ketosulfone 3.11 (Scheme 3.3A).  Mild methylation conditions could be used 
to access 3.11 due to the increased acidity of the ketosulfone.  It was our hope that the use 
of milder conditions would allow the methylation to be performed in improved yield.  
Sulfone 3.11 could be obtained through nucleophilic addition of a sulfur-based nucleophile 
into known cyclopropane 3.12 followed by decarboxylation and methylation.65  We 
expected the cyclopropane to be electrophilic at C1 due to the high strain in the tricyclic 
system along with the stabilized anion that would result from such an addition (Scheme 
3.3A).122, 123  
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Scheme 3.3: Initial retrosynthetic proposal of the briarane stereotetrad 3.5 
 
To affect the key sulfone Reformatsky reaction, β-ketosulfone 3.11 would be 
treated with a suitable single-electron reducing agent such as SmI2 (Scheme 3.4B).
124  After 
initial reduction of either the sulfone or the enone, the system would fragment into the p-
toluenesulfinate anion and α-keto radical 3.17.  Reduction by a second equivalent of SmI2 
would give the samarium enolate 3.18 that will undergo an aldol-type addition with an 
aldehyde, present in the reaction mixture, to give the desired product 3.10.  We hoped that 
the generation of the enolate under such mild conditions, and in the presence of the 
aldehyde, would minimize competitive rearomatization reactions that have we have 
observed in similar systems.   
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Scheme 3.4: (A) Proposed cyclopropane opening; (B) Proposed sulfone-Reformatsky reaction  
 
 3.2.3.  Enantioselective Oxidative Dearomatization Studies 
 Phenol 3.14 was synthesized on the 10+ gram scale by a known procedure.125  With 
phenol 3.14 in hand, we evaluated the catalytic, oxidative dearomatization of 3.14.  A 
variety of aryl-iodide catalysts were screened using m-CPBA as the terminal oxidant 
(Table 3.1) and H2O as the nucleophile.  Iodobenzene and 4-iodotoluene produced quinol 
3.19 in acceptable yield.  4-Iodoanisole and 4-iodobiphenyl gave lower yields.  
Surprisingly, converting the phenol to the TMS-ether11 prior to dearomatization resulted in 
no isolation of product.  We decided to use iodotoluene as the optimum catalyst due to the 
high reaction yield and ease of handling the solid reagent. 
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Table 3.1: Optimization of catalytic dearomatization conditions 
 
Entry Catalyst Yield (%) 
1 iodobenzene 57 
2 4-iodotoluene 58 
3 4-iodoanisole 36 
4 4-iodobiphenyl 37 
5 4-iodotoluenea N/R 
a. Phenol 3.14 was converted to the TMS ether before reaction 
 We recognized that the unsymmetrical nature of phenol 3.3 generates a new 
stereogenic carbon upon dearomatization.  A suitable chiral catalyst would enable the 
synthesis of enantioenriched quinol 3.19 and thus lead to enantioenriched Brianthein W.  
Our lab developed a series of tartrate-derived catalysts that were able to furnish compound 
3.19 in up to 35% ee (Section 1.1.4).27  While these results clearly demonstrate the potential 
to synthesize 3.19 in an enantioselective manner, further improvement is needed to obtain 
synthetically viable selectivity.  We briefly investigated other potential catalyst 
substructures in order to identify new lead structures for future optimization.  In order to 
maximize the potential for later optimization, we targeted structures that were readily 
amenable to library synthesis and screening. 
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We began by evaluating a series of iodoaryl oxazolines which are similar to those 
that have been used by Birman in enantioselective Iodine(V) oxidations.26  A series of 
amides (3.21a&b) were synthesized from the respective acid-chloride and amino-acid 
derived amino alcohols (Scheme 3.5).  Subsequent cyclization gave oxazolines 3.22a&b 
in acceptable yield.  We were encouraged to find that oxazolines 3.22a&b resulted in some, 
albeit extremely low, selectivity (Table 3.2).  Tetrafluoroborate salts 3.23a&b led to 
slightly higher selectivity.126  We also investigated camphor-derived oxazoline 3.26, which 
again resulted in low selectivity.127  A catalyst derived from naphthalene-based iodoacid 
3.29 gave little improvement.128  
Scheme 3.5: Synthesis of oxazoline catalysts 
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Table 3.2: Oxazoline catalysts in enantioselective dearomatization 
 
Entry Compound ee (%) 
1 3.22a 7 
2 3.22b 2 
3 3.23a 8 
4 3.23b 5 
5 3.26 7 
6 3.29 6 
While the above results showed potential, altering the structure of the oxazoline 
catalysts resulted in only minor changes in selectivity, casting doubt on whether significant 
improvement was possible using this catalyst substructure.  We turned our attention instead 
to other substructures in hopes of locating a more promising catalyst.   
Curran reported the use of configurationally stable iodine-substituted N-aryl amides 
in radical reactions.129  To our knowledge, the use of this class of substrates as catalyst 
motifs has not been reported.  The ease with which these structures can be synthesized 
inspired us to synthesize amides 3.31a&b for evaluation (Scheme 3.6).  The enantiomers 
could be resolved using chiral HPLC.  Preliminary resolutions for screening purposes were 
performed on very small scale using repeated injections of the substrate onto an analytical-
scale HPLC column.  If a promising catalyst was found, subsequent resolutions could be 
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performed using preparative or semi-preparative HPLC conditions.  When we evaluated 
compounds 3.31a&b in the dearomatization of 3.19, low selectivity was again observed 
(Table 3.3).   
 We hoped that better selectivity could be achieved if the stereochemical 
arrangement of the substituents on the amide was reversed, with the sterically bulky portion 
of the catalyst being directly bonded to the nitrogen and the sterically small portion of the 
catalyst bonded to the carbonyl.  However, despite repeated attempts, we were unable to 
synthesize catalyst 3.32a.  An analogous trifluoroacetate substrate 3.32b could be prepared, 
though we were unable to separate the enantiomers by HPLC.  It is unclear at this time 
whether 3.32b is configurationally unstable or simply unable to be separated using our 
HPLC columns.  Recent renewed interest in these structures has shown that substrate 3.33iii 
provides the quinol in an encouraging 11% ee.  Work is underway in our lab to further 
investigate this promising result. 
                                                          
iii Work performed by Dr. Andrew Harned 
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Scheme 3.6: Synthesis of iodoamide catalysts 
 
 
Table 3.3: Iodoamide catalysts in enantioselective dearomatizations 
Entry Catalyst ee (%) 
1 3.31a 5 
2 3.31b 6 
3 3.33 11 
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 The final substructure that we investigated drew inspiration from the work of Kita 
(Section 1.1.3).130   While their µ-oxo-bridged diiodide catalyst 1.66 performs excellently 
in ortho dearomatization reactions to give 2,4-cyclohexadienones, its preparation is quite 
lengthy and the substrate must be resolved via HPLC prior to use.  As such, it is not easily 
amenable to modification.  We decided to target diiodides 3.35–3.47 as similar, though 
significantly easier to access, analogues.  These structures have the advantage of being 
available in a minimum number of steps from known and commercially available chiral 
diamines and diols.  It was our hope that the more rigid, bridged diiodide structure (Figure 
3.1) would restrict the number of available conformations, leading to higher selectivity.  
Bridging oxygen atoms have also been shown to be beneficial for increasing 
dearomatization yields.14 
Figure 3.1: Proposed bridging structure 
 
We began by synthesizing bis-amide 3.55iv.  While the conversion and yield for the 
dearomatization using catalyst 3.55 was very low, a small amount of quinol 3.19 could be 
isolated in a promising 8% ee (Scheme 3.7).  To our delight, both the yield and selectivity 
increased significantly when 3.55 was methylated (3.56a).  Inspired by this significant 
improvement, we sought to evaluate the effect of different N-substituents on the selectivity.  
All bis-tertiary amides displayed extremely broad 1H NMR spectra, which precluded any 
spectral interpretation.  The identity of the catalyst could be confirmed instead by mass 
spectrometry.  The selectivity did not change significantly when benzylated substrate 3.58b 
was utilized.  Pentafluorobenzyl catalyst 3.56c gave lower selectivity (Table 3.4).   
Switching from a trans-cyclohexanediamine backbone to a DPEN backbone (3.39a&b) 
                                                          
iv Work performed with the assistance of Eve Yang 
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led to improved selectivity.  The BINAM backbone (3.41a&b) resulted in significantly 
diminished selectivity.  Bis-pyrrolidine catalyst 3.43 also gave reasonably promising 
results, though this substructure is not as easily modified.  The presence of an amide in the 
catalyst was confirmed to be important; when dimethltartrate-derived catalyst 3.45 or 
BINOL-derived catalyst 3.47 were screened, significantly diminished selectivity was 
observed.   
These bis-amide catalysts showed great promise in the enantioselective para-
dearomatization of phenols with external nucleophiles.  At this point, multiple questions 
regarding these catalysts still remain.  It is unclear whether the system adopts the proposed 
bridging structure or if the selectivity is simply due to the sterically congested nature of the 
catalysts.  Work is ongoing to determine the exact nature of the active catalyst structure, as 
well as to further optimize the dearomatization selectivity. 
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Scheme 3.7: Synthesis of bis-amide catalysts 
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Table 3.4: Bis-amide catalysts in enantioselective dearomatization 
 
Entry Catalyst ee (%) 
1 3.37 8 
2 3.38a 15 
3 3.38b 16 
4 3.38c 6 
5 3.41a 20 
6 3.41b 4 
7 3.43a 2 
8 3.43b 3 
9 3.45 17 
10 3.47 4 
11 3.49 5 
 
3.2.4. Synthesis of the Sulfone-Reformatsky Precursor 
After briefly investigating the potential for forming 3.19 enantioselectively, we 
elected to move forward with the synthesis of racemic 3.12 (Scheme 3.8) with hopes of 
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revisiting this problem once a viable route had been determined. Racemic quinolv 3.19 was 
esterified using DCC and DMAP to furnish malonate ester 3.13.  Treatment of 3.13 with 
two equivalents of K2CO3 led to direct formation of cyclopropane 3.12 by way of presumed 
intermediate lactone 3.48.  The cyclopropane was found to be highly unstable to silica-gel 
chromatography.  However, filtration of the reaction mixture through a plug of florisil 
furnished the cyclopropane in nearly quantitative yield and with high purity.  Once isolated, 
the highly strained molecule was stable indefinitely in the freezer. 
Scheme 3.8: Synthesis of cyclopropane 3.12 
 
With cyclopropane 3.12 in hand, we began to investigate conditions for the 
proposed nucleophilic cyclopropane opening.  To our surprise, treating cyclopropane 3.12 
with p-toluenethiol in acetonitrile at 50 °C cleanly gave the conjugate-addition product 
3.50 in 60% yield with no observed cyclopropane opening (Scheme 3.9).  Changing the 
reaction time, temperature, solvent, or the addition of a Lewis acid did not alter the result.  
We decided to turn instead to the harder nucleophile sodium p-toluenesulfinate.  Treatment 
of 3.12 with sodium p-toluenesulfinate at 75 °C in DMF gave the desired 3.49 as the sole 
product.  The reaction could be slightly improved by adding an excess of the nucleophile 
along with a catalytic amount of NiClO4·6H2O.
123  We observed a significant discrepancy 
between the crude yield of 3.49 and the yield after silica-gel chromatography.  The use of 
stationary phases other than silica gel did not improve this result.  As the crude product 
was satisfactorily clean by 1H NMR spectroscopy, we elected to avoid chromatographic 
                                                          
v Unless otherwise stated, all compounds were synthesized in racemic form.  All specified stereochemistry 
is relative, not absolute. 
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purification entirely and carry the crude material forward directly.  This change improved 
the isolated yield of 3.51 from 50% to 78%. 
Scheme 3.9: Nucleophile addition to cyclopropane 3.12 
 
 Sulfone 3.49 was decarboxylated to give 3.51 through a procedure involving the 
cleavage of the tert-butyl ester with TFA followed by decarboxylation with NEt3 in THF 
(Scheme 3.10).  Significant material loss was again observed upon attempted 
chromatographic purification.  As the crude material was again sufficiently clean, we again 
elected to carry the material forward into the subsequent methylation step without further 
purification.   
Scheme 3.10: Elaboration to the sulfone-Reformatsky precursor 3.11 
 
 Our initial attempts to methylate sulfone 3.51 produced the desired methylated 
product 3.11 as an inconsequential mixture of diastereomers in 24% yield.  Along with 
3.11, we also isolated a large amount of an unidentified side-product.  Examination of the 
crude 1H NMR spectrum revealed that the product existed as a 5.2:1 mixture of 
diastereomers, and the combined diastereomeric products were formed in a 2:1 ratio with 
the side-product.  In light of previous observations, we hypothesized that the lower yields 
could be due in part to material loss during chromatographic purification.  We decided to 
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find conditions such that the side-product was formed in sufficiently small quantities as to 
allow direct use of the crude material in the key sulfone Reformatsky reaction. 
 While we were able to isolate a very small amount of the undesired side-product, 
various impurities co-eluted, complicating 1H NMR analysis.  Examination of the side-
product by mass spectrometry revealed it to be an isomer of 3.11.  We proposed compounds 
3.55 and 3.56 as plausible structures of the side-product (Scheme 3.11).  Both of these 
structures are consistent with the observed 1H NMR spectrum, which contained a 
distinctive singlet in the alkene region of the 1H NMR spectrum at 6.07 ppm.  Compound 
3.55 could be formed via base-promoted elimination of the sulfone followed by addition 
of the resulting sulfinate anion into the other alkene with subsequent methylation (Scheme 
3.11, Path A).  Alternatively, compound 3.56 could be formed via a retro-Michael reaction 
followed by Michael addition into the opposite enone with subsequent methylation 
(Scheme 3.11, Path B).  While we did not make any effort to determine the exact identity 
of the side-product, we were optimistic that the proper choice of base and solvent 
conditions would minimize the formation of the undesired side-product. 
Scheme 3.11: Possible mechanisms for side-product formation 
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 We screened a variety of bases and solvents in the reaction (Table 3.5).  A brief 
survey of bases revealed little effect on the ratio of products to side-product.  We turned 
instead to a survey of solvents.  Because of its low price and availability, we elected to use 
K2CO3 as the base for the solvent screening.  Several polar, aprotic solvents were screened.  
The nature of the solvent appeared to exert some influence on the diastereomer ratio of the 
methylated products, though this change was inconsequential as the stereocenter at C1 
would be ablated in the subsequent sulfone Reformatsky reaction.  None of the polar, 
aprotic solvents that were screened improved the ratio of products to side-products to 
synthetically useful levels.  However, when the reaction was performed in the toluene with 
a catalytic amount of 18-crown-6, the ratio of methylated products to side product 
increased to an encouraging 7.5:1 (with a concomitant increase in the dr).  Switching the 
solvent to DCM or using BTEA-Cl as the phase transfer catalyst resulted in no reaction.  
We found that we could improve the ratio of products further to 9.1:1 by using only 1.2 
equivalents of K2CO3.  It is likely that the nonpolar nature of the solvent decreases the 
amount of base present in solution, which in turn decreases the rate of side-product 
formation.  The less-coordinated 18-crown-6-complexed potassium counterion also likely 
increases the nucleophilicity of the enolate, increasing the rate of methylation relative to 
side-product formation.   We decided to use these conditions as the optimum conditions to 
synthesize the sulfone Reformatsky precursor. 
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Table 3.5: Optimization of methylation conditions 
 
 
Entry Base Solvent Additive Products:Side-
Product 
dr 
1 K2CO3 MeCN -- 2.0:1 5.0:1 
2 Cs2CO3 MeCN -- 2.2:1 4.7:1 
3 NaH THF -- decomp decomp 
4 KF.H2O DMF -- 3.1:1 5.4:1 
5 Na2CO3 DMF -- 3.3:1 5.7:1 
6 KOH DMF -- mixture mixture 
7 K2CO3 DMF -- 3.1:1 7.7:1 
8 K2CO3 DMF HMPA 3.0:1 11.2:1 
9 K2CO3 Acetone -- 2.1:1 8.0:1 
10 Cs2CO3 Acetone -- 2.2:1 7.1:1 
11 K2CO3 Acetone 18-cr-6 2.5:1 4.7:1 
12 K2CO3 DMSO -- 3.5:1 6.9:1 
13 K2CO3 Toluene 18-cr-6 7.:1 10.5:1 
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14 K2CO3
a Toluene 18-cr-6 9.1:1 16.2:1 
15 K2CO3 DCM 18-cr-6 mixture mixture 
16 K2CO3 Toluene BTEA-Cl NR NR 
a. 1.2 eq. K2CO3 
3.2.5.  Evaluation of the Sulfone Reformatsky Reaction 
 3.2.5.a.  Evaluation of a Model Substrate 
 As we were optimizing the methylation conditions, we investigated model substrate 
3.62 in order to study the proposed sulfone Reformatsky reaction (Figure 3.12).  
Compound 3.60 could be synthesized by brominating cyclohexanone with NBS and 
NH4OAc to give 3.60 in excellent yield.
123  Displacement of the bromine with sodium p-
toluenesulfinate followed by methylation gave the model substrate 3.62 in good yield.   
Scheme 3.12: Synthesis of model substrate 
 
 Investigation into the SmI2 promoted sulfone Reformatksy reaction revealed that 
the reaction was highly sensitive to temperature and the order of addition (Table 3.6).  
Adding the substrate and aldehyde to SmI2 led to a complex mixture of products.  Use of 
the SmI2/HMPA complex did not improve the results.  If the order of addition was reversed 
such that the SmI2 was added to a concentrated solution of the aldehyde and ketone, a 
complex and inseparable mixture of products were isolated (Figure 3.2). Investigation of 
the products by mass spectrometry revealed that the observed products were the result of 
various pinacol-type additions between 3.62, itself, and hydrocinnimaldehyde.  
Reformatsky product 3.63 could be obtained in low yield when the temperature was 
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lowered to −78 °C.  Use of a large excess (5 eq.) of aldehyde gave sulfone Reformatsky 
product 3.63 in acceptable yield as a ~19:1 mixture of unassigned diastereomers. 
Table 3.6: Optimization of model sulfone-Reformatsky reaction 
 
Entry Conditions Temperature (°C) Result 
1 SmI2
ac 0  mixture  
2 SmI2/HMPA
ac 0 decomp. 
3 SmI2
bce 0 side product 
4 SmI2
bc −78 °C 32% 
5 SmI2
bd −78 °C 66% 
a. Substrate added to SmI2; b. SmI2 added to substrate; c.1.5 eq. aldehyde; d. 5.0 eq. aldehyde; 
e.See figure 3.2. 
Figure 3.2: Possible pinacol and aldol-type products 
 
 3.2.5.b Evaluation of the cyclohexadienone-derived substrate  
When 3.11 was subjected to the optimized reaction conditions, no reaction was 
observed (Table 3.7).  Performing the reaction at 0 °C led to a complex mixture of products 
that could not be chromatographically separated.  Though carbinol signals in the 1H NMR 
spectrum indicated the possible formation of aldol-like products, mass spectrometry 
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showed no evidence of the desired product 3.10.  The observed masses corresponded 
instead to a mixture of pinacol-type coupling products between the aldehyde and the keto-
sulfone.  We hypothesized that the low solubility of 3.11 in THF could be preventing 
effective reaction.  However, using MeCN as the solvent did not improve the reaction.  
Other reducing agents including Zn, Mg, and photocatalytic conditions were also 
evaluated.  In all cases, either no reaction or decomposition was observed.    
While we were able to achieve the sulfone Reformatsky reaction in simplified 
systems, the reaction was not amenable to the synthesis of briarane intermediate 3.5.  Low 
substrate solubilities at cryogenic temperatures could have precluded initial reduction, 
leading to the reisolation of starting material.  In cases where higher temperatures were 
used, the enone moiety is likely more readily reduced than the sulfone, leading to 
preferential pinacol coupling products instead of undergoing the desired sulfone 
fragmentation.  At this point, we turned our attention from our proposed sulfone 
Reformatsky reaction and focused on other potential methods to form the key stereocenter 
at C1. 
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Table 3.7: Sulfone-Reformatsky studies on 3.11 
 
Entry Reductant Temperature 
(°C) 
Solvent Additive Result 
1 SmI2 −78 THF -- NR 
2 SmI2 rt THF -- Pinacol 
Products 
3 SmI2 0 MeCN -- NR 
4 SmI2 0 MeCN HMPA NR 
5 Zn rt THF/MeCN BrCH2CH2Br NR 
6 Mg rt MeOH -- NR 
7 Bu3SnH reflux toluene AIBN NR 
8 Ru(bipy)3(PF6) 
hν 
rt DCM CuTC NR 
9 Ru(bipy)3(PF6) 
hν 
rt DCM CuI NR 
10 Ir(ppy)3 rt DMF DIPEA/HCO2H decomp. 
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3.3. Second Synthetic Approach 
 3.3.1. Second Retrosynthetic Proposal 
In formulating a new strategy, we reconsidered some of the assumptions which had 
guided our previous efforts.  We speculated that the C11-C12 alkene could be formed 
through dehydration of intermediate 3.67 instead of the previously proposed Zn-mediated 
reductive cleavage (Scheme 3.13).  The hydrogenated substrate 3.71 would be more 
resistant to rearomatization which would enable the use of harsher conditions to perform 
the key aldol-type addition.  The amide bond would be installed directly from 3.68 through 
a Weinreb amidation.131  The key stereocenter at C1 could be forged through either a 
Mukaiyama aldol reaction from silyl-enol ether 3.69, or a Reformatsky reaction from α-
bromoketone 3.70.  Both 3.69 and 3.70 could be obtained from bicyclic lactone 3.71.  In 
order to form lactone 3.71 through the conjugate addition of a tethered malonate, the 
regioselectivity of the conjugate addition would need to be reversed in order to direct the 
addition into the more-hindered enone.  This reversal could be accomplished by first 
protecting the less-hindered enone as compound 3.72.  Removal of the protecting group 
after the desired conjugate addition would give the result of a formal conjugate addition 
into the more hindered enone of 3.73.   Both Diels-Alder adduct and sulfide conjugate 
addition-based protecting groups would be evaluated for their relative ease of installation 
and removal.  Compound 3.72 could be synthesized from 3.73 through protection and 
esterification of cyclohexadienone quinol 3.73. 
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Scheme 3.13: Second retrosynthetic proposal 
 
3.3.2.  Studies Utilizing a Diels-Alder Adduct as a Protecting Group 
We selected a cyclopentadiene Diels-Alder adduct as the first protecting group to 
evaluate.  Cyclopentadiene is known to perform cycloadditions with 2,5-
cyclohexadienones with high stereo- and regioselectivity (Section 1.2.3).77, 78  Diels-Alder 
cycloaddition of 3.73 promoted by BF3·OEt2 cleanly gave adduct 3.74 as a single 
diastereomers (Scheme 3.14).  We were able to confirm the relative stereochemistry of 
3.74 as endo through NOE correlations.  Unfortunately, attempts to install the malonate 
side-chain on this highly hindered substrate were unsuccessful.   
  
Chapter 3: Bicyclic Approaches to the briaranes                               | 112 
 
Scheme 3.14: Initial Diels-Alder studies 
 
We then attempted the Diels-Alder reaction on substrate 3.77 which already 
possesses the malonate ester (Scheme 3.15).  When 3.77 was subjected to the previous 
Diels-Alder conditions, the desired adduct 3.78 could be formed, though in modest yield.  
Performing the Diels-Alder reaction under thermal conditions in trifluoroethanol 
significantly improved the yield, once again giving the product as a single diastereomer.  
With malonate 3.78 in hand, we were pleased to find that the desired lactone 3.78 could be 
obtained in 97% yield by heating 3.75 in MeCN with K2CO3.  Unfortunately, attempts to 
perform the retro Diels-Alder reaction were met with rearomatization, giving phenol 3.79 
instead of the desired product.  This propensity for rearomatization is presumably due to 
the thermal instability of the lactone.  Use of additives in the retro Diels-Alder reaction 
such as maleic anhydride did not improve the results. 
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Scheme 3.15: Evaluation of the Diels-Alder protecting group 
 
 
3.3.3.  Studies Utilizing a Sulfide as a Protecting Group 
3.3.3.a.  Initial Studies and Optimization 
We then decided to consider other protecting groups that could be removed under 
milder conditions.  Sulfides, which are known to facilely undergo retro-conjugate additions 
would be an ideal candidate (Section 1.2.2.c).  The addition should occur with the desired 
regiochemistry and the sulfide could be removed under mild, basic conditions after the 
lactone is forged.   
We selected p-toluenethiol as the nucleophilie due to its ease of handling and 
relatively manageable odor.  When quinol 3.73 was treated with p-toluenethiol and 
stoichiometric triethylamine, the desired mono-addition product 3.80 was formed along 
with the double-addition product 3.81 in a 10:1 ratio (Table 3.8).  The mono-addition 
product could be isolated chromatographically in 64% yield.  The yield, though not the 
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product ratio, could be improved by switching the solvent to THF.  Lowering the 
temperature to 0 °C resulted in a significantly decreased yield, though the ratio of mono to 
double-addition products increased.  A less polar solvent such as toluene resulted in good 
yield, but a slightly lower ratio of products.  To our delight, the ratio increased to almost 
50:1 when a base such as DABCO was used in catalytic quantities.  Switching the base to 
quinine gave higher yield with a similarly good ratio of products.   
Table 3.8: Optimization of sulfide addition 
 
Entry Base 
(eq.) 
 
Solvent 3.80:3.81 Yield 3.80 
(%) 
1 NEt3 (2) DCM 10:1 65 
2 NEt3 (2) THF 11:1 75 
3 NEt3 (2) THF 20:1 35 
4 NEt3 (2) toluene 8:1 70 
5 DABCO toluene 48:1 63 
6 quinine toluene 56:1 71 
 
3.3.3.b.  Kinetic Resolution of Quinols 
After observing the success of the sulfide conjugate addition when catalytic 
quantities of quinine were used as a base, we wondered if a chiral base such as quinine 
could be used to accomplish a kinetic resolution of 2,5-cyclohexadienones.132  The reaction 
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could easily be run to incomplete conversion by controlling the stoichiometry of the 
sulfide, providing either enantioenriched sulfide 3.80 or quinol 3.73 after chromatographic 
purification (Table 3.9).  As current methods to access quinols such as 3.73 in 
enantioenriched form through enantioselective oxidative dearomatization are not yet 
synthetically useful (Section 1.1.4), kinetic resolution might be a viable alternative to 
obtain enantioenriched 3.73. 
We were able to determine HPLC conditions that could resolve the enantiomers of 
both the starting material and product in a single run.  To our delight, when the reaction 
was conducted with quinine as the catalyst to approximately 60% conversion (determined 
by 1H NMR spectroscopy), the resulting quinol could be obtained in 27% ee.  Because it 
gave slightly better results, (-)-cinchonidine was selected as the catalyst for further 
screening.  A survey of solvents found toluene to be optimal.  The krel value decreased 
slightly when the reaction was warmed to room temperature.  Running the reaction at 
cryogenic temperatures resulted in an even lower krel and an extremely sluggish reaction.  
This change in krel is possibly due to the highly decreased solubility of the catalyst at lower 
temperatures, leading to different catalyst aggregation states. 
A series of known or commercially available organocatalysts were screened in the 
resolution (Table 3.10).133, 134  Other cinchona alkaloids did not significantly improve the 
selectivity.  Increasing the steric bulk (3.84)135 or restricting the conformational flexibility 
(3.85)136 were also ineffective.  The dimer (DHQD)2Pyr (3.90) did not give significant 
selectivity.133   The krel values could be significantly improved when bifunctional, thiourea 
catalysts were used (3.86-3.88).  To date, Takemoto’s catalyst137 (3.88) has given the best 
result, though significant improvement is still necessary; krel values of upwards of 50 are 
usually necessary to obtain synthetically useful enantioenrichment of the product.132  
Future work will focus on the synthesis of other catalyst substructures known to facilitate 
enantioselective thio-Michael addition reactions on cyclic enone substrates (Section 
1.2.2.c).71  
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Table 3.9: Optimization of sulfide-addition kinetic resolution 
 
Entry Solvent Temp    
(o C) 
Conversion 
(%) 
Sulfide 
ee (%) 
Quinol 
ee (%) 
krel* 
1 DCM 0 33.3 8.4 4.2 1.23 
2 CHCl3 0 31.0 −1.8 2.8 1.04 
3 CCl4 0 43.8 10.6 7.8 1.33 
4 THF 0 25.4 −8.4 −2.4 1.21 
5 Et2O 0 40.8 0 1.2 1.0 
6 trifluorotoluene 0 42.2 6.6 4.3 1.19 
7 toluene 0 41.0 17.0 12.1 1.57 
8 toluene 22 35.5 16.2 8.4 1.50 
9 toluene −50 38.3 14.2 5.2 1.44 
* krel determined based on the conversion and ee of the sulfide product 
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Table 3.10: Catalyst screening in sulfide-addition kinetic resolution 
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Table 3.10 Continued: 
Entry Catalyst Conversion 
(%)a 
Sulfide ee 
(%)b 
Quinol ee 
(%)b 
krelc 
1 3.85 37.1 29.6 17.7 2.17 
2 3.86 41.9 −33.2 −22.0 2.49 
3 3.87 39.8 17.8 11.4 1.60 
4 3.88 27.0 −3.6 0.0 1.09 
5 3.89 50.2 −56.6 −43.8 6.28 
6 3.90 40.1 −62.2 −37.2 6.50 
7 3.91 40.6 64.4 45.4 7.05 
8 3.92 37.0 18.7 12.7 1.62 
a. Determined by 1H NMR spectroscopy of crude product; b. Determined by chiral HPLC; c. krel 
determined from conversion and ee of sulfide product 3.80 
3.3.3.c.  Elaboration to the Mukaiyama and Reformatsky Precursors 
With racemic sulfide 3.80 in hand, we set out to prepare the precursor for the key 
aldol-type reaction at C1.  When we attempted to prepare the malonate ester as before 
(DCC/DMAP), we were disappointed to find that the reaction only proceeded to low 
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conversion, even after extended reaction times (Table 3.11).  This observation is not 
surprising given the highly hindered nature of the sulfide-flanked tertiary alcohol.  When 
we attempted the sulfide addition into malonate 3.72, a mixture the desired 3.90 as well as 
the product resulting from the addition of the malonate chain resulted. As such, alternative 
esterification conditions were screened.  The acid-chloride of monoethyl malonate 
produced complex reaction mixtures, though some product (3.90) could be isolated.  The 
yield could be increased by adding the acid-chloride slowly to a solution of the alcohol and 
2,6-lutidine.  When the half-ester was first converted to the mixed anhydride with TFAA 
and subsequently treated with 3.80 in DME, 3.90 could be obtained in quantitative yield.65   
Table 3.11: Survey of esterification conditions 
 
Entry X Conditions Yield 
1 OH DCC, DMAP, DCM, rt decomp. 
2 Cl 2,6-lutidine, DCM, rt 48% 
3 OCOCF3 DME, rt quant. 
To our surprise, when 3.90 was treated with NaH, lactone 3.91 was isolated 
(Scheme 3.16A).  This product is the result of conjugate addition into the enone with 
concomitant sulfide elimination.  As the sulfide elimination was the next step in our 
intended synthetic sequence, this was a welcome discovery.  Using DBU as a base resulted 
in the isolation of the other lactone regioisomer 3.93, resulting from elimination of the 
  
Chapter 3: Bicyclic Approaches to the briaranes                               | 120 
 
sulfide followed by conjugate addition into the less-hindered enone (Scheme 3.16B).  
Further screening (Table 3.12) found K2CO3 in MeCN to be the ideal conditions. 
Scheme 3.16: (A) Cyclization-elimination cascade; (B) Divergent pathways in regioisomer 
formation 
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Table 3.12: Base screening in cyclization reaction 
 
Entry Base eq. solvent 2.92:2.93 dr yield (%) 
1 NaH 1.2 THF <50:1 10:1 49 
2 DBU 2.0 THF 2.2:1 4.4:1 37 
3 KOt-Bu 3.0 THF NA NA decomp. 
4 K2CO3 3.0 MeCN <50:1 3.6:1 53 
5 Cs2CO3 3.0 MeCN <50:1 8.3:1 58 
We then began to investigate the decarboxylation of the ethyl ester in 3.92.  
Subjection of lactone 3.92 to Krapcho conditions (Scheme 3.17) led to the isolation of 
rearomatized product 3.94.  Once again, we attributed the observed rearomatization to the 
thermal instability of the enone-lactone.  As this thermal instability appeared to be a general 
feature in these bicyclic lactones, we reduced the enone double-bond first in order to 
increase stability. The material was cleanly hydrogenated and taken directly forward into 
the Krapcho decarboxylation.  While the reaction successfully gave 3.95, the sequence 
occurred in low yield that could not be improved.   
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Scheme 3.17: Krapcho decarboxylation studies 
 
We hoped to find a different ester substituent that could be more amenable to 
decarboxylation.  A benzyl ester was an ideal candidate, as it could be possible to reduce 
the enone and decarboxylate the ester in a single step under hydrogenation conditions.  The 
benzyl malonate 3.96 could be synthesized in excellent yield using our established 
conditions (Scheme 3.18).  However, when malonate 3.96 was subjected to the optimized 
cyclization & elimination conditions, a small amount of an impurity corresponding to 
regioisomer 3.98 was also observed in addition to desired 3.97.  The bulkier benzyl ester 
likely cyclizes at a slower rate than the ethyl ester, leading to competitive sulfide 
elimination.  A second screen of bases (Table 3.13) found that the formation of 3.97 could 
be minimized by using Cs2CO3 as a base and running the reaction at lower temperatures 
for extended times.  This led to an inconsequential change in dr presumably due to base-
catalyzed equilibration.  On larger scales, we found it sometimes necessary to heat the 
reaction mixture after all starting material was consumed (as determined by TLC) to 50 °C 
in order to drive the sulfide elimination to completion.  Under these conditions, 3.97 could 
reliably be obtained in good yields.  With substrate 3.97 in hand, we investigated 
hydrogenation conditions.  Unfortunately, the molecule appeared to be highly recalcitrant 
to catalytic hydrogenation, and starting material was returned instead. 
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Scheme 3.18: Evaluation of a benzyl ester substrate 
 
 
Table 3.13: Reoptimization of cyclization for the cyclization of benzyl ester 3.96 
Entry Base (3 eq.) Solvent Temp (°C) 3.97:3.98 dr 
1 Cs2CO3 MeCN 50 21.7:1 8.5:1 
2 NaH (1.2 eq.) 
then DBU THF 0 7.7:1 10.6:1 
3 NaH THF 0 1:1 13.8:1 
4 Cs2CO3 MeCN 22 64.8:1 1:1.2 
Given our previous successes (Scheme 3.10), we decided to return to t-butyl esters.  
The ester 3.99 could be formed using our established mixed anhydride method (Scheme 
3.19).  The optimized cyclization conditions gave lactone 3.70 in good yield.  Compound 
3.70 was hydrogenated using Pd/C in EtOAc followed by decarboxylation using the 
conditions previously described to give hydrogenated lactone 3.95.  This lactone could be 
converted to silyl enol ether 3.68 using TMS-Cl and NaI with NEt3, which was used 
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without further purification.  Silyl-enol ether 3.68 could be converted to bromide 3.69 
through treatment with NBS in THF. 
Scheme 3.19: Synthesis of Mukaiyama/Reformatsky precursors 
 
3.3.3.d.  Evaluation of the Mukaiyama & Reformatsky Conditions 
We undertook an evaluation of conditions to affect the addition to form the C1 
stereocenter through Mukaiyama-type aldol reactions on silyl enol ether 3.68 (Scheme 
3.20).  The silyl enol ether was cleaved using a number of Lewis Acids such as Li, Ti, and 
B to generate their respective enolates followed by treatment with hydrocinnimaldehyde.138  
In all cases, we reisolated the ‘protonated’ lactone 3.95 instead of the desired adduct 3.100.  
Lactone 3.100 results from cleavage of the silyl enol ether followed by protonation instead 
of aldol addition. 
Attempts to perform more traditional Mukaiyama addition reactions by changing 
the order of substrate addition did not lead to product formation.  Only the protonated 
lactone 3.95 was observed when TiCl4 was added to a cold mixture of 3.68 and 
hydrocinnimaldehyde.139  Other Lewis acids were also screened.  A mild Lewis Acid such 
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as InCl3 resulted in no reaction.
140  Stronger Lewis Acids such as BF3·Et2O, Yb(OTf)3 
resulted in isolation of 3.95.
141 
We turned our attention instead to Reformatsky reactions.  Use of reducing agents 
such as Zn142 or Zn/Ag activated by Et2AlCl
143 led to the isolation of 3.95 as well.  We also 
screened homogenous reducing agents such as CrCl2, which also led to the reisolation of 
3.95.144  A large excess of aldehyde or a catalytic amount of LiI did not improve the result. 
Scheme 3.20: Evaluation of Mukaiyama & Reformatsky conditions 
 
It was clear at this time that the enolates formed from either reduction of the α-
bromoketone or cleavage of the silyl enol ether are extremely unreactive.  We believe that 
this unreactivity is due to the doubly deactivated nature of the enolate derived from 3.68 or 
3.69 (Scheme 3.21).  We anticipated that the concave approach of the aldehyde through 
TS3.1A would be deactivated due to steric congestion from the lactone ring.  However, we 
were surprised by the effect of torsional strain in this system.145  If the aldehyde approaches 
the convex face through TS3.2B, the methyl group at C1 begins to eclipse the lactone ring.  
This eclipsing interaction raises the energy of the transition state, and deactivates the 
convex approach as well.  It is likely that the extremely unreactive enolate is formed either 
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from the silyl enol ether or the α-bromoketone.  However, it does not react with the 
aldehyde and is instead protonated either by exogenous proton sources or upon workup.  
This unreactivity demonstrated the unsuitability 2,5-cyclohexadienone derived bicyclic 
lactones in our synthetic route.   
Scheme 3.21: Stereochemical rationalization of lactone unreactivity 
 
3.4.  Conclusion 
Two routes to the briarane stereotetrad were investigated.  The first took advantage 
of a reactive cyclopropane to install a sulfone moiety.  However, this sulfone did not 
undergo the proposed sulfone Reformatsky reaction.  When a new route was evaluated 
involving a more stable hydrogenated lactone, we were able to furnish an enolate at C1.  
However, this enolate was extremely unreactive, and did not lead to the desired product.  
We concluded that the presence of the lactone moiety decreases the reactivity and is likely 
responsible for product instability as well.  As a result, we decided to turn our attention to 
systems which did not possess this strained, bicyclic lactone.  
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Chapter 4 
Monocyclic Approaches to the   
Briarane diterpenoids 
After evaluating several approaches to the briarane stereotetrad core involving 
the use of bicyclic lactones, we hypothesized that the bicyclic nature of our 
intermediates could in fact be responsible for the difficulties that we had experienced.  
The highly strained bicyclic lactone substrates appear to be highly recalcitrant to aldol 
additions.  The rigidity imparted by the lactone would prevent conversion to a more 
reactive conformer, precluding any desired reactivity.  Additionally, the ring-strain from 
the lactone could be responsible for the facile rearomatization that we often observed.  
We hoped that alleviating the ring strain would in turn decrease the propensity towards 
elimination and rearomatization, allowing us to utilize strong bases in order to affect 
productive reactions such as methylations and aldol additions.  The more 
conformationally mobile system might also allow for access to a reactive conformer in 
the key aldol addition step. 
 4.1. Third Synthetic Approach 
 4.1.1. Retrosynthetic proposal 
 We postulated 4.1 as a suitable briarane stereotetrad structure (Scheme 4.1).  
This structure could be made from 4.2 from a Zn-mediated reductive cleavage and 
stereoselective ketone reduction.  The key bond at C1 would come through a boron-
mediated aldol addition.146  While such reactions were not successful on bicyclic 
substrates, we hoped that the reduced ring strain on ketone 4.3 would result in a more 
stable and sterically accessible enolate.  Compound 4.3 would be made through C10 
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fragment instillation and C1 methylation of substrate 4.4.  Once again, we hoped that 
the increased stability of monocyclic derivatives will allow methylation to occur under 
strongly basic conditions, which did not work well in our previous efforts.  The 
functionality of the C10 fragment would be selected such that it could later be converted 
into an aldehyde or carboxylic acid.  We proposed an allyl group or a protected acetylide 
(Scheme 4.1B) as possible candidates for this fragment.  The allyl group (4.5) could be 
converted into an aldehyde (4.6) through dihydroxylation and oxidative cleavage.147  
The TMS-acetylide (4.7) could be directly converted to a carboxylic acid (4.8) through 
hydroboration-oxidation.148  Achieving the conjugate addition was expected to be 
challenging, as reagents known to typically undergo conjugate additions, such as 
cuprates, have been observed to often lead to rearomatization of 2,5-cyclohexadienones. 
67  We were aware that the enolate resulting from a conjugate addition could also 
undergo rearomatization under basic conditions.  Aubé observed that the products of 
conjugate addition into electron-deficient cyclohexadienones display a tendency 
towards rearomatization (Section 1.2.2.b).60  Nevertheless, we were optimistic that 
suitable conditions could be found that would enable the isolation of product. 
Scheme 4.1: Retrosynthetic proposal utilizing monocyclic systems 
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4.1.2 Synthesis of the Aldol Precursor 
 We began by attempting the conjugate addition of an allyl fragment into quinol 
(4.9a&b, Scheme 4.2).  Attempted ligand-assisted nucleophilic addition (LANA) into 
quinol 4.9b using allylmagnesium bromide gave exclusively the 1,2 addition product 
4.10.40, 41   
We were inspired by a report by Taber, in which a formal conjugate addition of 
an allyl fragment could be accomplished in two steps by first performing a 1,2-addition 
of allylmagnesium bromide followed by an anionic oxy-cope rearrangement.149 
Allylmagnesium bromide was added into cyclohexadienone 4.9a in acceptable yield to 
give 4.10, as an approximately 1:1 mixture of diastereomers.28  When 4.10 was treated 
with KH and 18-crown-6 in THF, the product 4.11 could be obtained in 10% yield along 
with 10% recovered starting material, indicating substantial decomposition.  
Interestingly, the dr of 4.11 and 4.10 were not identical, indicating that one diastereomer 
of 4.10 reacts preferentially over the other, though no effort was made to assign the 
relative stereochemistry of either product.   
With this encouraging result, we sought to optimize this reaction.  Heating the 
reaction mixture to 60 °C led to decomposition of the substrate.  Decomposition was 
also observed when the base was switched to KOt-Bu.  Attempts to perform the reaction 
thermally led to rearomatization, which is consistent with our previous observations of 
the thermal instability of cyclohexadienone-derived products (Section 3.3.2).  We also 
attempted to install an allyl group through Sakurai chemistry (allyltrimethylsilane, 
TiCl4), but our limited investigation yielded no promising results; only rearomatized 
products were observed. 
 At this time, we began to investigate C10 side-chains other than allyl.  Inspired 
by the wide variety of chemistry that can be performed on acetylides, we proposed 
trimethylsilylacetylene as a suitable alternative.  Attempted addition of a reagent made 
from the magnesium acetylide of trimethylsilylacetylene and MAD gave no product.43  
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A Ni-catalyzed Al acetylide addition was similarly unsuccesful.150  We were delighted 
to find that the LANA addition of 2 equivalents of the Mg acetylide of 
trimethylsilylacetylene into 4.9a at −78 °C for 1.5 hours followed by stirring at room 
temperature for 1 hour led to incomplete conversion of the compound into 4.12 as the 
only observed product.  The reaction could be driven to completion by adding 3 
equivalents of the acetylide at −78 °C, stirring for 15 minutes, then warming to room 
temperature for 2 hours.  Conversion of 4.9a to the lithium alkoxide prior to acetylide 
addition as well as the addition of HMPA was not necessary in this case.  The hydroxyl 
group in 412 could be protected as a TMS ether giving 4.13 in good yield.   
Scheme 4.2: Initial C10 functionalization studies 
 
 We began to evaluate conditions for the C1 methylation of enone 4.13.  Initial 
deprotonation of 4.12 with LDA in THF for 30 minutes at ‒78 °C led to isolation of 
4.14 in 76% conversion, along with unreacted starting material (Table 4.1).  
Unfortunately, 4.14 was inseparable from the starting material (4.13), complicating 
purification.  Extending the reaction time did not improve the conversion.  Allowing the 
deprotonation to occur for extended times led to very low conversion, though the 
conversion improved significantly when HMPA was added.  Deprotonating at 0 °C led 
to side-product formation.  We also screened several other bases.  While initial results 
with LiHMDS gave better results, these results were inconsistent from run to run.  
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LiNEt2 performed poorly.  Due to the good conversion and consistency when LDA was 
used as a base, these were taken as the optimum conditions (Entry 4). 
Table 4.6: Optimization of methylation conditions 
 
Entry Base Additive Deprot. 
Temp 
(°C) 
Deprot. 
Time 
(min) 
Rxn 
Time (h) 
Conversion 
(%) 
1 LDA -- −78  30 1.5 76 
2 LDA -- −78 30 4.5 77 
3 LDA -- −78 60 4.5 17 
4 LDA HMPA −78 60 4.5 90 
5 LDA HMPA 0 60 4.5 94a 
6c LiHMDS HMPA −78 60 2 ~100b 
7c LiNEt2 HMPA −78 60 2.5 47 
a. A significant number of side-products formed as well; b. Conversions were not consistent between 
runs; c. Reaction performed with enone 4.12 instead. 
 Subjecting 4.14 to boron-aldol conditions resulted in the isolation of desilylated 
4.15 as the only observed product (Scheme 4.3A).  Attempts to install more acid-stable 
protecting groups such as TBS of Bz were met with failure, presumably due to the 
sterically hindered nature of the tertiary alcohol in 4.12.  However, we were able to 
successfully install a TES ether which we hoped would be stable to aldol conditions 
(Scheme 4.3B).  Synthesis of methylated TES substrate 4.17 proceeded according to 
our previous methods from 4.12 without incident. 
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Scheme 4.3: (A) Initial aldol studies; (B) Synthesis of TES-protected substrate 
 
4.1.3. Evaluation of Aldol Conditions 
When 4.17 was subjected to boron-aldol addition conditions, we were excited to 
isolate a small amount of material that was identified by mass spectrometry to be aldol 
adduct 4.18.  Starting material 4.17 and desilylated product 4.15 were also isolated.  
Encouraged by this result, we investigated other boron Lewis acids.  Lewis-acids such 
as Cy2BOTf or PhBCl2
151
 gave aldol products in very low conversion and yield.  We 
determined that the desilylation could be minimized by changing the order of addition 
and adding the Lewis acid to a mixture of the substrate and base. 
We were unsure at this time whether the incomplete conversion of the substrate 
was due simply to incomplete deprotonation or the unreactivity of the resulting enolate 
due to steric and torsional strain, in analogy to substrates 3.71 & 3.72 (Section 3.3.3.d).  
In order to probe this question, we undertook a brief deuterium incorporation study 
(Table 4.2).  Deprotonation of 4.17 with LDA at −78 °C for 1h led to only 30% observed 
D incorporation.  However, adding the LDA at −78 °C followed by warming to 0 °C for 
30 minutes resulted in complete deuterium incorporation, with no observed 
decomposition. 
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Table 4.2: Deuterium incorporation studies 
 
Entry Time (min) Temp 
(°C) 
D Incorporation (%) 
1 60 −78 30 
2 30 0 100 
 
We then returned to the investigation of Li, B, and Ti enolates using our 
improved deprotonation conditions (Table 4.3).  We were able to achieve 50% 
conversion from the Li enolate which was a significant improvement.  The aldol 
addition of the Li enolate resulted in an inseparable mixture of all four possible 
diastereomers in a 10:6.2:3.9:1 ratio.  Due to significant spectral overlap, we were 
unable to assign the relative configuration of these products.  Formation of a Ti enolate 
resulted in improved conversion of 70%.138  In this instance, only two diastereomers 
were obtained, in a 3.2:1 dr.  The improved selectivity is likely due to the transition 
from an open to a closed transition state under the Ti-promoted conditions.  To our 
delight, performing a boron aldol reaction utilizing elevated deprotonation temperatures 
and the less-bulky base NEt3 led to full consumption of the starting material.
vi  The 
resulting aldol adduct 4.18 could be obtained in 67% yield as a single diastereomer. 
 
 
                                                          
vi Subsequent attempts to replicate this result at a later date were unsuccessful 
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Table 4.3: Aldol addition studies 
 
Entry Conditions Conversion (%) dra 
1 LDA 50 10 : 6.2 : 3.9 : 1 
2 LDA then 
Ti(OiPr)3Cl 
70 10 : 3.1 
3 Bu2BOTf, NEt3 100 >20:1 
a. Diastereomers were inseparable, relative configurations unassigned 
Unfortunately, a clear NOE correlation between the C10 methine and both the 
C15 and C20 methyl groups in 4.18 indicated that the product possessed the undesired 
C1 stereochemistry (Scheme 4.4).  Once again, the influence of torsional strain appears 
to dominate the stereoselectivity in these systems.145  In this case, developing eclipsing 
interactions in TS4.1A led to more favorable electrophilic approach from the same side 
as the alkyne (TS4.1B).  We were surprised at the extent to which this torsional steering 
operates in these systems, as it appears to be common occurrence in these rigid, highly 
substituted molecules.  The generality of this trend has not been further studied, though 
such studies are warranted. 
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Scheme 4.4: Rationale for aldol stereochemical outcome 
 
 We briefly attempted to coopt our existing route to take advantage of the 
preference for electrophilic approach syn to the acetylide.  We postulated that the proper 
stereochemistry could be introduced by first alkylating at C1 with a moiety that could 
serve as a masked aldehyde followed by methylation at C1 (Scheme 4.5A).  After 
elaboration, the aldehyde could be revealed and a side chain could be introduced in a 
manner similar to that used by Ito/Iguchi.117  We selected an allyl group, which could 
be converted to an aldehyde after isomerization to the internal alkene (4.20) and 
oxidative cleavage (4.21).  Allylated ketone 4.22 could be synthesized using our 
previously optimized conditions using allyl iodide as the electrophile.  Unfortunately, 
attempted methylation of 4.22 resulted in low yields and numerous, inseparable side-
products, though with the desired relative stereochemistry.  While we were able to 
achieve promising success in affecting the isomerization to 4.20 using the Grubbs’ 
second generation catalyst in MeOH152, we elected to abandon this route.  The relatively 
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low yields, higher step-count, and required use of highly toxic reagents such as OsO4 
suggested that there could be a more efficient way to take advantage of the inherent 
selectivity of these substrates. 
Scheme 4.5: (A) Proposed conversion of 4.19 to aldehyde 4.20; (B) Synthetic elaboration to 
that end 
 
4.2. Fourth Synthetic Approach 
 4.2.1. Retrosynthetic Proposal 
 In light of the fact that the electrophilic approach to substrates such as 4.17 
appears to be directed primarily by torsional steering effects, we decided to take 
advantage of this selectivity and introduce the methyl group after the other carbon 
fragment at C1 (Scheme 4.6).  This approach would require a significant revision of the 
retrosynthesis in order to allow methylation at C1 after a second fragment had been 
introduced.  We proposed that the alcohol at C2 would now be formed through a 
stereoselective organometallic addition to aldehyde (4.24, Scheme 4.6).  Ito & Iguchi 
employed a similar strategy in their synthesis of a briarane fragment.117  Aldehyde 4.24 
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could be furnished from ketoester 4.25 through a stereoselective reduction of the C14 
ketone followed by functional-group manipulations.  Methylated ketoester 4.25 would 
be formed through conjugate addition of an acetylide into cyclohexadienone 4.26 
followed by stereoselective methylation.   
Scheme 4.6: Revised retrosynthetic proposal 
 
 4.2.2. Initial Synthetic Studies 
Attempts at dearomatizing phenol 4.27 using PIDA as the oxidant in MeOH 
proceeded to incomplete conversion.  The salicylate ester is presumably less active in 
the dearomatization due to the electron-withdrawing ester group.  We were pleased to 
discover that μ-oxo-bridged diiodide 4.29 provided 4.26 in good yield (Scheme 4.7).14  
Use of H2O as a nucleophile gave unstable products which could not be isolated cleanly. 
We began to investigate methods to add an acetylide into 4.26 (Table 4.4).  
Addition of a Mg-acetylide gave primarily 1,2-addition.  A promising result came from 
the addition of a Zn-acetylide using conditions reported by Carriera.153 While the crude 
1H NMR spectrum suggested 4.28 as a product from the acetylide addition, the crude 
material was subjected to methylation immediately to minimize rearomatization of the 
sensitive compound.  MeI and Cs2CO3 were used as the initial methylation conditions 
for the optimization of the acetylide addition.  The resulting compound appeared to be 
diastereomerically pure 4.25 by 1H NMR spectroscopy, though the relative 
stereochemistry could not be confirmed due to the lack of any diagnostic NOE 
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correlations.  The stereochemistry could be confirmed by later NOE investigation of 
acetonide 4.32a (Section 4.2.3).  Further optimization using Zn acetylides was unable 
to improve the yield.  Attempts to utilize catalytic amounts of the expensive Zn(OTf)2 
resulted in no conversion of the starting material.  The conjugate addition could be 
performed using Mg acetylides by adding catalytic quantities of Cu(I) salts, though a 
significant amount of unidentified side-products formed as well.154  The use of Al 
acetylides in a nonpolar solvent such as toluene allowed the formation of the desired 
methylated product in 25 % yield as a single diastereomer.155  While the yield was 
nominally lower than that obtained under the Cu-catalyzed conditions, the isolated 
products were significantly cleaner by 1H NMR spectroscopy.  A survey of methylation 
conditions revealed that the use of K2CO3 in toluene with 18-crown-6 once again 
provided optimum results, giving an acceptable 41% yield over two steps, and 
minimizing rearomatization of the product.  Though the yield of this sequence is lower 
than we would have liked, the low yield is balanced by the significant increase in 
molecular complexity; a key carbon fragment, an all-carbon quaternary stereocenter, 
and the C1–C10 stereochemical relationship are all set with almost perfect selectivity in 
only a few synthetic transformations. 
Treatment of ketoester 4.25 with Zn in AcOH provided the reduced product 4.29 
in good yield.121  Use of a 10-fold excess of activated Zn allowed the reaction to be 
performed at room temperature, which further improved the yield.  Use of cosolvents 
such as THF along with AcOH led to decreased yields. 
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Scheme 4.7: Elaboration to fragment 4.29 
 
 
Table 4.4: Screening of acetylide/methylation conditions 
Entry [M] Solvent 
(temp) 
Methylation 
Conditions 
Yield of 4.25 
(%)a 
 
1 MgBr THF 
(‒78 °C) 
Cs2CO3, MeI 
MeCN, rt 
decomp 
2 ZnOTf MeCN 
(60 °C) 
Cs2CO3, MeI 
MeCN, rt 
10 
3 MgBrb THF 
(‒78 °C) 
Cs2CO3, MeI 
MeCN, rt 
33 
4 Et2Al Et2O/toluene/Hexane 
(0 °C) 
Cs2CO3, MeI 
MeCN, rt 
25 
5 Et2Al Et2O/toluene/Hexane 
(0 °C) 
K2CO3, MeI 
18-crown-6 
toluene, rt 
37 
6 Et2Al Et2O/toluene/Hexane 
(0 °C) 
K2CO3, MeI 
18-crown-6 
toluene, rt 
41c 
a. After isolation by chromatography; b. w/ 0.1 eq. CuCl; c. reaction performed on a 1.44 
mmol scale 
 
 To our great delight, the stereoselectivity of both the acetylide addition and 
methylation appeared to be very high, giving the desired diastereomer of 4.25 almost 
exclusively.  The stereochemistry of the acetylide addition could be rationalized through 
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coordination of the Lewis acid on the acetylide with the oxygen of the methyl ether.  An 
alternative, plausible explanation for the selectivity could be the “syn oxygen effect” 
which has been investigated computationally by Houk and Paquette (Section 1.2.3).44, 
78 
We sought to briefly investigate the preference for methylation syn to the 
acetylide computationally (Figure 4.1)vii.  The enolate of ketoester 4.28 can exist with 
the acetylide in either the axial (4.31a) or equatorial (4.31b) conformer.  DFT ground-
state calculations indicate that the axial conformer is more stable by about 4.0 kcal/mol.  
From these two conformers, four possible transition states could be envisioned.  From 
4.31b, the electrophile could approach either syn to the acetylide (TS4.2A) or anti to 
the acetylide (TS4.2B).  The axial conformer would have two similar syn and anti-
transition states (TS4.2C) and TS4.2D respectively).  TS4.2B and TS4.2C would be 
disfavored due to torsional strain.  However, the two remaining transition states 
(TS4.2A and TS4.2D) would give diastereomeric products.  Given the high observed 
selectivity, another effect is clearly operative.  We hypothesize that the reaction 
proceeds under Curtin-Hammett conditions.  While conformer 4.31b is 
thermodynamically favored, 4.31a is the more reactive conformer.  Initial calculations 
on a related substrate indicate that this is a plausible explanation, though additional 
computational and experimental work is needed to more fully investigate this 
hypothesis. 
                                                          
vii Computations performed by Dr. Andrew Harned 
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Figure 4.1: (a) Conformational analysis of enolate 4.31; (b) Transition-state analysis of 4.31a 
and 4.31b 
 
 4.2.3. Completion of the Briarane Stereotetrad Synthesis 
With ketone 4.29, which possesses the heretofore unattainable correct C1 
stereocenter, in hand, we began to investigate the stereoselective reduction of the C14 
ketone (Table 4.5).  We were extremely surprised to find that both LiAl(Ot-Bu)3H and 
NaBH4 gave the same diastereomeric product 4.32b.  The relative stereochemistry could 
be confirmed by reducing 4.32b to the diol followed by conversion to acetonide 4.33b.  
The lack of NOE enhancement between the C14 methine and C15 methyl group led us 
to tentatively assign the product as the undesired, axial alcohol product 4.32b.   The 
stereoselectivity is perhaps due to complexation of the Al or B Lewis acids with the 
carbonyl of the ester, resulting in equatorial approach of the hydride (Figure 4.2).  The 
preference for axial-disposition of the acetylide could be further biasing the approach 
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of the hydride towards and equatorial trajectory by blocking the top face from 
nucleophilic approach. 
Figure 4.2: Stereoselectivity model for equatorial hydride attack 
 
Drawing inspiration from work by Fraga156 in which Lewis acids played an 
important role in the stereochemical outcome of the reduction of cyclic ketoesters, we 
screened a variety of Lewis acids and reducing agents.  Changing the BH4
‒  counterion 
to either Bu4N
+ or Li+ (Entries 3 & 27) did not significantly improve the ratio.  The use 
of other reduction conditions such as SmI2 or Al(Oi-Pr)3 in i-PrOH did not give 
promising results either.  Gratifyingly, when a Lewis acid such as CaCl2 was used, the 
ratio improved somewhat (Entry 4).  However, the improvement was not significant 
enough to be synthetically useful.  We undertook an extensive screen of Lewis acids to 
further improve the selectivity.  Mn(II), Mg(II), Fe(II), and Ti(IV) all led to rapid 
conversion, though the diastereomer ratio was not improved.  Some Lewis acids such 
as Bi(OTf)3, SnCl2, FeCl3 and ZnCl2 appeared to give other either metal hydride or 
boride products; addition of the NaBH4 led to rapid and often highly exothermic 
formation of solids and incomplete conversions even after extended reaction times 
(24h).  The selectivity favored the axial alcohol in all cases.  The only exception was 
when L-selectride was used as a reducing agent.  In this case, the products could be 
produced in a 1.9:1 ratio of 4.32a:4.32b (as observed by crude 1H NMR spectroscopy).  
However, the reaction did not proceed to completion and significant decomposition and 
side-product formation was observed.  Further investigation into this class of reagents 
is needed in order to determine better conditions.   
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The first truly promising result came when the lanthanide salt CeCl3·7H2O was 
employed as the Lewis acid.  The diastereomer ratio improved significantly to 1:2.9, 
though still favoring axial alcohol 4.32b.  We found that the reaction could be run at 
room temperature with no erosion in selectivity.  However, the use of isopropanol as 
the solvent led to decreased selectivity.  A screen of various other lanthanide salts found 
Y(OTf)3 to be best.  The triflate counterion appears to be important, as a decrease in 
selectivity was observed when YCl3·6H2O was used.  Methanol was once again the best 
solvent.  It is possible that the less-coordinating nature of the triflate counterion 
increases the coordination number of solvent ligands on the Lewis acid.  Higher 
coordination could lead to a more sterically demanding substrate and better shield the 
equatorial trajectory of hydride attack.  Further study is necessary to fully understand 
the details of this reduction.  Though the nearly 1:1 diastereoselectivity was not ideal, 
we decided to carry the material forward at this point in order to evaluate the remainder 
of the sequence.   
Table 4.5: Screening of ketone reduction conditions 
 
Entry Reductant Lewis Acid Solvent Temp 
(°C)  
conv.
a (%) 
 
4.32a:4.32bb 
1 LiAlH(Ot-Bu)3 -- THF −78 100 1:49.0 
2 NaBH4 -- MeOH 0 100 1:16.2 
3 Bu4NBH4 -- MeOH 0 100 1:24.6 
4 NaBH4 CaCl2 MeOH 0 100 1:7.9 
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5 NaBH4 CeCl3·7H2O MeOH 0 100 1:2.9 
6 NaBH4 CeCl3·7H2O i-PrOH 0 100 1:8.1 
7 NaBH4 CeCl3·7H2O MeOH rt 100 1:2.7 
8 NaBH4 MnSO4·H2O MeOH rt 100 1:12.8 
9 NaBH4 ZnCl2 MeOH rt 37 1:28.8 
10 NaBH4 MgCl2 MeOH rt 100 1:8.4 
11 NaBH4 FeCl2 MeOH rt 100 1:7.5 
12 NaBH4 FeCl3 MeOH rt 89 1:10.8 
13 NaBH4 AlCl3 MeOH rt 33 1:4.1 
14 NaBH4 Ti(i-PrO)4 MeOH rt 100 1:10.8 
15 NaBH4 SnCl2·2H2O MeOH rt 62 1:22.6 
16 NaBH4 InCl3 MeOH rt 90 1:32.5 
17 NaBH4 Y(OTf)3 MeOH rt 100 1:1.3 
18 NaBH4 Y(OTf)3 THF rt 100 decomp. 
19 NaBH4 Y(OTf)3 EtOH rt 100 1:9.8 
20 NaBH4 YCl3·H2O MeOH rt 100 1:2.2 
21 NaBH4 Yb(OTf)3 MeOH rt 100 1:1.5 
22 NaBH4 Sc(OTf)3 MeOH rt 100 1:6.9 
23 NaBH4 Eu(OTf)3 MeOH rt 100 1:1.7 
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24 NaBH4 Bi(OTf)3 MeOH rt 22 <1:50 
25 NaBH4 LiBr DME rt 0 NA 
26 NaBH4 Amberlyst-
15 
THF rt 100 deomp 
27 LiBH4 -- THF rt 100 decomp 
28 SmI2 -- THF/H2O rt 100 1:6.6 
29 Al(i-PrO)3 -- i-PrOH 80 17 1:1.8 
30 L-Selectride -- THF rt 76% 1.9:1 
a.After 24 h of reaction; b. Determined by crude 1H NMR Spectroscopy  using the integration 
of the C15 Me signals (δ 1.43 for 10a & 1.31 for 10b); b. Significant impurities were observed 
in crude 1H NMR spectrum.  Ratio was determined using C12 vinyl protons (δ 5.27 ppm for 
10a and 5.32 ppm for 10b). 
Gratifyingly, the reduction of 4.29 on a larger scale allowed for the clean 
isolation of 4.32a and 4.32b in reasonable quantities.  The relative stereochemistry of 
the reduction products was further confirmed by reducing the ester to the diols followed 
by immediate conversion to the acetonides 4.33a and 4.33b.  The acetonide (4.33a) 
from equatorial alcohol 4.32a showed NOESY enhancement between the C14 methine 
and the C15 methyl group, which was absent in 4.33b (Scheme 4.8).  Enhancement 
between the C10 methine and the C2 methylene in both substrates also confirmed the 
correct relative stereochemistry of the acetylide and methyl group.   
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Scheme 4.8: Stereochemical confirmation of the reduction 
 
We then carried 4.32a forward to complete the synthesis of the briarane 
stereotetrad (Scheme 4.9).  Reduction of the ester in 4.32a with LiAlH4 followed by 
immediate oxidation of the primary alcohol with TEMPO gave aldehyde 4.24 in 
acceptable yield.  When we attempted the Grignard addition of allylmagnesium 
bromide, followed by immediate conversion to the acetonide, we isolated 1:1.4 mixture 
of inseparable diastereomers 4.34a:4.34b in poor yield.  Examination of the NOESY 
spectrum of the two diastereomers was inconclusive due to the significant spectral 
overlap between the two diastereomers. We were however able to identify the 13C NMR 
shifts for the acetonide methyl groups in both diastereomers through the use of HSQC.  
The chemical shifts for the major diastereomer (δ 30.33, 19.55 ppm) are consistent with 
Rychnovsky’s prediction for syn 1,3-diols.157  Similarly, the values for the minor 
diastereomer (δ 27.35, 25.24 ppm) are consistent with the desired anti 1,3-diol.  
Gratifyingly, when the same reaction was attempted in Et2O, a significantly improved 
dr of 3.1:1 (observed in crude NMR spectrum) in favor of the desired anti diol 4.34a  
was obtained.  Examination of the NOESY spectrum of this compound confirmed the 
relative stereochemistry.  The reaction also proceeded in DME, though with a decreased 
ratio of 4.34a:4.34b of 2.2:1.   
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The selectivity of Grignard addition to our system appears to be significantly 
lower than that observed by Ito and Iguchi, who observed a single diastereomer.  There 
could be several factors affecting the selectivity.  First, the smaller TMS-acetylide 
moiety in the analogous equatorial conformer 4.35b is smaller than the bulky 
CH2OTBDPS group, which could provide less effective steric shielding (Figure 4.3).  
We have previously observed a preference for the acetylide moiety in these substrates 
to adopt an axial conformation, which could be occurring in this situation as well.  A 
different conformational population relative to the one observed by Ito and Iguchi could 
also lead to different levels of selectivity.  Finally, the less-coordinating solvent Et2O 
could be improving the extent of chelation of the Mg with the aldehyde prior to addition.  
Further work, both computational and experimental, is necessary to more fully reveal 
the nature of these preferences.  Solving some of the problems encountered earlier (see 
section 4.3 for potential solutions), will result in higher material throughput that will 
easily enable further investigation of this key step. 
Scheme 4.9: Completion of the synthesis 
 
 
Table 4.6: Screening of solvent conditions in Grignard addition to 4.24 
Entry Solvent 4.34a:4.34b Yield (%) 
1 THF 1:1.4 34 
2 Et2O 4.2:1 34 
3 DME 2.2:1 N/A 
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Figure 4.3: Possible chelated conformers 
 
4.3. Future Work 
We have demonstrated a promising strategy towards the synthesis of the 
stereotetrad core of the briarane diterpenoids.  While some of the steps in our current 
strategy are far from ideal, solutions to each of the problems are quite tractable.  The 
desire to solve those problems is especially motivated by the significantly abbreviated 
nature of the synthesis; the best current method to access a similar stereotetrad core 
reported by Bates involves 16 steps while ours only requires 8.118   
The first major problem that should be solved involves the development of a 
catalytic version of the oxidative dearomatization.  While the dearomatization using 
oxidant 4.30 proceeds well, the reaction is far from ideal.  Compound 4.30 is not 
commercially available, and its preparation requires large amounts of other oxidants 
such as PIDA along with large volumes of solvent, which limits the amount that can be 
practically made at one time.  Additionally, the potentially explosive nature of the 
iodosobenzene intermediate would make the large-scale preparation of 4.30 particularly 
hazardous.  The challenge of preparing 4.30 on large-enough scales, coupled with the 
formally 2 equivalents of oxidant (relative to I) and the large molecular weight 
difference between the substrate and the oxidant (approximately 4 g of oxidant needed 
for every 1 g of substrate) severely limited the material throughput of the sequence.  A 
catalytic version of the dearomatization would ameliorate many of these difficulties. 
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As it appears that the bridged-nature of the oxidant significantly improved the 
reaction, similar substructures should be investigated in the catalytic reaction (Scheme 
4.10).  Kita has reported diiodobiaryl substrates 4.38 for iodine(III) mediated 
organocatalytic cross-coupling reactions.158  These substrates can be easily synthesized 
with a variety of substituents on the aromatic rings.  A screen of a variety of these 
catalysts, along with potential additives such as TFA, TFE, and HFIPA would likely 
lead to conditions for a catalytic dearomatization of electron-deficient phenols.  This 
would be a useful discovery in and of itself, as the efficient iodine-based 
dearomatization of electron deficient phenols is currently an unsolved problem.  A 
reliable method to access such substrates would open the door to further synthetic 
investigations.  It is likely that the development of a catalyst such as 4.38 would further 
improve the yields of catalytic dearomatizations generally, which are often lackluster. 
Scheme 4.10: Proposed catalyst for dearomatization 
 
The most important step to improve is the ketone reduction to give 4.32a.  While 
the exact reasons for the strong preference for equatorial hydride delivery remain 
unclear, it is apparent that this is a significant selectivity barrier to overcome.  Given the 
fact that the poor selectivity and yield of this step greatly diminished the material 
throughput of the sequence, solving this problem is of utmost importance.  The problem 
could be solved in one of two ways.  The first would be to further screen reducing agents 
in the reduction.  The promising result using L-Selectride warrants further investigation.  
It is possible that the efficiency of the reduction will be highly solvent and counterion 
dependent.  Other related reducing agents such as superhydride (LiEt3BH) could also 
be investigated.    Stereoselective, reagent-controlled reduction conditions should also 
be investigated.  Brown has reported reasonable levels of control over the reduction of 
  
Chapter 4: monocyclic approaches to the briaranes                            | 150 
 
a related substrate.159  His DIP-Cl reagent would be an ideal candidate due to its ease of 
preparation and handling, along with the ready and inexpensive availability of both 
enantiomers of the reagent.  Noyori and CBS reduction conditions could also be 
screened. 
The other approach to the reduction problem would be to invert the stereocenter 
after its formation (Scheme 4.11).  Preliminary investigations into performing a 
Mitsunobu reaction on this highly hindered substrate were not promising.  Additionally, 
Huffman has reported the inversion of hindered stereocenters through reaction of alkyl-
mesylates with CsOAc.160  We were able to easily prepare the mesylate of 4.32b, though 
reaction with CsOAc was not promising.  An inversion approach also adds steps to the 
reaction sequence, which decreases its synthetic utility. 
Scheme 4.11: Attempted hydroxyl inversion 
 
Solving the aforementioned problems will allow access to more material to 
further optimize the Grignard addition to the aldehyde.  Variation of the order of 
addition, nature of the Mg counterion, or even the investigation of other organometallic 
reagents could all be investigated.  In analogy to Liottta’s LANA procedure, the 
formation of the lithium alkoxide of the alcohol at C14 could also be accomplished.  
Optimization of the yield and selectivity of this addition will lead to a highly useful 
synthesis of the briarane stereotetrad, which can be used to rapidly access the remainder 
of the briarane molecules. 
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4.4 Conclusion 
In conclusion, we have investigated two routes to the briarane stereotetrad core 
that utilize monocyclic intermediates.viii  While we were validated in our hypothesis that 
monocyclic derivatives would be significantly more stable, aldol additions proceeded 
with the incorrect diastereoselectivity due to torsional steering effects.  A route that 
utilized conjugate addition into a cyclohexadienone ester was significantly more 
successful, and the stereotetrad core could be obtained in only 8 steps.  Future efforts 
geared at improving the weaker steps in the sequence are underway and will enable the 
efficient synthesis of the briarane diterpenoids. 
 
 
 
 
 
 
 
 
 
 
 
                                                          
viii Published as: Moon, N. G.; Harned, A. M. Org. Lett. 2015, 17, 2218-2221. 
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Chapter 5 
 Iodine(III) Mediated Oxidative  
Cyclizations to form oxazolines 
 
5.1. Introduction and Background 
 5.1.1. Synthesis of Oxazolines 
 5.1.1.a. Traditional Method of Oxazoline Synthesis 
 Oxazolines are a heterocyclic motif that have found extensive applications as 
bioactive compounds (5.2a, Figure 5.1)161 and organometallic ligands (5.3).162  
Additionally, the oxazoline substructure has been found in various natural products such 
as bistramide A (5.1).163  As such, numerous methods have been developed to access 
oxazolines. 
Figure 5.1: Oxazolines in natural products, bioactive compounds, and as ligands in organic    
synthesis 
 
 Many traditional methods to synthesize oxazolines involve the dehydration of a β-
hydroxyamide (Figure 5.2), which can be readily prepared from the corresponding amino 
alcohols.  Common dehydration methods include, but are not limited to: conversion of the 
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hydroxyl group to a tosylate/mesylate followed by nucleophilic displacement164 and 
dehydration with a variety of dehydrating agents such as SOCl2
165, POCl3
127, and TFA166.  
These methods necessitate the formation of the amide in a separate step, which often 
requires chromatographic purification.  The subsequent cyclization often takes place under 
harsh conditions, and requires the eventual removal of the dehydrating reagents and other 
byproducts, which are often used in large excess.   
Methods also exist to convert an amino-alcohol to an oxazoline directly.  Nitriles 
can be directly converted to oxazolines at elevated temperatures in the presence of a 
suitable Lewis acid catalyst such as ZnCl2.
167  Alternatively, treatment of the imidate salt 
obtained from the corresponding nitrile in ethanolic HCl with an amino alcohol and base 
also leads directly to the oxazoline.168  Once again, these methods require the action of 
harsh conditions including high temperatures and strong acids.  The imidate substrate is 
also quite sensitive, and can be challenging to prepare.  Since the methods traditionally 
used to access oxazolines are often unsuitable for more complex and sensitive substrates, 
there is demand for the development of milder methods to synthesize oxazolines. 
Figure 5.2: Traditional methods for synthesizing oxazolines 
 
  
Chapter 5: Iodine(III) mediated oxidative cyclizations                                    | 154 
5.1.1.b. Oxazolines Through Electrophilic Cyclization 
 Electrophilic cyclization is a general and useful method to forge heterocycles.  In 
an electrophilic cyclization, an alkene or alkyne is initially activated with an electrophile 
(I, Br, S, Se etc.) that undergoes a nucleophilic attack, forming a new ring along with an 
additional substituent that is determined by identity of the electrophile.  This method is 
useful not only due to the mild conditions under which the cyclization proceeds, but also 
due to the additional substituent (such as an alkyl halide) which is available for further 
elaboration. 
 Early reports of oxazoline synthesis via electrophilic cyclization involved the use 
of halogens as the electrophile.  In the course of studying neighboring group participation 
in reactions of benzamidopropene, Winstein observed that oxazoline 5.5 could be obtained 
when allylamide 5.4a was treated with Br2 (Scheme 5.1).
169  Some years later, Cardillo 
and coworkers synthesized iodooxazolines 5.7a  and 5.7b by treatment of trichloroamide 
5.6 with NIS en route to oxazolidinone 5.8.170   
Scheme 5.1: Early reports of oxazoline synthesis by electrophilic cyclization 
 
 A related iodocyclization was reported by Mikinata and Komatsu (Scheme 5.2).171  
In this report, unsaturated sulfonamides 5.9 were treated with an electrophile derived from 
Chloramine T and I2 to give N-heterocycles such as 5.10.  This reaction was found to occur 
with a variety of substrates, including terminal and internal alkenes.  The cyclization did 
not proceed when the nitrogen atom was protected with a Boc-group, possibly due to the 
reduced acidity of the N-H bond in this case.  The authors also found that N-allylamides 
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and N-thioamides underwent cyclization to give the oxazoline and thiazoline products 
5.12a and 5.12b. 
Scheme 5.2: Mikinata & Komatsu's electrophilic cyclization 
 
 Oxazolines can also be formed through electrophilic cyclization using non-halogen 
electrophiles.  Tiecco/Tingoli, and Engman, have reported the synthesis of oxazolines 
using selenium electrophiles (Scheme 5.3).  Tingoli found that diphenyl diselenide could 
be treated with ammonium peroxydisulfate to generate an active electrophile that was able 
to affect the cyclization of numerous substrates.172  When compound 5.4 was subjected to 
the reaction conditions, oxazolines 5.13 were obtained in good yield.  A similar cyclization 
using PhSeSePh could be performed using PIDA to generate the selenium electrophile.173 
Engman further investigated the synthesis of oxazolines through selenium-
mediated oxidative cyclizations.174  A variety of allylamides were treated with PhSeBr to 
furnish both the endo and exo products.  In cases where the allyl group was unsubstituted, 
the exo product was isolated as the sole product.  Similar results were observed for both 
phenyl and methyl substituents on the portion of the molecule bonded to the carbonyl.  
Substitution of the allyl group at the 1-position also led to exclusive exo product formation.  
Use of internal alkene 5.14 led to the isolation of a mixture of endo and exo products 5.15a 
and 5.15b, with the endo product predominating.  Disubstitution at the terminal position 
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did not result in any productive reaction.  The authors also found that thioamides were also 
nucleophiles for the reaction. 
Scheme 5.3: Oxazoline formation with selenium electrophiles 
 
Sulfur electrophiles have also been used in the synthesis of oxazolines (Scheme 
5.4).175  When N-allylamides (5.16) were treated with PhSSPh and Mn(OAc)3, oxazoline 
5.17 could be obtained in good yield.  A variety of substituents were tolerated on the 
position bound to the carbonyl.   
Scheme 5.4: Oxazoline formation with sulfur electrophiles 
 
 5.1.2. Hypervalent Iodine-Promoted Oxidative Cyclizations of Alkenes &  
          Alkynes 
 5.1.2.a. Iodine(III)-mediated Cyclizations Involving Alkenes 
 The first example on a hypervalent iodine-mediated cyclization was reported by 
Koser and coworkers.  Inspired by earlier results in which they were able to achieve 
ditosylation of alkenes using Koser’s reagent (PhI(OH)OTs),176 the authors hypothesized 
that an analogous lactonization reaction could be accomplished.177  When 4-pentenoic acid 
(5.18b) was added slowly to Koser’s reagent in DCM, tosyllactone 5.19 could be isolated 
in reasonable yield (Scheme 5.5).  Use of acid 5.18a led to regioisomer 5.20.  Further 
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investigation of the scope of the reaction allowed for the formation of larger rings (5.21).  
Substituents α to the acid were also tolerated (5.22). 
Scheme 5.5: Koser's oxidative lactonization with selected substrate scope 
 
 The authors discovered that when cyclic substrate 5.23, which possesses an internal 
alkene, was subjected to the reaction conditions, bicyclic lactone 5.24 was obtained 
(Scheme 5.6). This product likely results from the elimination of the intermediate tosylate.  
The authors were able to maximize the yield by treating the reaction mixture with DBU 
after initial consumption of the starting material.  Similar results were observed, albeit in 
lower yield, for internal alkene 5.25.  Investigation of norbornene-derived substrates led to 
isolation of rearranged substrate 5.28 in the case of the monoacid 5.27.  The diacid 5.29 
furnished bis-lactone 5.30.  
Scheme 5.6: (A) Cyclization on internal alkenes; (B) Cyclization of norbornene derivatives 
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 In investigating a similar cyclization of substrate 5.31, Wirth and coworkers 
observed an intriguing aryl shift involving an intermediate phenonium ion (Scheme 
5.7A).178  When 5.31 was treated with PIDA, compound 5.35, resulting from a phenyl shift, 
was observed instead of the expected product 5.33.  The authors attribute this result to 
formation of phenonium ion 5.34 after displacement of the aryliodane moiety in 5.32.  
Subsequent attack by acetate yields the observed product.   
A screen of other phenyl group substituents revealed that para-substituted aryl 
acids proceeded more slowly than the parent compound (Scheme 5.7B).  In some cases, 
unrearranged products were also observed.  A brief attempt to utilize chiral, nonracemic 
oxidant 5.39 (Scheme 5.7C) led to product, though the observed ee was a paltry 4%. 
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Scheme 5.7: (A) Mechanism of cyclization with phenonium-ion shift; (B) Scope of cyclization; 
(C) Cyclization with chiral oxidant 
 
Tan and coworkers found that a similar lactonization could be performed using a 
catalytic amount of hypervalent iodine oxidant (Scheme 5.8).179  When substrate 5.40 was 
treated with PIDA along with TBAI, iodolactone 5.41 was isolated in good yield.  Further 
investigation found that when the amount of PIDA was decreased to 10 mol% with m-
CPBA as the stoichiometric oxidant, the product was obtained in 16% yield.  Use of 
NaBO3·H2O significantly improved the yield.  Iodobenzene could be used instead of PIDA 
with similar yields.  The addition of five equivalents of AcOH further improved the yield.  
An investigation into the scope found that the reaction was tolerant of a number of 
substituents α to the acid. 
Chapter 5: Iodine(III) mediated oxidative cyclizations                                    | 160 
Scheme 5.8: Tan's catalytic iodine(III) oxidative cyclization 
 
Huang reported the synthesis of N-acyl aminals through oxidative cyclization of N-
acylenamines (5.42, Scheme 5.9).180  Compound 5.42 was treated with PIDA and MeOH 
in a variety of solvents to give mixtures of methyl ether 5.43 along with acetate 5.44 as a 
side product.  In cases where TFE was used, some trifluoroethyl ether 5.45 was also 
observed.  Use of HFIPA in place of TFE suppressed this undesired side-reaction.  The 
cyclization was found to be amenable to a number of different substrates. 
Scheme 5.9: Huang's N-acylenamine cyclization 
 
In contrast to previous examples, the authors proposed a mechanism in which the 
hypervalent iodine reagent performs a single-electron oxidation to generate radical cation 
(5.47, Figure 5.10), which subsequently undergoes cyclization.  After subsequent 
oxidation, the resulting carbocation is trapped by the nucleophile which leads to the 
formation of product 5.43.  An SN2’-like mechanism is also possible (not shown). 
Scheme 5.10: Huang's proposed cyclization mechanism 
 
A particularly intriguing set of examples of iodine(III)-promoted oxidative 
cyclizations were reported by the Michael group (Scheme 5.11).  In the first report, the 
authors investigated the iodine(III)-promoted cyclization of unsaturated ureas (5.50) onto 
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unactivated alkenes.181  While catalytic Pd was necessary for cyclization to occur in the 
presence of PIDA, the more active oxidant formed from PhIO and TMSOTf 
(PhI(OTMS)(OTf)) formed isourea compound 5.51 in the absence of Pd.  Only trace 
quantities of the diamination product 5.52 were observed.  The reaction was found to 
proceed with PIDA in the presence of TMSOTf as well. 
Scheme 5.11: Michael's urea cyclization 
 
A number of Lewis and Brønsted acids such as TIPSOTf, TfOH, Tf2O, HBF4, 
BF3·OEt2, (R)-CSA, Sc(OTf)3, Zn(OTf)2, TFA, BzOH, and AcOH were able to promote 
the reaction.  Interestingly, the ratio of oxyamination to diamination (5.51:5.52) was found 
to be highly dependent on the strength of the acid used.  Stronger acids such as TfOH and 
(R)-CSA furnished isourea 5.51 in >20:1 ratio.  In contrast, the use of weaker acids such 
as BzOH or AcOH reversed the selectivity, giving urea 5.52 in 1:>20 ratio of 5.51:5.52.  
The authors attribute the greater preference for oxygen attack under strongly acidic 
conditions to the greater nucleophilicity of the oxygen atom. 
The authors investigated the effect of N-substituents in the reaction.  A 3-
trifluoromethylphenyl group proceeded well and gave the isourea product exclusively.  An 
N-Benzoyl substrate also proceeded, though the urea product was also isolated.  
Surprisingly, when N-alkyl substituted ureas were used, 7-membered ring compound 5.53 
was isolated instead (Scheme 5.12).  The authors undertook an investigation into the 
reaction scope.  Polycyclic products such as 5.54 and 5.55 could be formed efficiently and 
internal alkenes were tolerated.  Compound 5.56 could be formed using a Z-methyl 
substrate, though a reasonable amount of the 7-membered ring side-product 5.57 was also 
formed.  When germinal, disubstituted alkenes were used, eliminated product 5.60 was 
obtained in addition to the expected 5.59.   
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Scheme 5.12: Scope of Michael's urea cyclization 
 
The authors advanced a mechanism wherein the alkene is initially activated by the 
potent electrophile PhI(OTMS)(OTf) (Scheme 5.13).  When R is an electron-deficient 
group such as Ts, the initial nucleophilic attack by nitrogen gives intermediate 5.62.  
Subsequent intramolecular attack by either O (strongly acidic conditions) or N (weakly 
acidic conditions) in a 5-exo fashion leads to products 5.51 or 5.52 respectively.  In 
contrast, when 562 contains an electron-rich N-alkyl group, 7-exo attack predominates, 
leading to 7-membered ring product 5.65.  In this intermediate, no further intramolecular 
attack is possible.  The aryoiodanyl group is instead displaced by the triflate counterion, to 
give product 5.65.   
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Scheme 5.13: Mechanism of regiodivergent product formation 
 
A few years later, the Michael group reported a PIDA-mediated regioselective 
aminotrifluroracetoxylation of alkenes (Scheme 5.14).182  When sulfonyl alkene 5.66 was 
treated with PIDA activated by TFA, they were surprised to isolate 6-endo product 5.67 as 
opposed to the expected 5-exo product.  The reaction was found to be tolerant of a variety 
of ring sizes and N-substituents.  When screening the scope of the cyclization with various 
tethers, the authors found the reaction to be anti-selective in the case of the 6-endo 
cyclization, as opposed to the syn selectivity which would be the result of a double SN2 
displacement mechanism that is usually proposed in electrophilic cyclizations.  The authors 
proposed the initial formation of aziridinium ion 5.75 after the initial iodonium opening.  
Nucleophilic attack on the aziridinium would yield the product as the observed anti-
diastereomer. 
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Scheme 5.14: (A) Michael's oxidative aminotrifluoroacetoxylation reaction with selected scope; 
(B) Mechanism of 6-endo product formation 
 
Oxidative cyclization strategies have also been applied to the synthesis of aromatic 
heterocycles such as benzofurans and 2-nitrobenzofurans (Scheme 5.15).  Liu and 
coworkers synthesized a variety of nitrobenzofurans (5.80) by treating nitro compound 
5.79 with PIDA and NEt3.
183  The addition of TBAI was also found to be beneficial.  A 
wide variety of heterocycles could be synthesized in this manner.    A related report by 
Wirth furnished benzofurans (5.82) from styrenes (5.81) using PIDA in MeCN.184  A wide 
variety of substrates were amenable to the cyclization conditions. 
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Scheme 5.15: (A) Liu's oxidative nitrobenzofuran synthesis; (B) Wirth's oxidative furan synthesis 
 
 5.1.2.b. Iodine(III)-mediated Cyclizations Involving Alkynes 
 Iodine(III) oxidants have been used to synthesize a variety of heterocycles from 
alkynes through electrophilic cyclization.  An early report came from the labs of Tellitu 
and Dominguez.185  In their study, they performed the cyclization of N-substituted amides 
(5.83) to form pyrrolidinones (5.84, Scheme 5.16).  In previous work, they had 
demonstrated a similar reaction using N-aryl amides and it was believed that these reactions 
proceeded through acyl-nitrenium intermediates.  The authors were surprised to find that 
substituents that should not stabilize the nitrenium, such as alkyl, allyl, and benzyl groups, 
were also competent to undergo the cyclization.  The authors also subjected carboxylic acid 
5.85, which is incapable of forming a nitrenium, to similar conditions, giving lactone 5.86. 
Scheme 5.16: Oxidative cyclizations on alkynes 
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 With this data, the authors speculated that the reaction proceeds via a different 
mechanism (Scheme 5.17).  Instead of forming a nitrenenium ion (5.92), the PIFA serves 
to electrophilically activate the alkyne, giving intermediate 5.88.  Nucleophilic attack by 
the nitrogen yields vinyliodane 5.89.  Displacement of the aryliodane by the 
trifluoroacetate counterion generates the final pyrrolidinone 5.91 after trifluoroacetate 
cleavage.  These observations demonstrate that alkynes are capable of undergoing 
electrophilic activation by hypervalent iodine compounds in a manner analogous to 
alkenes. 
Scheme 5.17: Mechanism of oxidative cyclization on alkynes 
 
 Furans have also been synthesized through oxidative cyclization (Scheme 5.18).  
Liu found that highly unsaturated allylic alcohols of type 5.93 could be treated with PIFA 
along with I2 and NaHCO3 to form furan product 5.94.
186  The reaction was found to be 
amenable to substitution at multiple positions, though highly unsubstituted substrates did 
not cyclize efficiently.  The authors proposed a mechanism similar to that proposed by 
Dominguez and Telliteu.  Furans could also be synthesized by treating propargyl-
substituted β-diketones with PIFA activated by TFA (Scheme 5.18B).187  Furans could be 
obtained after carbonate workup.   
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Scheme 5.18: Furan synthesis by oxidative cyclization by (A) Liu and (B) Saito 
 
 Hanzawa reported a useful synthesis of oxazoles through the oxidative 
cycloisomerization of propargylamide substrates (Scheme 5.19).188  Treatment of 
propargylamide 5.97 with PIDA produced oxazole 5.98.  A screen of solvent conditions 
found HFIPA to be important.  The yield could be further improved by performing the 
reaction in AcOH, though the reaction proceeded more slowly.  The reaction was found to 
be tolerant of several different substituents on the amide including electron-deficient and 
electron-rich aromatics, heteroromatics, alkenes, and alkyl groups.  The authors proposed 
a mechanism in which the oxidant initially activates the alkyne.  Attack by the carbonyl 
gives intermediate 5.100, which is deprotonated to give 5.101.  Cycloisomerization of 
5.101 gives phenyliodonium 5.104 that undergoes nucleophilic attack by AcOH gives the 
final product 5.98. 
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Scheme 5.19: (A) Oxazoles by oxidative cyclization; (B) Mechanism of oxazole formation 
 
 Hou synthesized pyrroles (5.106) through treatment of 3-alkynylamines (5.105) 
with PIDA (Scheme 5.20).189  AcOH was found to be the ideal solvent.  A variety of 
substituents on the tether were tolerated in the cyclization.  Carbocycles have also been 
synthesized by the Fan group by treatment of alkynylmalonate 5.107 with iodosobenzene 
activated by TBAI to give diidomethylene indane substrate 5.108.190  Trifluoroethanol was 
found to be the ideal solvent in this case.  The reaction was found to be tolerant of 
methoxide and halide substitution of the aryl group tether. 
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Scheme 5.20: (A) Hou's oxidative pyrrole synthesis; (B) Fan's oxidative diiodimethylene indane 
synthesis 
 
 5.1.3. Enantioselective Oxidative Cyclizations of Alkenes 
 5.1.3.a. Iodine(III)-promoted cyclizations 
 To date, the use of chiral, hypervalent iodine reagents or catalysts to affect 
enantioselective electrophilic cyclizations remains rare.  The only reports to date come 
from the Fujita lab and involve the use of lactate-derived hypervalent iodine reagents 
5.113a-e & 5.114.191  The initial screen involved the treatment of substrate 5.109 with 
TsOH·H2O as an activating reagent to give endo-tosylate 5.110a as the primary product, 
along with a small amount of exo-tosylate 5.110b (Table 5.1).  Bis-lactate reagent 5.112 
was found to be ideal, giving lactone 5.110a in 97% ee and 65% yield.  They were also 
able to perform the reaction with BF3·Et2O and AcOH, to give acetate 5.114a.  After 
optimization, 5.114a could be obtained in 88% ee and 68% yield with reagent 5.112. 
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Table 5.1: Enantioselective iodine(III)-promoted oxidative cyclizations 
 
Entry Ox* Yield (%) 
(5.110a:5.110b) 
ee 5.110a 
(%) 
ee 5.110b 
(%) 
 
1 5.111a 66 (93:7) 75 18 
2 5.111b 69 (96:4) 90 42 
3 5.111d 70 (96:4) 76 22 
4 5.111e 74 (86:14) 60 28 
5 5.112 65 (95:5) 97 26 
 
Scheme 5.21: Formation of acetate product 5.114a 
 
 In a later report, the authors reported the synthesis of dihydrofuran 5.116 under 
catalytic conditions (Scheme 5.22).192  When aryl iodide 5.114 was utilized along with m-
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CPBA as the terminal oxidant with added TFA, compound 5.116 was isolated in up to 91% 
ee.  This result gives hope that similar cyclizations can be performed using catalytic 
quantities of chiral aryl iodides. 
Scheme 5.22: Enantioselective dihydrofuran synthesis 
 
5.1.3.b. Enantioselective Synthesis of Oxazolines Through Electrophilic  
Cyclization 
 Despite their utility, only a few reports of the enantioselective synthesis of 
oxazolines through electrophilic cyclization have been reported.  Borhan reported a 
chlorocyclization promoted by an amine organocatalyst (Scheme 5.23).193  The authors 
chose amide 5.117 as the ideal substrate for optimization, which cyclized to give oxazoline 
5.118.  After catalyst screening, the authors found cinchonidine dimer (DQDH)2PHAL to 
be the optimum catalyst.  An extensive screen of solvent and chlorine source revealed 
DCDPH (dichlorodiphenyl hydantoin) to be the ideal chlorine source and trifluoroethanol 
to be the ideal solvent.  Under these conditions, chlorooxazoline 5.118 could be obtained 
in 90% ee with catalyst loadings as low as 2%. 
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Scheme 5.23: Borhan's enantioselective chlorocyclization 
 
 The authors then screened the identity of the aromatic substituent on the amide in 
an attempt to increase the selectivity (Scheme 5.24).  They note that that substituent can 
be thought of as a traceless directing group, as the aryl moiety is removed upon oxazoline 
hydrolysis.  Screening a variety of groups revealed that para-substituted aryl groups 
improved the selectivity, while ortho-substituted groups led to highly diminished 
selectivity.  The p-bromophenyl substrate 5.119a was selected as the ideal substrate for 
future reactions.  The authors screened the scope of the reaction of a variety of substrates 
with substitution on the alkene.  The reaction was tolerant of a variety of aryl groups with 
substituents including halogens, electron-withdrawing groups, and electron-donating 
groups.   
Scheme 5.24: Scope of aryl-group substitution in Borhan's chlorocyclization 
 
Chapter 5: Iodine(III) mediated oxidative cyclizations                                    | 173 
 Another particularly striking example of enantioselective cyclization to form 
oxazolines comes from Toste and coworkers (Scheme 5.25b).194  They used phosphoric 
acid 5.124 as a chiral phase-transfer catalyst to promote an electrophilic fluorination 
reaction.  In the reaction, the chiral phosphate solubilizes the electrophilic fluorinating 
reagent Selectfluor to achieve an electrophilic cyclization.  The resulting products are 
highly intriguing, incorporating a stereogenic carbon containing a fluoride, a motif that is 
quite difficult to access.  Amide 5.120 was treated with 5.124 along with Selectfluor and 
proton sponge in fluorobenzene to give spiro-oxazoline 5.121 in excellent yields and ee.  
The reaction was found to be tolerant of halide, alkyl, and electron withdrawing 
substituents on the aryl group.  Dihydropyran and dihydronapthalene substrates also 
underwent in the reaction.  The authors demonstrated the unique mildness of their phase-
transfer methodology by subjecting benzothiophene substrate 5.122a&b to cyclization 
conditions under homogenous (MeCN) and phase-transfer conditions.  While the 
homogenous conditions resulted in a complex mixture of products, the sensitive oxazoline 
5.123a&b could be obtained in reasonable yield and high ee using phase-transfer 
conditions.  This methodology represents a useful method to introduce a stereogenic 
fluoride through electrophilic cyclization.  More generally, the use of anionic phase-
transfer catalysts is a potentially fruitful strategy form many other related transformations. 
Scheme 5.25: Toste's enantioselective electrophilic fluorocyclization 
 
 Electrophilic cyclization has been shown to be a highly versatile method for 
synthesizing heterocycles.  The relatively mild conditions, as well as the wide variety of 
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available electrophiles enable the accessing of many important motifs.  Though 
electrophiles such as halogens are widely used, the use of hypervalent iodine reagents in 
electrophilic cyclization remains relatively rare.  As a part of our program studying the 
reactions of hypervalent iodine reactions, we became interested in other possible 
iodine(III)-promoted electrophilic cyclizations. 
5.2 Initial Reaction Discovery & Optimization 
 In the course of studying palladium-catalyzed oxidative cyclizations, we 
investigated the cyclization of allyl sulfonamide 5.125 to give morpholine 5.126 (Scheme 
5.26).  We discovered that the reaction cold be achieved using a presumed PdII-PdIV 
catalytic cycle with PIDA as the terminal oxidant, though in low yield.  Due to the 
formation other side-products including the 7-endo isomer, we decided to pursue the 
cyclization of the simpler N-allyl amide 5.4a instead.   
Scheme 5.26: (A) Proposed Pd-catalyzed morpholine formation; (B) Initially observed oxazoline 
formation 
 
 To our delight, we discovered that when amide 5.4a was treated with palladium 
pincer complex 5.128 and PIDA in AcOH, the resulting oxazoline 5.127a could be 
obtained in 66% conversion and 46% isolated yield.  Upon further investigation, the 
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reaction was found to proceed in the absence of Pd catalyst.  We hypothesized that the 
reaction proceeds through an electrophilic iodonium species 5.130 (Figure 5.27).  
Subsequent nucleophilic attack by the amide leads to aryliodane species 5.131 which is 
displaced by AcOH to give 5.127a.  Because of the utility of oxazolines in natural-product 
synthesis, medicinal chemistry, and organometallic catalysis, we decided to further 
investigate the generality of this transformation.  A deeper understanding of the behavior 
of the reaction would also facilitate the development of more complicated reaction systems. 
Scheme 5.27: Proposed mechanism of oxazoline formation 
 
Treatment of amide 5.4a with PIDA in AcOH at 50 °C led to low conversion after 
24 h (Table 5.2).  We found that the addition of catalytic amounts of BF3·OEt2 improved 
the conversion and yield somewhat.  In light of this observation, it is possible that the 
increased conversion under the Pd catalyzed conditions proceeds through activation of the 
PIDA by exogenous triflic acid from the Pd catalyst, and not the Pd itself.  Pd could also 
be functioning as a Lewis acid to activate the PIDA.  We found that the use of a 
stoichiometric amount of BF3·OEt2 led to complete conversion.  Further optimization 
revealed that the reaction could also be carried out in DCM with added AcOH with similar 
yields.  The reaction did proceeded in the absence of added AcOH, albeit in lower yield 
and with longer reaction times.  In this case, the trapping acetate nucleophile is provided 
by the oxidant itself.  As was expected, no reaction occurred in the absence of PIDA.  
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Table 5.2: Optimization of cyclization conditions 
 
Entry Additive (eq.) Solvent Temp (°C) Yield (%)a 
1 -- 5:1 AcOH:Ac2O 50 23
b 
2 BF3·OEt2 5:1 AcOH:Ac2O 50 45
c 
3 BF3·OEt2 5:1 AcOH:Ac2O 50 86 
4 BF3·OEt2 5:1 AcOH:Ac2O 25 64 
5d BF3·OEt2 DCM w/ 10 eq. AcOH 25 84 
6e BF3·OEt2 DCM (no AcOH) 25 55 
7f BF3·OEt2 DCM 25 N.R.
 
a. After chromatographic purification; b. 31% conversion after 24h by 1H NMR analysis; c. 68% conversion 
after 24h by 1H NMR analysis; d. Reaction time = 2h; e. Reaction time = 5h; f. Without PIDA 
Observation of the crude 1H NMR spectrum of the product from entry xx showed 
signals shifted relative to the isolated product.  We hypothesized that the BF3 strongly 
coordinates to the oxazoline product, forming a relatively stable adduct.  This tendency 
was confirmed when oxazoline 5.127a was treated with BF3·OEt2 in an NMR tube.  
Complete consumption of the oxazoline product was observed immediately.  
Operationally, we observed that the direct, chromatographic purification of the BF3 adduct 
was problematic, with the product eluting very slowly in a wide band with concomitant 
material loss.  This problem could be solved by quenching the reaction with aqueous NH3.  
This modification significantly improved the isolated yield. 
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5.3. Evaluation of the Substrate Scope 
5.3.1. Synthesis of Starting Materials 
We began our investigation into the scope of the reaction by synthesizing a series 
of amides with varying substitution on the carbonyl portion of the amide.  We treated 
allylamine with either the requisite acid chloride or anhydride (Scheme 5.28, Path A) or 
the mixed ethyl carbonate the carboxylic acid (Scheme 5.28, Path B).  In some cases, 
coupling with DCC gave superior results (Scheme 5.28, Path C).  The results are 
summarized below (Table 5.3).  
Scheme 5.28: Methods for substrate synthesis 
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Table 5.3: Summary of substrate synthesis results 
Entry R Compound Method Yield (%) 
1 
 
a A 78 
2 
 
b B 69 
3 
 
c B 23 
4 
 
d B 53 
5 
 
e A 38 
6 
 
f B 76 
7 
 
g B 64 
8  h A 36 
9  i B 77 
10  j A 50 
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11  k A 76 
12  l A 48 
13  m A 90 
14 
 
n C 69 
 
We also synthesized a set of substrates that contained stereogenic carbons in order 
to evaluate the diastereoselectivity of the cyclization.  To install a stereogenic element on 
the fragment bound to the carbonyl, we began by forming the carbamate of (L)-valine 
(5.132, Scheme 5.29).  Attempts to form the amide through DCC coupling led to formation 
of 5.133.  However, we were unable to separate 5.133 from the dicylohexylurea byproduct.  
Using method B instead cleanly led to formation of substrate 5.133, albeit in low yield.   
Attempts to synthesize substrates with stereogenic elements on the nitrogen-bound 
portion of the molecule were significantly more difficult. (Figure 5.29).  We synthesized 
compound 5.136 from (L)-phenylalaninol 5.135 and benzoyl chloride.  Attempts to oxidize 
the alcohol to an aldehyde were met with difficulty.  A variety of conditions including 
Parikh-Doering, Swern, and DMP oxidations were screened.  The aldehyde from 
successful oxidations was found to be highly unstable.  After screening a variety of 
oxidation conditions, we found that Swern oxidation on 5.137 followed by immediate 
Wittig olefination gave compound 5.138 in low yield. 
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Scheme 5.29: Synthesis of substrates containing a stereogenic carbon 
 
We envisioned that internal alkenes could be accessed through the use of cross-
metathesis on substrate 5.4a.  However, attempts to affect the cross-metathesis were met 
with no observed reactivity.  We decided to instead furnish the amides from the requisite 
amines, which could in turn be accessed from the appropriate alcohol (5.140a&b).  A 
procedure involving the conversion of the alcohol to the trifluoroacetate mixed-anhydride 
followed by displacement with sodium azide, immediate Staudinger reduction, and 
acidification with p-toluenesulfonic acid allowed the tosylate salt of the amines (5141a&b) 
to be isolated as stable solids.195  This procedure was selected because it did not require the 
isolation or even concentration of the potentially explosive azide intermediates or volatile 
amines.  The amides (5.142) could be formed directly from tosylate salts 5.141 using 
conditions A, though with additional added base (Figure 5.30), giving the desired amides 
in reasonable yield. 
Scheme 5.30: Synthesis of substrates containing an internal alkene 
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5.3.2. Evaluation of the Substrate Scope 
We began by evaluating the effect of substrate substitution at R (Table 5.4).  The 
reaction was tolerant of a wide-variety of aromatic substituents.  Both electron rich and 
poor aromatic substituents were suitable in the reaction (Entries 1-5).  Additionally, both 
nitrogen and oxygen heteroaromatic compounds were tolerated (Entries 6-7).  The 2-
pyridyl substrate 5.4a cyclized more slowly and with decreased yield.  The decrease in rate 
could be due to competitive coordination of the BF3 Lewis acid to the Lewis basic pyridyl 
group.  The high polarity of the substrate could have also complicated the isolation of the 
product.  Surprisingly, furan substrate 5.4g cyclized with no observed Friedel-Crafts 
products.   
The reaction of vinyl-substituted substrate 5.4h led to decomposition.  However, 
cinnamyl-substituted substrate 5.4i proceeded normally.  Attempts to perform the reaction 
with aliphatic substituents were more problematic.  The resulting oxazolines were highly 
polar and difficult to visualize on a TLC plate.  As such, their chromatographic isolation 
resulted in significantly diminished yields.  When the yield of aliphatic products 5.4j and 
5.4k was determined by 1H NMR spectroscopy using mesitylene as an internal standard, 
the yields improved.  Trifluoroacetate substrate 5.4l resulted in decomposition and 
malonate ester product 5.4n proceeded with only trace-products observed.  The 
unreactivity of malonate 5.4n is again likely due to competitive coordination of 5.4n with 
the BF3·OEt2 Lewis acid. 
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Table 5.4: Summary of substrate scope 
  
Entry R Compound Time (h) Yield (%) a 
1 
 
a 2 84 
2 
 
b 2 77 
3 
 
c 2 68 
4 
 
d 2 85 
5 
 
e 2.5 80 
6 
 
f 5.5 44 
7 
 
g 2 75 
8  h 2 decomp. 
9  i 2.5 74 
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10  j 2 24 (48
b) 
11  k 2 57 (78
b) 
12  l 2 decomp. 
13  m 2 decomp 
14 
 
n 2 tracec,d 
a. After chromatographic purification; b. Yield determined by 1H NMR w/ mesitylene as an internal 
standard; c. 3 eq. BF3·OEt2 used; d. <10% observed by 1H NMR. 
     We investigated the influence of a stereogenic carbon on the substrates (Scheme 5.31).  
When substrate 5.134 was subjected to the cyclization conditions, a 1:1 mixture of 
inseparable diastereomers of 5.143 was isolated in good yield.  The low diastereoselectivity 
is not surprising given the relative flexibility of the portion of the molecule that contains 
the stereogenic center as well as its distance from the reacting center.  The influence of a 
stereogenic carbon in 5.138 was significantly higher.  The oxazoline 5.144 was isolated in 
good yield as a 10:1 mixture of diastereomers.  We were able to assign the relative 
stereochemistry in the oxazoline in the major product to be trans through the NOE 
correlation between HA and the isopropyl group (Scheme 5.31).  The JA-JB coupling 
constant was consistent with that observed in an analogous substrate 5.145 prepared by 
Roush and coworkers.196 
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Scheme 5.31: Scope of substrates containing a stereogenic carbon 
 
Attempts to cyclize internal alkenes led the isolation of oxazole 5.146 and oxazoline 
5.147 as the presumed products in low yield.  We speculate that the super leaving-group 
ability of the aryoiodanyl group (~106 x better than triflate) is responsible for this 
observation.197  Fragmentation leads to the relatively more stable (compared to primary) 
carbocation 5.149 (Figure 5.32B).  Elimination leads to either vinyl-oxazoline 5.147 or 
5.150.  An additional oxidation of 5.151 gives the oxazole product 5.146.  Subjecting aryl 
alkene 5.142b to the reaction conditions led to decomposition.  Work subsequent to ours 
by the Nachtsheim group discovered that this problem could be solved through the use of 
TMSOTf as the Lewis acid at cryogenic temperatures to give similar cyclization products 
on internal alkenes.198 
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Scheme 5.32: (A) Attempts to cyclize substrates with internal alkenes; (B) Proposed mechanism 
for product formation 
 
5.4. Experiments with Other Nucleophiles 
We attempted to perform the reaction using nucleophiles other than acetic acid.  To 
our surprise, when we performed the reaction with 10 equivalents of benzoic acid instead 
of acetic acid, the benzoate product 5.154 was obtained along with acetate product 5.127a 
in a 1:1 ratio (Scheme 5.33), despite the large excess of benzoic acid used relative to the 
acetate from the PIDA.  A brief survey of the effect of stoichiometry (Table 5.5) on the 
product ratio revealed that even a full 25 equivalents (leading to a saturated solution of 
benzoic acid) still only resulted in a 1:2.3 ratio of the acetate to the benzoate.  Use of an 
Chapter 5: Iodine(III) mediated oxidative cyclizations                                    | 186 
electron-deficient benzoic acid derivative did not change the ratio of products (Scheme 
5.33).  NaCN did not participate in the nucleophilic displacement, leading to only isolation 
of the acetate product.  We also evaluated the effect of solvent on the product distribution.  
The use of low-polarity solvents led to an increased acetate incorporation, though the effect 
was not particularly pronounced. 
Scheme 5.33: Reactions with added nucleophiles 
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Table 5.5: Effect of stoichiometry and solvent on nucleophile incorporation 
Entry Equiv. BzOH Solvent 5.127a:5.154 
1 1.2 DCM 7.7:1 
2 10 DCM 1:1 
3 25 DCM 1:2.3 
4 10 CCl4 2.6:1 
5 10 benzene 2.0:1 
6 10 CHCl3 1.4:1 
7 10 MeCN 1.3:1 
 
A significant discovery came when the related iodine(III) oxidant PhI(OH)OTs 
(Koser’s reagent) was used in place of PIDA (Scheme 5.34).  In this case, BF3·OEt2 was 
not necessary to obtain conversion to the product.  To our surprise, when the reaction was 
performed with 10 equivalents of either benzoic or acetic acid, tosylate 5.159 was the only 
observed product.  Similarly, use of PIFA led to slightly higher amounts of trifluoroacetate 
incorporation over the benzoate product 5.158, which was not isolated due to instability.   
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Scheme 5.34: Effect of oxidant on reactions with added nucleophile 
 
These observations indicate that the mechanism of this reaction is more 
complicated than that which is usually invoked for iodine(III)-mediated oxidative 
cyclizations.  We propose that the oxidant is initially activated through carboxylate 
extraction by the BF3·OEt2 (Scheme 5.35).  The resulting iodonium cation exists as a tight-
ion pair with the BF3 carboxylate.  After the initial nucleophilic attack, the second 
nucleophilic displacement occurs through the aforementioned tight ion-pair (5.161), 
leading to preferential incorporation of the nucleophile that was initially bound to the 
oxidant.  The product distribution is then governed by the equilibrium distribution of 
carboxylate ligands on the iodine(III) nucleus.  A less polar solvent would result in a 
stronger ion-pair, which would in turn increase the incorporation of the acetate on the 
Iodine nucleus.  Further study is needed to confirm this mechanistic proposal. 
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Scheme 5.35: Revised mechanistic proposal 
 
5.5. Miscellaneous Experiments 
We briefly evaluated cyclization conditions using catalytic quantities of an aryl-
iodide.  Catalytic versions of these reactions would result in simpler purifications and 
would decrease reliance on relatively expensive PIDA as the oxidant.  Catalytic variants 
could also eliminate the need for two potentially competitive nucleophiles, further 
expanding the scope of potential products.  Most importantly, the development of catalytic 
conditions would enable the use of catalytic amounts of chiral aryl-iodide substrates, 
simplifying the discovery of an enantioselective version of this cyclization. 
Using 4-iodotoluene as the iodine source and AcOH/Ac2O as the solvent, we 
screened a wide variety of oxidant sources including m-CPBA, H2O2, benzoyl peroxide, 
oxone, NaBO3, and K2S2O8. We were only able to obtain a small amount of oxidized 
product when oxone or NaBO3 were used as oxidants, even after extended reaction times.  
When DCM was used as the solvent, no conversion was obtained with a variety of terminal 
oxidants with the exception of m-CPBA, which is known to be a good oxidant for catalytic 
iodine(III) oxidations.  However, when the reaction was performed in the absence of 4-
iodotoluene, a similar cyclization occurred to give 5.127a.  Presumably, the reaction 
proceeds through initial formation of the epoxide 5.164, followed by BF3 promoted ring-
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opening.  This reaction is known, though previous observations have demonstrated 
extremely slow epoxidations.  The BF3·OEt2 likely accelerates both steps of the reaction. 
Scheme 5.36: Catalytic oxidation attempts 
 
While we were not able to achieve a useful catalytic version of the reaction (though 
preliminary evidence indicates that it is possible), we decided to investigate 
enantioselective versions of the reaction using stoichiometric amounts of oxidant.  While 
this approach is far from ideal, it would allow us to discover promising oxidant structures 
which could then drive further efforts towards catalytic variants of the reaction.  None of 
the oxidants prepared (5.166 – 5.168) resulted in cyclization. 
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Scheme 5.37: Enantioselective cyclization attempts 
 
We also attempted to apply our conditions to iodine(III)-promoted oxidative 
cyclizations on several other substrates.  We prepared trichloroacetimidate 5.169 from allyl 
alcohol.  A successful cyclization of substrate 5.169 would result in isomeric oxazoline 
5.170.  Additionally, the well-established use of stereoselective aza-Claisen 
rearrangements would give branched alkenes that could lead to potentially useful 
oxazolines in enantioenriched form.199  When substrate 5.169 was subjected to the reaction 
conditions, a complex mixture of at least two compounds which could not be separated 
resulted.  The similarity of 1H NMR signals between the two products led us to speculate 
that there might be a competitive BF3 promoted aza-Claisen rearrangement
200 followed by 
cyclization, resulting in a mixture of oxazolines 5.170 and 5.127m.  Using Koser’s reagent 
instead did not lead to improvement in the reaction.   
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Scheme 5.38: Trichloroacetimidate cyclization attempts 
 
We also attempted the cyclization of amide 5.171 to give potentially useful 
oxindole product 5.172.  When a variety of arylamides were subjected to the reaction 
conditions with both PIDA and Koser’s reagent, only decomposition was observed.  
Methylated analogue 5.173 gave similar results.  To date, we have not observed any other 
successful cyclization reactions under our previously reported conditions, though we 
believe these problems could be overcome.   
Scheme 5.39: Oxindole formation attempts 
 
5.6 Conclusion 
In conclusion, we developed an oxidative cyclization of N-allylamides to form 
oxazolines.ix  The reaction was highly tolerant of a number of substituents, though aliphatic 
substrates did not perform as well.  Internal alkenes were not tolerated under our reaction 
                                                          
ix Published as: Moon, N. G.; Harned, A. M. Tetrahedron Letters 2013, 54, 2960-2963. 
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conditions.  We also uncovered the likely role of a tight-ion pair in the reaction mechanism, 
leading to preferential incorporation of the carboxylate species present on the iodine prior 
to reaction initiation.  This observation will aid in future reaction development both in our 
and others’ labs. 
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Materials & Methods 
 
Unless otherwise stated, reactions were performed in flame- or oven-dried glassware 
under an argon or nitrogen atmosphere using anhydrous solvents. Tetrahydrofuran 
(THF) was distilled from sodium/benzophenone or purchased in anhydrous form from 
Sigma Aldrich. Unless otherwise stated, reactions were monitored using thin-layer 
chromatography (TLC) using plates precoated with silica gel XHL w/ UV254 (250 mm) 
and visualized by UV light or KMnO4, phosphomolybdic acid, or anisaldehyde stains, 
followed by heating. Silica gel (particle size 32–63 mm) was used for flash column 
chromatography. 1H and 13C NMR spectra are reported relative to the residual solvent 
peak (δ 7.26 and δ 77.16 for 1H and 13C in CDCl3, δ 3.31 and δ 49.0 for 1H and 13C in 
CD3OD, respectively), or tetramethylsilane (δ 0.00 for 1H) when the residual solvent 
peak is obscured. Data for 1H NMR spectra are reported as follows: chemical shift 
(ppm) (multiplicity, coupling constant (Hz), integration). Multiplicity is described using 
the following abbreviations: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, bs = broad singlet, app = apparent. FTIR samples were prepared on NaCl 
plates either neat or by evaporation from CHCl3 or CH2Cl2. 
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Chapter 3 Experimental 
 
 
2-bromo-4-methylphenol (3.14): 
p-Cresol (10.0 g, 92.5 mol, 1 eq.) and KBr (12.1 g, 101.7 mmol, 1.1 eq.) were suspended 
in MeOH (470 mL, 0.2M).  Oxone (62.5 g, 101.7 mmol, 1.1 eq.) was added and the 
mixture was stirred until the reaction was complete by TLC.  The mixture was filtered 
and the MeOH was removed by rotary evaporation and purified by filtration through a 
silica plug with EtOAc.  The material was isolated as a reddish oil (18.18 g, 81% w/w, 
85% yield).  The remainder of the material was determined to be EtOAc by 1H NMR 
spectroscopy.  The crude xx was carried forward into the next step without further 
purification. 
1H NMR (500 MHz, CDCl3) δ 7.27 (dd, J = 0.6, 1.9 Hz, 1H), 7.01 (dd, J = 1.7, 8.2 Hz, 
1H), 6.90 (d, J = 8.3 Hz, 1H), 2.26 (s, 3H). 
 
 
2-bromo-4-hydroxy-4-methylcyclohexa-2,5-dien-1-one (3.19): 
2-bromo-4-methyl phenol (6.17 g 85 wt %, 5.00g actual, 26.73 mmol, 1 eq.) and 4-
iodotoluene (1.16 g, 5.35 mmol, 0.2 mmol) were dissolved in MeCN:H2O (2:1).  m-
CPBA (55 wt%, 16.8g, 53.5 mmol, 2 eq.) was added and the solution was stirred at 
room temperature for 18h.  Solid Na2S2O3 (13.3 g, 23.7 mmol, 1 eq.) was added and the 
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mixture was stirred for 1h.  NaHCO3 (4.5 g) was added and the mixture was stirred 15 
min.  The mixture was partially concentrated under vacuum and diluted with 50 mL 
H2O.  The aqueous layer was extracted with 3 x 50 mL DCM.  The combined organic 
extracts were washed with brine, dried with Na2SO4 and concentrated.  Purification by 
f.c.c. (1:2 EtOAc:Hexane) gave the product as a yellow solid (2.55g, 47%).  
1H NMR (500 MHz, CDCl3) δ 7.33 (d, J = 2.9 Hz, 1H), 6.91 (dd, J = 2.8, 10.0 Hz, 1H), 
6.24 (d, J = 10.0 Hz, 1H), 1.52 (s, 3H). 
 
 
2-iodobenzoyl chloride: 
o-Iodobenzoic acid (5.0 g, 20.16 mmol, 1 eq.) was suspended in DCM along with 5 
drops of DMF.  The suspension was cooled to 0 °C and (COCl)2 was added dropwise.  
The solution was stirred for 18h and concentrated under vacuum to give a yellow solid 
(5.25 g, 98%) which was stored under nitrogen in the freezer.  The compound was used 
without further purification. 
 
 
(S)-N-(1-hydroxy-3-phenylpropan-2-yl)-2-iodobenzamide (3.21a): 
(L)-Phenylalaninol (170.5 mg, 1.12 mmol, 1.2 eq.) was suspended in DCM (5 mL) and 
NEt3 (200 mg, 1.97 mmol, 2.1 eq.) was added.  The solution was cooled to 0 °C and o-
iodobenzoyl chloride (250 mg, 0.94 mmol, 1 eq.) dissolved in ~1 mL DCM was added 
dropwise.  The solution was stirred overnight, allowing the reaction mixture to come to 
room temperature.  The solution was quenched with 10 mL of saturated NaHCO3.  The 
mixture was diluted with DCM (~20 mL) until all solids dissolved.  The layers were 
separated and the aqueous layer was extracted with 3 x 5 mL DCM.  The combined 
organic layers were washed with brine, dried with Na2SO4, dried and concentrated.  The 
crude mixture was recrystallized from EtOAc:Hexane to give white crystals (262 mg, 
73%). 
1H NMR (500 MHz, CDCl3) δ 7.82 (dd, J = 0.8, 8.0 Hz, 1H), 7.21-7.33 (m, 7H), 7.07 
(dt, J = 1.5, 7.7 Hz, 1H), 6.10 (bd, J = 7.5 Hz, 1H), 4.42-4.36 (m, 1H), 3.81 (dd, J = 3.6, 
11.2 Hz, 1H), 3.70 (dd, J = 4.7, 11.2 Hz, 1H), 3.00 (d, J = 7.4 Hz, 2H), 2.62 (bs, 1H). 
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13C NMR (125 MHz, CDCl3, DEPT) δ 166.85 (C), 142.19 (C), 139.91 (CH), 137.63 
(C), 131.27 (CH), 129.50 (CH) 128.84 (CH), 128.30 (CH), 128.24 (CH), 126.89 (CH), 
100.11 (C), 92.54 (C), 63.76 (CH2), 53.38 (CH), 36.98 (CH2). 
 
 
 
 
(S)-N-(2-hydroxy-1-phenylethyl)-2-iodobenzamide (3.21b): 
Compound 3.2b was synthesized in the same manner and scale as 3.21a.  The 
compound was isolated in 68% yield. 
 
1H NMR (300 MHz, CDCl3) δ 7.87 (dd, J = 0.9, 8.0 Hz, 1H), 7.33-7.49 (m, 7H), 7.12 
(dt, J = 1.9, 7.6 Hz, 1H), 6.47 (bd, J = 6.8 Hz, 1H), 5.29 (dt, J = 4.7, 7.3 Hz- 1H), 4.05 
(d, J = 4.6, 2H), 2.41 (bs, 1H). 
 
 
(S)-4-benzyl-2-(2-iodophenyl)-4,5-dihydrooxazole (3.22a): 
Amide 3.21a (100 mg, 0.26 mmol, 1 eq.) and NEt3 (132 mg, 1.31 mmol, 5 eq.) were 
dissolved in DCM (2 mL, 0.15 M).  TsCl (68 mg, 0.36 mmol, 1.3 eq.) was added and 
the solution was heated under N2 at 55 °C for 6.5 h.  H2O (0.4 mL) was added and the 
temperature was increased to 75 °C for 2h.  The reaction was cooled to rt and let stand 
overnight.  The solution was quenched with 5 mL saturated NH4Cl.  The aqueous layer 
was extracted with 3 x 5 mL DCM.  The combined organic extracts were washed with 
brine, dried with Na2SO4 and concentrated.  The compound was purified by f.c.c. (1:4 
EtOAc:Hexane) to give 3.22a (77 mg, 81%). 
 
1H NMR (500 MHz, CDCl3) δ 7.93 (app. d, J = 7.9 Hz, 1H), 7.59 (dd, J = 1.5, 7.7 Hz, 
1H), 7.39-7.22 (m, 6H), 7.11 (ddd, J = 0.9, 7.3, 8.1 Hz, 1H), 4.67-4.61 (m, 1H), 4.39 (t, 
J = 8.9 Hz, 1H), 4.18 (t, J = 7.9 Hz, 1H), 3.26 (dd, J = 5.4, 13.8 Hz, 1H), 2.82 (dd, J = 
8.4, 13.8 Hz, 1H). 
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(S)-2-(2-iodophenyl)-4-phenyl-4,5-dihydrooxazole (3.22b): 
The reaction was performed using the same procedure reported for 3.22a using 200 
mg (0.54 mmol) of 3.21b.  Compound 3.22b was isolated (148.1 mg,79%) 
 
1H NMR (300 MHz, CDCl3) δ 7.98 (dd, J = 1.1, 8.0 Hz, 1H), 7.72 (dd, J = 1.7, 7.7Hz, 
1H), 7.44-7.32 (m, 6H), 7.15 (dt, J = 1.7, 7.7 Hz, 1H), 5.46 (dd, J = 86, 10.2 Hz, 1H), 
4.85 (dd, J = 8.4, 10.2 Hz, 1H), 4.30 (t, J = 8.5 Hz, 1H). 
 
 
(S)-3,4-dibenzyl-2-(2-iodophenyl)-4,5-dihydrooxazol-3-ium tetrafluoroborate 
(3.23a): 
Oxazoline 3.22a (25 mg, 0.069 mmol, 1 eq.) was dissolved in MeCN (0.45 mL, 0.15 
M).  BnBr (353 mg, 0.206 mmol, 3 eq.) was added and the mixture was stirred at 80 °C 
for 18 h.  The solution was concentrated under vacuum to remove excess BnBr.  The 
crude material was dissolved in DCM and AgBF4 was added.  The mixture was stirred 
for 15 min., filtered, and concentrated to give 3.23a as a brown solid (49.4 mg, <100%), 
which was used directly without further purification. 
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(S)-3-benzyl-2-(2-iodophenyl)-4-phenyl-4,5-dihydrooxazol-3-ium 
tetrafluoroborate (2.32b): 
Oxazoline 3.22b (20 mg, 0.0572 mmol) was dissolved in chlorobenzene (0.1 mL) and 
BnBr (9.8 mg, 0.572 mmol, 1 eq.) was added.  The mixture was stirred for 18 h at 130 
°C.  After concentration, successful benzylation was confirmed by MS.  The salt 
metathesis was performed in an analogous manner.  The final salt was isolated as a 
brown salt (11.2 mg, 37%). 
 
 
(1R,4S)-3-(hydroxyimino)-1,7,7-trimethylbicyclo[2.2.1]heptan-2-one (S1): 
KOt-Bu (8.85g, 78.8 mmol, 1.2 eq.) was suspended in THF (26 mL) and cooled to ‒20 
°C.  (R)-(+)-Camphor (10.0 g, 65.7 mmol, 1 eq.) dissolved in THF (14 mL) was added 
dropwise and stirred for 10 min.  n-Butyl nitrite (8.13 g, 78.8 mmol, 1.2 eq.) was added 
dropwise.  The solution was stirred for 30 min. at ‒20 °C and allowed to warm to rt.  
The solution was stirred at rt for 18 h.  The THF was removed under vacuum and ~60 
mL H2O was added and was acidified with HCl.  The aqueous layer was extracted with 
3 x 20 mL Et2O.  The combined organic layers were washed with brine, dried with 
Na2SO4, and concentrated.  The crude material was recrystallized from pentane to give 
oxime S1 (5.17 g, 43%). 
 
1H NMR (500 MHz, CDCl3) δ 9.93 (bs, 1H), 3.25 (d, J = 4.5 Hz, 1H), 2.10-1.97 (m, 
1H), 1.81-1.70 (m, 1H), 1.56 (td, J = 5.9, 9.0 Hz, 2H), 1.00 (s, 3H), 0.97 (s, 3H), 0.85 
(s, 3H). 
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(1S,2R,3S,4R)-3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-2-aminium 
methanesulfonate (3.24): 
LiAlH4 (630 mg, 16.6 mmol, 1.2 eq.) was suspended in Et2O (70 mL) and cooled to ‒
78 °C.  Oxime S1 (2.5 g, 13.8 mmol, 1 eq) was added.  The solution was allowed to 
warm to rt and stirred for 18 h.  The reaction was quenched with 1.5 mL H2O followed 
by 1.5 mL of 3M NaOH sol’n then 4.5 mL H2O.  The mixture was stirred for 1h, filtered, 
and concentrated.  The crude mixture was redissolved in 10 mL Et2O and 
methanesulfonic acid (1.33g, 13.8 mmol, 1 eq.) was added.  The salt was collected as a 
precipitate from ether (569.3 mg, 16%). 
 
N-((1S,2R,3S,4R)-3-hydroxy-4,7,7-trimethylbicyclo[2.2.1]heptan-2-yl)-2-
iodobenzamide (3.25): 
 
Amino-alcohol 3.24 (150 mg, 0.41 mmol, 1.1 eq.) and NEt3 (165 mg, 1.64 mmol, 4 eq.) 
were dissolved in DCM (2 mL) and cooled to 0 °C.  o-Iodobenzoyl chloride was added 
and the reaction was allowed to stir for 18 h.  The reaction was quenched with 5 mL 
saturated NaHCO3 and extracted with 3 x 2 mL DCM.  The combined organic layers 
were washed with brine, dried with Na2SO4 and concentrated.  The amide was purified 
by f.c.c. (5% MeOH in DCM) to give product 3.25 (127 mg, 85%). 
 
 1H NMR (500 MHz, CDCl3) δ 7.86 (dd, J = 0.5, 8.0 Hz, 1H), 7.37-7.36 (m, 2H), 7.09 
(ddd, J = 3.2, 5.9, 8.0 Hz, 1H), 6.47 (bd, J = 3.6 Hz, 1H), 3.99 (t, J = 6.8 Hz, 1H), 3.90 
(dd, J = 3.9, 7.6 Hz, 1H), 2.27 (d, J = 3.7 Hz, 1H), 2.01 (d, J = 4.5 Hz, 1H), 1.77 (tt, J 
= 4.6, 12.4 Hz, 1H), 1.54 (dt, J = 4.1, 12.5 Hz, 1H), 1.25 (ddd, J = 3.8, 9.3, 12.8 Hz, 
1H), 1.13 (s, 3H), 1.08 (ddd, J = 5.6, 3.5, 14.7 Hz, 1H), 0.96 (s, 3H), 0.84 (s, 3H). 
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13C NMR (125 MHz, CDCl3, DEPT) δ 169.40 (C), 142.53 (C), 140.04 (CH), 131.12 
(CH), 128.26 (CH), 128.17 (CH), 92.83 (C), 80.06 (CH), 58.47 (CH), 50.29 (CH), 49.43 
(C), 47.10 (C), 33.36 (CH2), 26.39 (CH2), 21.66 (CH3), 21.44 (CH3), 11.45 (CH3). 
 
 
(3aR,4S,7R,7aS)-2-(2-iodophenyl)-7,8,8-trimethyl-3a,4,5,6,7,7a-hexahydro-4,7-
methanobenzo[d]oxazole (3.26): 
 
Amide 3.25 (10 mg, 0.025 mmol, 1 eq.) was suspended in benzene (0.1 mL) in a 
sealed tube.  TFA (~1 drop) was added.  The mixture was stirred for 10 min. at rt then 
heated to 140 °C for 2h.  The reaction was quenched with aqueous NaHCO3 and 
extracted with EtOAc (3 x 1 mL).  The combined organic extracts were washed with 
brine, dried with Na2SO4 and concentrated.  The product was purified by f.c.c. (1:6 to 
1:2 EtOAc:Hexane) to give oxazoline 3.26 (4.6 mg, 48%). 
 
1H NMR (500 MHz, CDCl3) δ 7.96 (dd, J = 1.0, 8.0 Hz, 1H), 7.66 (dd, J = 1.6, 7.7 
Hz, 1H), 7.37 (dt, J = 1.1, 7.7 Hz, 1H), 7.09 (dt, J = 1.5, 7.7 Hz, 1H), 4.45 (d, 8.6, 
1H), 4.26 (d, J = 8.6 Hz, 1H), 2.21 (d, J = 4.6 Hz, 1H), 1.82-1.75 (m, 1H), 1.58-1.52 
(m, 3H), 1.12-1.08 (m, 4H), 1.03 (m, 3H), 0.89 (s, 3H). 
 
 
o-(hydroxymercuri)-1-napthoic acid anhydride (S2): 
Napthoic anhydride (5.00 g, 25.22 mmol, 1 eq.) was suspended in an aqueous NaOH 
sol’n prepared from NaOH (3.53 g, 88.27 mmol, 3.5 eq.) in 150 mL H2O.  The 
suspension was refluxed until all solids had dissolved.  Excess NaOH was neutralized 
with glacial AcOH.  Hg(OAc)2, prepared by dissolving HgO (6.00 g, 27.7 mmol, 1.1 
eq.) in 14 mL hot, glacial acetic acid and diluting with 30 mL H2O, was added in one 
portion.  The solution was refluxed for 30 min. and an additional 5 mL AcOH was 
added.  The reaction mixture was refluxed for an additional 48 h and cooled to rt.  The 
resulting solid was filtered, washed with H2O and dried under vacuum, giving the 
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product (7.84g, 84%) which was stored in the freezer and used without further 
purification.   
 
 
8-iodo-1-naphthoic acid (3.27) 
Organomercury compound S2 (3.0 g, 8.1 mmol, 1 eq.) and KI (5.64 g, 34.02 mmol, 4.2 
eq.) were suspended in H2O.  I2 (2.16 g, 8.5 mmol, 1.05 eq.) was added and the solution 
was refluxed for 15 h.  The solution was cooled to rt and filtered.  The filtrate was 
quenched with NaS2O3 and acidified with HCl.  The resulting solid was filtered and 
recrystallized from CHCl3 to give 3.27 as a white solid (514.6 mg, 21%). 
 
1H NMR (500 MHz, DMSO-d6) δ8.27 (d, J = 7.3 Hz, 1H), 8.07-8.04 (m, 2H), 7.70 (d, 
J = 7.1 Hz, 1H), 7.58-7.55 (m, 1H), 7.30-7.27 (m, 1H). 
 
 
(S)-N-(1-hydroxy-3-methylbutan-2-yl)-8-iodo-1-naphthamide (3.28): 
8-Iodo-1-napthoic acid (500 mg, 1.67 mmol, 1 eq.) was suspended in DCM (7 mL) 
along with 1 drop of DMF.  (COCl)2 (276 mg, 2.17 mmol, 1.3 eq.) was added dropwise 
and stirred for 18 h.  The solvent and excess (COCl)2 was removed under vacuum and 
the crude product was used directly.  (S)-Valinol (215 mg, 2.08 mmol, 1.3 eq.) and NEt3 
(506 mg, 5.01 mmol, 3.0 eq.) were dissolved in DCM (4 mL) and cooled to 0 °C.  The 
crude acid chloride in 8 mL DCM was added dropwise and stirred for 18 h.  The reaction 
was diluted with DCM (10 mL) and quenched with 1M HCl (10 mL).  The aqueous 
layers were extracted with 2 x 10 mL DCM.  The organic layers were washed with 
brine, dried with Na2SO4 and concentrated.  The product was recrystallized from 
EtOAc:Hexane to give the product (245.7 mg, 38%). 
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1H NMR (500MHz, CDCl3) δ 8.24 (dd, J = 1.1, 7.4 Hz, 1H), 7.86 (ddd, J = 1.0, 4.6, 
8.1 Hz, 2H), 7.62 (d, J = 6.8 Hz, 1H), 7.43 (dd, J = 7.1, 8.1 Hz, 1H), 7.16 (t, J = 7.8 Hz, 
1H), 6.26 (bs, 1H), 3.97 (d, J = 9.4 Hz, 2H), 3.88-3.86 (m, 1H), 2.09 (dd, J = 6.5, 13.2 
Hz, 1H), 1.07 (d, J = 6.9 Hz, 3H), 1.05 (d, J = 6.8 Hz, 3H). 
 
(S)-2-(8-iodonaphthalen-1-yl)-4-isopropyl-4,5-dihydrooxazole (3.29): 
 
SOCl2 (1.85 g, 15.6 mmol, 120 eq.) was cooled to 0 °C.  Amide 3.28 (50 ng, 0.13 mmol, 
1 eq.) in DCM (1.5 mL) was added dropswise.  The solution was allowed to warm 
slowly to rt and stirred for 24 h.  The solution was concentrated under vacuum to remove 
excess SOCl2.  The product was dissolved in 10 mL DCM and washed with 10 mL 1M 
NaOH.  The aqueous layer was washed with 2 x 5 mL DCM.  The combined organic 
layers were washed with brine, dried with Na2SO4 and concentrated.  The product was 
purified by f.c.c. (1:4 EtOAc:Hexane) to give product xx (29.9 mg, 63%). 
 
1H NMR (500 MHz, CDCl3) δ 8.24 (dd, J = 1.2, 7.4 Hz, 1H), 7.87 (ddd, J = 1.1, 8.2, 
16.8 Hz, 2H), 7.80 (dd, J = 1.2, 7.1 Hz, 1H), 7.47 (dd, J = 7.1, 8.2 Hz, 1H), 7.13 (dd, J 
= 7.4, 8.1 Hz, 1H), 4.64-4.60 (m, 1H), 4.25 (t, J = 7.8 Hz, 1H), 4.19 (d, J = 5.3 Hz, 1H), 
2.06-2.00 (m, 1H), 1.13 (d, J = 6.4 Hz, 3H), 1.02 (d, J = 6.8 Hz, 3H). 
 
 
2-iodo-4,6-dimethylaniline (3.30):  
4,6-Dimethylaniline (1.5 g, 12.37 mmol, 1 eq.) and NaHCO3 (3.2 g, 37.1 mmol, 3 eq.) 
were suspended in DCM:H2O (75 mL total, 2:1 DCM:H2) and stirred vigorously.  I2 
(3.14 g, 12.37 mmol, 1 eq.) and the mixture was stirred for 18 h.  The organic layer was 
separated and the aqueous layer was washed with 2 x 20 mL DCM.  The combined 
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layers were washed with brine, dried with Na2SO4 and concentrated to give 3.30 as a 
brown, sticky solid (2.22 g, 73%). 
 
1H NMR (500 MHz, CDCl3) δ 7.36 (app. s, 1H), 6.84 (app. s, 1H), 3.93 (s, 2H), 2.20 
(s, 3H), 2.19 (s, 3H). 
 
N-(2-iodo-4,6-dimethylphenyl)pivalamide (S3): 
Iodoaniline 3.30 (250 mg, 1.01 mmol, 1 eq.) was dissolved in DCM (1 mL).  NaOH (1 
mL of a 10% aqueous sol’n) was added and the mixture was stirred vigorously for 4h.  
The aqueous layer was diluted with 5 mL H2O and extracted with 2 x 2 mL DCM.  The 
combined organic layers were washed with brine, dried with Na2SO4 and concentrated.  
Purification by f.c.c. (1:5 EtOAc:Hexane) gave amide S3 (160.7 mg, 46%). 
 
1H NMR (500 MHz, CDCl3) δ 7.50 (app. s, 1H), 7.01 (app. s, 1H), 2.26 (s, 3H), 2.21 
(s, 3H), 1.59 (s, 1H), 1.37 (s, 9H). 
 
N-(2-iodo-4,6-dimethylphenyl)isobutyramide (S4): 
The reaction was performed in the same manner and on the same scale as in the previous 
example.  Compound S4 was isolated in 24% yield. 
 
1H NMR (500 MHz, CDCl3) δ 7.51 (dd, J = 0.6, 1.3 Hz, 1H), 7.02 (d, J = 0.4 Hz, 1H), 
6.80 (bs, 1H), 2.62 (td, J = 6.9, 13.9 Hz, 1H), 2.26 (s, 3H), 2.23 (s, 3H), 1.32 (d, J = 6.9 
Hz, 6 H). 
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N-(2-iodo-4,6-dimethylphenyl)-N-methylpivalamide (3.31a): 
Iodoamide S3 (50 mg, 0.15 mmol, 1 eq.) was dissolved in THF (1.5 mL) and cooled to       
0 °C.  NaH (8 mg of a 60 wt% powder in mineral oil, 0.19 mmol, 1.25 eq.) was added 
and the solution was stirred at 0 °C for 30 min.  MeI was added and the solution was 
allowed to warm to rt and stirred for 18 h.  The solution was quenched with aqueous 
NH4Cl (5 mL) and extracted with 3 x 2 mL EtOAc.  The combined organic layers were 
washed with brine, dried with Na2SO4 and concentrated.  The crude product was 
purified by f.c.c. (1:6 EtOAc:Hexane) to give a white solid (33.1 mg, 64%).  A small 
amount of material could be resolved through repeated injections onto an analytical-
scale HPLC column (2% i-PrOH in Hexane, 1 mL/min, Chiralcel OJ, approx.. 8 
injections) and collection of the resulting waste stream. 
 
1H NMR (500 MHz, CDCl3) δ 7.53 (dd, J = 0.6, 1.3 Hz, 1H), 7.01 (td, J = 0.6, 1.3 Hz, 
1H), 3.08 (s, 3H), 2.28(+) (s, 3H), 2.28(-) (s, 3H), 1.05 (s, 9H). 
 
 
N-(2-iodo-4,6-dimethylphenyl)-N-methylisobutyramide (3.31b): 
The reaction was performed on S4 (50 mg, 0.157 mmol) in the same manner as 3.31a 
to give 3.31b after purification by f.c.c. (1:6 EtOAc:Hexane) (37.1 mg, 71%). A small 
amount of material could be resolved through repeated injections onto an analytical-
scale HPLC column (2% i-PrOH in Hexane, 1 mL/min, Chiralcel OJ, approx.. 8 
injections) and collection of the resulting waste stream. 
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1H NMR (500 MHz, CDCl3) δ 7.57 (dd, J = 0.6, 1.3 Hz, 1H), 7.05 (07, 1.3 Hz, 1H), 
3.09 (s, 3H), 2.28 (s, 3H), 2.24 (s, 3H), 2.19 (tt, J = 5.9, 12.0 Hz, 1H), 1.13 (d, J = 6.7 
Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H). 
 
2,2,2-trifluoro-N-(2-iodo-4,6-dimethylphenyl)acetamide (S5): 
Iodoaniline 3.30 (50 mg, 0.2 mmol, 1 eq.) was dissolved in DCM (1 mL).  NEt3 (41 mg, 
0.4 mmol, 2 eq.) was added and the solution was cooled to 0 °C.  TFAA (53 mg, 0.25 
mmol, 1.25 eq.) was added.  The reaction was allowed to warm to rt and stirred for 24h.  
TLC showed incomplete conversion.  An additional ~10 µL of TFAA and ~10 mg 
DMAP were added and stirred an additional 24h, at which time full consumption was 
achieved.  The reaction was quenched with 5 mL saturated NaHCO3 and the aqueous 
layer was extracted with 3 x 2 mL DCM.  The combined organic layers were washed 
with brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:6 
EtOAc:Hexane) gave the product (37.6 mg, 55%). 
 
1H NMR (500 MHz, CDCl3) δ 7.69 (s, 1H), 7.55 (d, J = 0.6 Hz, 1H), 7.06 (s, 1H), 2.29 
(s, 3H), 2.24 (s, 3H). 
 
N-benzyl-2,2,2-trifluoro-N-(2-iodo-4,6-dimethylphenyl)acetamide (3.32b): 
Trifluoroacetamide S5 (37.6 mg, 0.11 mmol, 1 eq.), Cs2CO3 (71 mg, 0.22 mmol, 2 eq.), 
BnBr (19 mg, 0.17 mmol, 1.5 eq.), and NaI (18 mg, 0.12 mmol, 1.1 eq.) were dissolved 
in DMF (1 mL) and stirred at rt for 48 h.  The reaction mixture was diluted with 5 mL 
H2O and extracted with 3 x 2 mL EtOAc.  The combined organic layers were washed 
with brine, dried with Na2SO4 and concentrated.  The crude material was purified by 
f.c.c. (1:20 EtOAc:Hexane) to give the product (26.6 mg, 56%). 
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1H NMR (500 MHz, CDCl3) δ 7.62 (dd, J = 0.6, 1.3 Hz, 1H), 7.32-7.24 (m, 3H), 7.22-
7.19 (m, 2H), 6.90 (dd, J = 0.7, 1.3 Hz, 1H), 5.59 (d, J = 13.8 Hz, 1H), 4.14 (d, J = 13.8 
Hz, 1H), 2.28 (s, 3H), 1.50 (s, 3H). 
 
 
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-iodobenzamide) (3.35): 
Cyclohexanediamine tartrate (500 mg, 1.88 mmol, 1 eq.) was suspended in Et2O (13 
mL) and NaOH (15 mL of a 2M sol’n, 30 mmol, 16 eq.) was added.  o-Iodobenzoyl 
chloride was added and the mixture was stirred vigorously overnight.  The resulting 
solid was filtered to give bis-amide 3.35 (216.5 mg, 20%) as a white solid. 
 
1H NMR (500 MHz, DMSO-d6) δ 8.30 (t, J = 7.7 Hz, 2H), 7.86 (dd, J = 1.0, 7.9 Hz, 
2H), 7.41 (dt, J = 1.1, 7.5 Hz, 2H), 7.30 (dd, J = 1.7, 7.6 Hz, 2H), 7.13 (dt, J = 1.7, 7.7 
Hz, 2H), 3.80 (td, J = 4.4, 9.5 Hz, 2H), 1.93 (d, J = 13.3 Hz, 2H), 1.72 (dd, J = 2.5, 
5.2 Hz, 2H), 1.48-1.41 (m, 2H), 1.28-1.24 (2H). 
 
 
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-iodo-N-methylbenzamide) (3.36a): 
Bis-amide 3.35 (50 mg, 0.087 mmol, 1 eq.) was dissolved in DMF (0.9 mL).  NaH (10 
mg of a 60 wt% slurry in mineral oil, 0.26 mmol, 3 eq.) was added and the mixture was 
stirred for 15 min.  MeI (37 mg, 0.26 mmol, 3 eq.) was added and the mixture was 
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stirred for 18 h.  The solution was diluted with 5 mL H2O and extracted with 3 x 2 mL 
EtOAc.  The combined organic fractions were washed with brine, dried with Na2SO4 
and concentrated.  The compound was purified by f.c.c. (1:4 to 1:2 EtOAc:Hexane) to 
give the product as a white solid (40.1 mg, 76%).  The structure was confirmed by MS.  
MS (ESI+) Calc’d for C22H24I2N2O2Na+ 624.9819, found 624.9830. 
 
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-iodo-N-(2-
(perfluorophenyl)ethyl)benzamide) (3.36c): 
Compound xx was synthesized in the same manner as 3.36a, but Pentafluorobenzyl 
bromide was utilized as the electrophile.  The compound was purified by f.c.c. (1:6 
EtOAc:Hexane) to give the product as a white solid (54.8 mg, 67%).  The compound 
identity was confirmed by MS 
MS (ESI+) Calc’d for C34H22F10N2O2Na+ 956.9503 found 956.9531. 
 
(1R,2R)-N1,N2-dibenzylcyclohexane-1,2-diamine (S6): 
R,R-Cyclohexadiamine tartrate (500 mg, 1.88 mmol, 1 eq.) and K2CO3 (519.6 mg. 3.76 
mmol, 2 eq.) were stirred in H2O (2.5 mL) until all solids had dissolved.  EtOH (10 mL) 
was added and heated to reflux.  Benzaldehyde (399.0 mg, 3.76 mmol, 2 eq.) in EtOH 
(4 mL) was added slowly over 30 min. The solution was refluxed for 2.5 h and cooled 
to rt.  H2O (2.5 mL) was added and the mixture was placed in the freezer for 5.5 h.  The 
solvent was removed and the aqueous layer was extracted with 3 x 10 mL DCM.  The 
combined organic layers were washed with brine, dried with Na2SO4 and concentrated.  
The crude material (369.7 mg, 68%) was pure by 1H NMR spectroscopy and was used 
directly in the next step. 
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The bis-imine (345.5 mg, 1.2 mmol, 1 eq.) from the previous step was dissolved in 
MeOH (2.5 mL).  NaBH4 was added portionwise and stirred for 24 h.  The reaction was 
quenched by added H2O (3 mL) dropwise to the solution.  The solution was extracted 
with 3 x 3 mL DCM.  The combined organic layers were washed with brine, dried with 
Na2SO4 and concentrated.  The compound was pure by 
1H NMR spectroscopy (299.2 
mg, 85%). 
 
N,N'-((1R,2R)-cyclohexane-1,2-diyl)bis(2-iodobenzamide) (3.36b): 
Bis-benzyl cyclohexanediamine S6 (100 mg, 0.34 mmol, 1 eq.) was dissolved in DCM 
(2 mL) and NEt3 (103 mg, 0.68 mmol, 2 eq.) and DMAP (~10 mg) were added.  The 
solution was cooled to 0 °C and 2-iodobenzoyl chloride was added and the solution was 
stirred for 18 h.  The reaction was quenched with 5 mL saturated NaHCO3.  The solution 
was extracted with 3 x 2 mL DCM.  The combined organic layers were washed with 
brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:4 to 1:2 
EtOAc:Hexane) gave the product as a white solid (158.1 mg, 62%).  The product was 
confirmed by MS. 
MS (ESI+) 777.0445 calc’d for C34H32I2N2O2Na+, 777.0282 found. 
 
N,N'-((1R,2R)-1,2-diphenylethane-1,2-diyl)bis(2-iodobenzamide) (S7): 
R-R-DPEN (100 mg, 0.47 mmol, 1 eq.) was dissolved in DCM (5 mL).  NEt3 (190 mg, 
1.88 mmol, 4 eq.) and DMAP (6 mg, 0.05 mmol, 0.1 eq.) were added and the solution 
was cooled to 0 °C.  o-Iodobenzoyl chloride (263 mg, 0.99 mmol, 2.1 eq.) was added.  
The solution was allowed to warm slowly to rt and stirred at rt for 18h.  The reaction 
was quenched with aqueous HCl and filtered. To give 259.8 mg of a white solid (82%) 
which was carried forward directly. 
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N,N'-((1R,2R)-1,2-diphenylethane-1,2-diyl)bis(2-iodo-N-methylbenzamide) 
(3.39a): 
Bis-amide S7 (50 mg, 0.074 mmol, 1 eq.) was dissolved in DMF (0.75 mL) and NaH 
(12 mg of a 60% suspension, 0.3 mmol, 4 eq.) was added.  The solution was stirred for 
10 min. and MeI (42.6 mg, 0.3, 4 eq.) was added.  The solution was stirred for 48 hours.  
The solution was diluted with 5 mL H2O and extracted with 3 x 2 mL EtOAc.  The 
combined organic fractions were washed with brine, dried with Na2SO4 and 
concentrated.  Purification by f.c.c. (1:4 EtOAc:Hexane) gave the product as a white 
solid (21.8 mg, 42%).  The product identity was confirmed by MS. 
MS (ESI+) 723.0 found for C30H26I2N2O2Na
+, 723.1 found. 
 
N,N'-((1R,2R)-1,2-diphenylethane-1,2-diyl)bis(N-benzyl-2-iodobenzamide) 
(3.39b): 
Compound S7 was made using the same procedure as was used to make 3.39b. 
MS (ESI+) 875.0602 calc’d for C42H34I2N2O2Na+, 875.0668 found. 
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(S)-N,N'-([1,1'-binaphthalene]-2,2'-diyl)bis(2-iodobenzamide) (S8): 
R-BINAM (100 mg, 0.35 mmol, 1 eq.) was dissolved in DCM (3 mL).  2M NaOH (3 
mL, 6 mmol, 15 eq.) was added followed by o-iodobenzoyl chloride.  The mixture was 
stirred vigorously for 18h.  The solid product was filtered and dried under vacuum.  The 
product amide was isolated as a white solid (266.8 mg, 87%) and used directly in the 
next step. 
 
(S)-N,N'-([1,1'-binaphthalene]-2,2'-diyl)bis(2-iodo-N-methylbenzamide) (3.41a): 
Bis-amide (S8) (50 mg, 0.067 mmol, 1 eq.) was dissolved in DMF (0.7 mL) and NaH 
(8 mg of a 60% dispersion in mineral oil, 0.2 mmol, 3 eq.) was added.  The solution 
was stirred for 15 min. and MeI (30 mg, 0.2 mmol, 3 eq.) was added.  The solution was 
stirred for 18 h.  The reaction was quenched with H2O (5 mL) and extracted with 3 x 2 
mL EtOAc.  The combined organic layers were washed with brine, dried with Na2SO4 
and concentrated.  Purification by f.c.c. (1:4 EtOAc:Hexane) gave the product as a white 
solid (33.1 mg, 64%).  The product was confirmed by MS. 
 
MS (ESI+) 794.9976 calc’d for C36H26I2N2O2Na+, 795.0 found. 
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(S)-N,N'-([1,1'-binaphthalene]-2,2'-diyl)bis(N-benzyl-2-iodobenzamide) (xx): 
Compound S8 was synthesized on in the same manner using BnBr as the electrophile, 
along with 0.2 eq. NaI (~2 mg).  Compound xx could be obtained after f.c.c. (1:4 
EtOAc:Hexane) (22.7 mg, 37%).  The compound was confirmed by mass spectrometry. 
 
MS (ESI+) 947.0602 calc’d for C48H34I2N2O2Na+, 947.1 found. 
 
((2R,2'R)-[2,2'-bipyrrolidine]-1,1'-diyl)bis((2-iodophenyl)methanone) (3.43): 
(2R,2’R)-2,2’-bipyrrolidine (30 mg, 0.214 mmol, 1 eq.) was dissolved in DCM.  NEt3 
(87 mg, 0.856 mmol, 4 eq.) and DMAP (~10 mg) were added and the solution was 
cooled to 0 °C.  o-Iodobenzoyl chloride (128.3 mg, 0.48 mmol, 2.25 eq.) was added and 
the solution was allowed to warm to rt and stirred overnight.  The reaction was quenched 
with 5 mL NaHCO3 and extracted with 3 x 2 mL DCM.  The combined organic extracts 
were washed with brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:4 
EtOAc:Hexane) gave 3.43 as a white solid (77.5 mg, 60%). 
 
1H NMR (500 MHz, CDCl3) δ 7.80 (dd, J = 0.8, 8.0 Hz, 2H), 7.39 (dd, J = 1.6, 7.6 Hz, 
2H), 7.28 (dd, J = 1.0, 7.5 Hz, 2H), 7.01 (dt, J = 1.6, 7.7 Hz, 2H), 4.61-4.60 (m, 2H), 
3.55 (ddd, J = 4.4, 9.0, 10.6 Hz, 1H), 3.07 (td, J = 7.9, 10.6 Hz, 2H), 2.27-2.18 (m, 2H), 
2.11-2.04 (m, 2H), 1.97 (dtd, J = 4.4, 8.0, 15.9 Hz, 2H), 1.81 (ddd, J = 3.4, 8.0, 12.0 
Hz, 2H). 
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dimethyl (2R,3R)-2,3-bis((2-iodobenzoyl)oxy)succinate (3.45): 
(+)-Dimethyl tartrate (250 mg, 2.8 mmol, 1 eq.), o-iodobenzoic acid (690 mg, 5.6 mmol, 
2 eq.) and DMAP (35 mg, 0.28 mmol, 0.1 eq.) were suspended in DCM (8 mL) and 
cooled to 0 °C.  DCC (580 mg, 5.6 mmol, 2 eq.) was added and the reaction mixture 
was stirred at rt for 18 h.  The solid was filtered off and the resulting filtrate was washed 
with saturated NaHCO3 (10 mL) and brine.  The solution was dried with Na2SO4 and 
concentrated to give 3.45 as a white solid (635.5 mg, 36%). 
 
1H NMR (500 MHz, CDCl3) δ 8.02 (dd, J = 1.1, 8.0 Hz, 2H), 7.96 (dd, J = 1.7, 7.8 Hz, 
2H), 7.43 (dt, J = 1.2, 7.6 Hz, 2H), 7.20 (dt, J = 1.7, 7.7 Hz, 2H), 6.06 (s, 2H), 3.83 (s, 
6H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 166.19 (C), 164.81 (C), 141.80 (CH), 133.61 
(CH), 133.02 (C), 132.01 (CH), 128.26 (CH), 94.83 (C), 71.73 (CH), 53.49 (CH3).  
 
 
(R)-[1,1'-binaphthalene]-2,2'-diyl bis(2-iodobenzoate) (3.47): 
(R)-BINOL (50 mg, 0.175 mmol, 1 eq.) and DMAP (~10 mg) was dissolved in pyridine 
(0.6 mL) and cooled to 0 °C.  o-Iodobenzoyl chloride was added and the reaction was 
stirred at rt for 24 h.  The reaction was quenched with 10 mL H2O.  The aqueous layer 
was extracted with 3 x 5 mL DCM.  The combined organic layers were washed with 10 
  
Appendix 1  234 
mL 10% HCl and brine, dried with Na2SO4 and concentrated to give 3.47 as a white 
solid (106.4 mg, 81%). 
 
1H NMR (500 MHz, CDCl3) δ 8.05 (d, J = 8.8 Hz, 2H),  7.95 (d, J = 8.2 Hz, 2H), 7.85-
7.82 (m, 2H), 7.63 (d, J = 8.9 Hz, 2H), 7.47 (ddd, J = 1.7, 6.4 8.2 Hz, 2H), 7.42-7.32 
(m, 4H), 7.09 (dt, J = 1.3, 7.5 Hz, 2H), 7.01 (dd, J = 1.9, 7.7 Hz, 2H), 6.95 (dd, J = 1.7, 
6.7 Hz, 2H). 
 
General Procedure for Enantioselective Dearomatization: 
 
The appropriate phenol (amount) and catalyst (amount) were dissolved in MeCN:H2O 
(3:1) (amount).  m-CPBA was added and the solution was stirred for 18 h.  The 
reaction was quenched with 2 mL 10% aq. Na2S2O3 (2 mL) and saturated aq. 
NaHCO3.  The reaction was stirred for 15 min and extracted with 3 x 2 mL EtOAc.  
The combined organic fractions were dried with Na2SO4 and concentrated.  The 
product was purified by f.c.c. (1:4 to 1:2 EtOAc:Hexane).  The ee was determined by 
chiral HPLC (Compound 3.19: 8% i-PrOH in Hexane, Chiralcel OD-H, 1 mL/min; 
Compound 3.72: 10% i-PrOH in Hexane, Chiralcel OD-H, 1 mL/min.) 
 
 
 
3-bromo-1-methyl-4-oxocyclohexa-2,5-dien-1-yl tert-butyl malonate (3.13): 
Quinol 3.19 (2.56g, 12.6 mmol, 1 eq.), t-butyl malonate half ester (4.03g, 25.2 mmol, 2 
eq.), and DMAP (154 mg, 0.126 mmol, 0.1 eq.) were dissolved in DCM (30 mL) and 
cooled to 0°C.  DCC (5.20g, 25.2 mmol, 2 eq.) was added and the mixture was stirred 
overnight.  The reaction mixture was diluted with DCM and filtered through celite.  The 
organic filtrate was washed with saturated NaHCO3 (25 mL).  The organic layers were 
washed with brine, dried with Na2SO4 and concentrated.  The compound was purified 
by f.c.c. (1:4 EtOAc:Hexane) to give a yellow solid (3.59g, 82%).  
 
1H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 2.93 Hz, 1H), 6.93 (dd, J = 2.9, 10.1 Hz, 
1H), 6.37 (d, J = 10.1 Hz, 1H), 3.29 (s, 2H), 1.61 (s, 3H), 1.48 (s, 9H). 
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tert-butyl (2a1S*,5aS*)-5a-methyl-2,3-dioxo-2a1,2b,3,5a-
tetrahydrocyclopropa[cd]benzofuran-2a(2H)-carboxylate (3.12): 
 
Malonate 3.13 (1.15g, 3.33 mmol, 1 eq.) was dissolved in MeCN and K2CO3 (460 mg, 
3.33 mmol, 1 eq.) was added.  The mixture was stirred overnight.  The solution was 
diluted with ethyl acetate, filtered through a plug of florisil, and concentrated to give a 
yellow solid (844mg, 96%).  The cyclopropane was used without further purification as 
it was found to be unstable to chromatographic purification.  
 
1H NMR (500 MHz, CDCl3) δ 6.87 (dd, J = 0.2, 10.0 Hz, 1H), 6.19 (dd, J = 1.2, 9.8 
Hz, 1H), 3.18 (dd, J = 0.2, 7.5 Hz, 1H), 3.03 (dd, J = 1.2, 7.5 Hz, 1H), 1.80 (s, 3H), 
1.51 (s, 9H). 
 
  
tert-butyl (2a1S*,5aR*)-5a-methyl-2,3-dioxo-5-(p-
tolylthio)hexahydrocyclopropa[cd]benzofuran-2a(2H)-carboxylate (3.50): 
 
Cyclopropane 3.12 (10 mg, 0.038 mmol, 1 eq.) and p-toluenethiol (6 mg, 0.046 mmol, 
1.2 eq.) were dissolved in MeCN (0.15 mL).  The solution was heated to 50 °C for 1h 
20 min.  The solvent was removed and the compound was purified by f.c.c (1:2 
EtOAc:Hexane) to give sulfide 3.50 (10 mg, 60%). 
 
1H NMR (500 MHz, CDCl3) δ 7.34-7.32 (m, 2H), 7.17-7.15 (m, 2H), 3.56 (dd, J = 2.1, 
4.6 Hz, 1H), 3.08 (d, J = 7.3 Hz, 1H), 2.84 (td, J = 1.0, 7.3 Hz, 1H), 2.66 (ddd, J = 0.7, 
4.6, 18.7 Hz, 1H), 2.57 (ddd, J = 1.4, 1.9, 18.7 Hz, 1H), 2.35 (s, 3H), 1.88 (s, 3H), 1.50 
(s, 9H). 
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tert-butyl (3aS*,7aS*)-7a-methyl-2,5-dioxo-4-tosyl-2,3,3a,4,5,7a-
hexahydrobenzofuran-3-carboxylate (3.49): 
 
The cyclopropane 3.12 (844 mg, 3.19mmol, 1 eq.) and Ni(ClO4)2·6H2O (116mg, 0.32 
mmol, 0.1 eq.) were dissolved in DMF (13 mL).  Sodium p-toluenesulfinate hydrate  
(1.70g, 9.58 mmol, 3 eq.) was added and the mixture was stirred at 75 °C for 3h.  The 
reaction was cooled to room temperature and quenched with 50 mL of a 10% NaHSO4 
solution.  The mixture was extracted with 3 x 25 mL EtOAc, washed with brine, dried 
with Na2SO4, filtered and concentrated giving a tan solid (893 mg, 67%) which was 
used without further purification. 
 
IR (thin film) 2979, 2933, 2874, 1788, 1730, 1680, 1319, 1149 cm-1. 
1H NMR (500 MHz, CDCl3)  δ 7.68 – 7.67 (m, 2H), 7.39 (d, J=8.1 Hz, 2H), 6.79 (dd, 
J=1.8, 10.5 Hz, 1H), 6.21 (d, J=10.5 Hz, 1H), 4.13 (ddd, J=1.6, 1.6, 12.5 Hz, 1H), 3.99 
(d, J=0.7 Hz, 1H), 3.27 (d, J=12.4 Hz, 1H), 2.48 (s, 3H), 2.01 (s, 3H), 1.50 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 186.33 (C), 167.30 (C), 164.18 (C), 147.76 
(CH), 146.27 (C), 134.69 (C), 130.21 (CH), 129.16 (CH), 128.96 (CH), 84.48 (C), 79.50 
(C), 70.01 (CH), 52.55 (CH), 43.27 (CH), 28.06 (CH3), 25.67 (CH3), 21.96 (CH3).  
HRMS (ESI+) 443.1135 calc’d for C21H24O7SNa+, found 443.1444. 
 
 
(3aS*,7aS*)-7a-methyl-4-tosyl-3a,7a-dihydrobenzofuran-2,5(3H,4H)-dione (3.51): 
 
Sulfone ester 3.49 (893 mg, 2.12 mmol, 1 eq.) was dissolved in TFA (15 mL) and stirred 
at rt for 3 h.  The TFA was removed under vacuum and the residue was dissolved in 
THF (15 mL).  The solution was treated with NEt3 (1.07g, 10.6 mmol, 5 eq.) and the 
solution was heated to 60 °C for 1.5 h.  The reaction was cooled to rt and quenched with 
75 mL of 10% NaHSO4 solution.  The mixture was extracted with 3 x 25 mL EtOAc.  
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The combined organic extracts were washed with brine, dried with Na2SO4, filtered, 
and concentrated to give a brown solid (454mg, 3:1 dr, 67%).  The substrate was used 
without further purification. 
 
IR (thin film) 2931.88, 1780.28, 1682.99, 1318.30, 1148.37 cm-1. 
1H NMR (500 MHz, CDCl3) Major δ 7.66-7.68 (m, 2H), 7.38-7.40 (m, 2H), 6.78 (dd, 
J=1.8, 10.5 Hz, 1H), 6.20 (d, J=10.4 Hz, 1H), 3.94 (d, J=1.2 Hz, 1H), 3.84 (dddd, J=1.6, 
1.6, 9.2, 12.2 Hz, 1H), 2.89 (dd, J=9.2, 17.5 Hz, 1H), 2.45 (s, 3H), 2.40 (dd, J=12.4, 
17.7 Hz, 1H), 1.99 (s, 3H).  Minor δ 7.97-7.99 (m, 2H), 7.38-7.40 (m, 2H), 6.67 (dd, 
J=2.0, 10.2 Hz, 1H), 6.02 (d, J=10.2 Hz, 1H), 4.17 (d, J=4.7 Hz, 1H), 3.61 (dddd, J=2.0, 
4.7, 8.2, 12.9 Hz, 1H), 3.07 (dd, J=8.3, 18.0 Hz, 1H), 2.69 (dd, J=12.4, 18.0 Hz, 1H), 
2.46 (s, 3H), 1.73 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 186.61 (C), 171.95 (C), 147.68 (CH), 146.24 
(C), 134.43 (C), 130.15 (CH), 129.16 (CH), 128.62 (CH), 81.15 (C), 7.45 (CH), 39.45 
(CH), 35.43 (CH2), 25.78 (CH3), 21.95 (CH3). 
HRMS (ESI+) 343.0611 calc’d for C16H16O5SNa+, 343.0553 found. 
 
 
 
 
 
 
 
(3aS*,7aS*)-4,7a-dimethyl-4-tosyl-3a,7a-dihydrobenzofuran-2,5(3H,4H)-dione 
(3.11): 
 
The sulfone (200 mg, 0.62 mmol, 1 eq.), 18-crown-6 (15 mg, 0.06 mmol, 0.1 eq.), 
K2CO3 (102 mg, 0.74 mmol, 1.2 eq.), and MeI (880 mg, 6.2 mmol, 10 eq.) were 
suspended in toluene (6.2 mL) and stirred for 18 h at which time an additional 100 mg 
K2CO3  and 15 mg 18-crown-6 was added.  The reaction was stirred for an additional 
24 h and quenched with 10 mL 10% aq. HCl.  The reaction mixture was extracted with 
3 x 10 mL DCM (NOTE: The product is much less soluble in EtOAc).  The combined 
organic layers were washed with brine, dried with Na2SO4, filtered, and concentrated 
to give a brown solid (190.4 mg, 86% pure by 1H NMR, 79%).  This solid was used 
without further purification. 
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IR (thin film) 2927.38, 1787.09, 1773.95, 1302.40, 1145.34 cm-1 
1H NMR (500 MHz, CDCl3) δ 7.97-7.99 (m, 2H), 7.37-7.38 (m, 2H), 6.68 (dd, J=1.8, 
10.3 Hz, 1H), 6.03 (d, J=10.2Hz, 1H), 3.30-3.23 (m, 2H), 3.08-3.01 (m, 1H), 2.46 (s, 
3H), 1.78 (s, 3H), 1.51 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 191.989 (C), 172.91 (C), 146.15 (CH), 145.77 
(C), 133.76 (C), 131.76 (CH), 129.44 (CH), 127.55 (CH), 82.11 (C), 71.35 (C), 47.16 
(CH), 34.44 (CH2), 26.47 (CH3), 23.65 (CH3), 21.86 (CH3). 
HRMS (ESI+) 357.0767 calc’d for C17H18O5SNa+, 357.0782 found. 
 
 
2-bromocyclohexan-1-one (3.59): 
 
Cyclohexanone (1.00 g, 10.18 mmol, 1 eq.) and NBS (1.90 g, 10.68 mmol, 1.05 eq.) 
were suspended in Et2O (10 mL).  NH4OAc (7 mg, 0.1 mmol, 0.1 eq.) was added and 
the reaction was stirred at rt for 30 min.  The mixture was filtered and the filtrate was 
washed with H2O, dried with Na2SO4 and concentrated.  The product was 92% pure by 
1H NMR spectroscopy (1.62g, 90%). 
 
1H NMR (300 MHz, CDCl3) δ 4.44 (ddd, J = 1.4, 4.7, 6.2 Hz, 1H), 3.03-2.93 (m, 1H), 
2.38-2.17 (m, 3H), 2.09-1.68 (m, 4H). 
 
 
2-tosylcyclohexan-1-one (3.61): 
2-Bromocyclohexan-1-one (500 mg, 2.82 mmol, 1 eq.) and sodium p-toluenesulfinate 
(1.5g, 8.47 mmol, 3 eq.) were combined in DMF (10 mL) and heated to 75 °C for 1 h.  
The solution was cooled to rt and quenched with 50 mL H2).  The mixture was extracted 
with 3 x 15 mL EtOAc.  The combined organic extracts were washed with saturated 
NaHCO3, 5% aqueous LiCl, and brine, dried with Na2SO4 and concentrated to give a 
product that was 92% pure by 1H NMR spectroscopy (687.8 mg, 89%). 
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1H NMR (500 MHz, CDCl3) δ 7.77-7.75 (m, 2H), 7.35-7.33 (m, 2H), 3.81-3.79 (m, 
1H), 2.82 (ddd, J = 5.7, 10.1, 14.5 Hz, 1H), 2.58-2.53 (m, 1H), 2.45-2.40 (m, 4H), 2.23-
2.20 (m, 2H), 2.03-1.99 (m, 1H), 1.86-1.71 (m, 3H). 
 
 
2-methyl-2-tosylcyclohexan-1-one (3.61): 
Sulfone 3.61 (250 mg, 0.99 mmol, 1 eq.) was dissolved in DMF (4 mL).  MeI (703 mg, 
4.95 mmol, 5 eq.) and K2CO3 (274 mg, 1.98 mmol, 2 eq.) were added and the solution 
was stirred at rt for 18 h.  The reaction was quenched with 20 mL H2O and the mixture 
was extracted with 3 x 10 mL EtOAc.  The combined organic fractions were washed 
with brine, dried with Na2SO4, and concentrated to give product 3.62 as a white solid 
(226mg, 72%). 
 
1H NMR (500 MHz, CDCl3) δ 7.62 (d, J = 8.3 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 3.14 
(ddd, J = 6.5, 12.4, 14.9 Hz, 1H), 2.89-2.83 (m, 1H), 2.58-2.53 (m, 1H), 2.47-2.37 (m, 
4H), 2.18-2.11 (m, 1H), 1.81-1.68 (m, 3H), 1.23 (s, 3H). 
 
 
 
 
 
 
 
2-(1-hydroxy-3-phenylpropyl)-2-methylcyclohexan-1-one (3.63): 
Sulfone 3.62 (10 mg, 0.037 mmol, 1 eq.) was dissolved in THF (0.2 mL) and cooled to 
‒78 °C.  SmI2 (0.1M in THF, 1 mL, 0.1 mmol) was added (0.8 mL at first) dropwise.  
At this point, investigation by TLC revealed incomplete reaction.  An additional 0.2 mL 
SmI2 solution was added, at which time the reaction was deemed to be complete by 
TLC.  The reaction was quenched with 0.2 mL saturated NH4Cl and the mixture was 
passed through a florisil plug with EtOAc.  The filtrate was washed with brine, dried 
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with Na2SO4, and concentrated.  Purification by f.c.c (1:6 EtOAc:Hexane) gave the 
product (6 mg, 66%). 
 
1H NMR (500 MHz, CDCl3) δ 7.30-7.27 (m, 2H), 7.23-7.17 (m, 3H), 3.79-3.76 (m, 
1H), 3.51 (d, J = 3.3 Hz, 1H), 2.97 (td, J = 7.1, 13.6 Hz, 1H), 2.66-2.60 (m, 1H), 2.54 
(ddd, J = 61, 12.6, 14.3 Hz, 1H), 2.30-2.35 (m, 1H), 2.02-1.96 (m, 1H), 1.78-1.6 (m, 
6H), 1.19 (s, 3H). 
 
4-hydroxy-2,4-dimethylcyclohexa-2,5-dien-1-one (3.73): 
 
2,4-Dimethylphenol (2.5 g, 20.46 mmol, 1 eq.) was dissolved in MeCN:H2O (100 mL 
3:1 MeCN:H2O) and cooled to 0 °C.  Phenyliodine diacetate (PIDA) (7.25 g, 22.5 
mmol, 1.1 eq.) was added in one portion and the solution was stirred at 0 °C for 1h.  
The solution was partially concentrated under vacuum and the residue was dissolved in 
EtOAc (50 mL) and quenched with saturated, aqueous NaHCO3 (100 mL).  The organic 
layer was separated and the aqueous layer was extracted with 2 x 50 mL of EtOAc.  The 
combined organic fractions were washed with brine, dried with Na2SO4 and 
concentrated.  The compound was purified by f.c.c (1:4 to 1:2 EtOAc:Hexane) to give 
compound 3.73 as a yellow, amorphous solid (1.85 g, 65%). 
 
1H NMR (300 MHz, CDCl3) δ 6.84 (dd, J = 3.1, 10.1 Hz, 1H), 6.64 (dd, J = 1.4, 3.0 
Hz, 1H), 6.10 (d, J = 10.0 Hz, 1H), 2.10 (s, 1H), 1.86 (d, J = 1.3 Hz, 1H), 1.45 (s, 3H). 
 
 
(1R*,4S*,4aR*,8S*,8aS*)-8-hydroxy-6,8-dimethyl-4,4a,8,8a-tetrahydro-1,4-
methanonaphthalen-5(1H)-one (3.73): 
 
Cyclohexadienone 3.73 (250 mg, 1.81 mmol, 1 eq.) was dissolved in DCM (9 mL) and 
cooled to ‒78 °C.  BF3·OEt2 (282 mg, 2.0 mmol, 1.1 eq.) was added followed by 
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cyclopentadiene (239 mg, 3.62 mmol, 2 eq.).  The reaction was stirred at ‒78 °C for 2 
h.  The reaction was quenched with saturated, aqueous NaHCO3 (15 mL).  The aqueous 
layer was extracted with 3 x 10 mL DCM.  The combined organic layers were washed 
with brine, dried with Na2SO4, and concentrated.  Purification by f.c.c. (1:2 
EtOAc:Hexane) gave the product (265.6 mg, 72%). 
 
1H NMR (500 MHz, CDCl3) δ 6.21 (t, J = 1.4 Hz, 1H), 6.10 (dd, J = 2.9, 5.6 Hz, 1H), 
5.78 (dd, J = 2.9, 5.6 Hz, 1H), 3.32 (dq, J = 1.5, 2.7 Hz, 1H), 3.18 (d, J = 0.9 Hz, 1H), 
3.02 (dd, J = 4.4, 8.9 Hz, 1H), 2.71 (ddd, J = 1.3, 3.5, 8.9 Hz, 1H), 1.79 (s, 1H), 1.62 
(d, J = 1.5 Hz, 3H), 1.41 (td, J = 1.8, 8.4 Hz, 1H), 1.37 (s, 3H), 1.33 (d, J = 8.4 Hz, 1H). 
13C NMR (125 MHz, CDCl3) δ 201.16, 149.51, 135.63, 135.24, 134.12, 69.66, 51.37, 
49.25, 48.48, 48.29, 46.64, 35.30, 15.60. 
 
 
1,3-dimethyl-4-oxocyclohexa-2,5-dien-1-yl ethyl malonate (3.76): 
 
Quinol 3.73 (250 mg, 1.8 mmol, 1 eq.), monoethyl malonate (478 mg, 3.62 mmol, 2 
eq.) and DMAP (22 mg, 0.18 mmol, 0.1 eq.) were dissolved in DCM (4.5 mL) and the 
solution was cooled in an ice bath.  DCC (747 mg, 3.62 mmol, 2 eq.) was added.  The 
ice bath was removed and the reaction was stirred at rt for 2 h.  The solution was diluted 
with EtOAc and filtered through celite.  The filtrate was washed with 10 mL saturated 
NaHCO3.  The organic layer was washed with brine, dried with Na2SO4, and 
concentrated.  Purification by f.c.c. (1:4 to 1:2 EtOAc:Hexane) gave the product 3.77 
(360.1 mg, 79%). 
1H NMR (500 MHz, CDCl3) δ 6.88 (dd, J = 3.1, 10.0 Hz, 1H), 6.67-6.66 (m, 1H), 6.22 
(d, J = 10.0 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.35 (s, 2H), 1.90 (d, J = 1.5 Hz, 3H), 
1.55 (s, 3H), 1.29 (t, J = 7.2 Hz, 3H). 
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(1S*,4R*,4aS*,5S*,8aR*)-5,7-dimethyl-8-oxo-1,4,4a,5,8,8a-hexahydro-1,4-
methanonaphthalen-5-yl ethyl malonate (3.75): 
 
Malonate 3.77 (200 mg, 0.792 mmol, 1 eq.) was dissolved in trifluoroethanol (0.8 mL).  
Cyclopentadiene (524 mg, 7.9 mmol, 10 eq.) was added.  The reaction was protected 
from light and stirred for 48h.  The solution was concentrated and purified by f.c.c. (1:4 
to 1:2 EtOAc:Hexane) to give the product (182.9 mg, 73%). 
 
1H NMR (500 MHz, CDCl3) δ 6.39 (quint. J = 1.4 Hz, 1H), 5.96 (dd, J = 2.9, 5.5 Hz, 
1H), 5.72 (dd, J = 2.8, 5.6 Hz, 1H), 4.21 (dq, J = 1.6, 7.2 Hz, 1H), 3.37 (s, 2H), 3.28 
(ddd, J = 1.3, 2.6, 4.0 Hz, 1H), 3.17 (ddd, J = 1.4, 3.3, 8.7 Hz, 1H), 3.04-3.01 (m, 2H), 
1.65 (s, 3H), 1.62 (d, J = 1.5 Hz, 3H), 1.37 (td, J = 1.8, 8.6 Hz, 1H), 1.34-1.32 (m, 1H), 
1.28 (t, J = 7.2 Hz, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 200.44 (C), 166.58 (C), 165.74 (C), 144.40 
(CH), 136.22 (C), 135.52 (CH), 133.77 (CH), 82.17 (C), 61.73 (CH2), 51.68 (CH), 
49.02 (CH2), 48.23 (CH), 47.42 (CH), 46.19 (CH), 42.88 (CH2), 30.51 (CH3), 15.47 
(CH3), 14.21 (CH3). 
 
 
ethyl (5aR*,6S*,9R*,9aS*,9bS*)-4,9b-dimethyl-2,5-dioxo-2,3,3a,4,5,5a,6,9,9a,9b-
decahydro-6,9-methanonaphtho[1,2-b]furan-3-carboxylate (3.78): 
 
Malonate 3.74 (44.6 mg, 0.14 mmol, 1 eq.) was dissolved in MeCN (1.4 mL) and K2CO3 
(21.3 mg, 0.15, 1.1 eq.) was added.  The reaction mixture was heated to 85 °C for 1.5 
h.  The reaction was quenched with 5 mL 10% NaHSO4 solution.  The aqueous layer 
was extracted with 3 x 5 mL EtOAc.  The combined organic layers were washed with 
brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:4 EtOAc: Hexane) 
to give the product as a yellow oil (43.4 mg, 97%). 
 
1H NMR (500 MHz, CDCl3) δ 6.27 (dd, J = 3.1, 5.7 Hz, 1H), 6.05-6.04 (m, 1H), 4.20 
(q, J = 7.1 Hz, 2H), 3.26 (bs, 1H), 3.19 (dd, J = 5.1, 12.2 Hz, 1H), 3.18-3.16 (m, 1H), 
3.08-3.07 (m, 2H), 2.82-2.78 (m, 1H), 2.78 (d, J = 12.2 Hz, 1H), 1.81 (s, 3H), 1.44 (td, 
J = 1.9, 8.6 Hz, 1H), 1.27 (t, J = 7.1 Hz, 3H), 1.25-1.23 (m, 1H), 0.87 (d, J = 6.7 Hz, 
3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 210.46 (C), 170.47 (C), 168.06 (C), 138.57 
(CH), 135.97 (CH), 84.26 (C), 62.48 (CH2), 55.51 (CH), 53.78 (CH), 52.58 (CH), 50.48 
  
Appendix 1  243 
(CH), 48.72 (CH2), 46.61 (CH), 43.95 (CH), 42.37 (CH), 32.91 (CH3), 14.10 (CH3), 
11.96 (CH3). 
 
 
(4R*,5S*)-4-hydroxy-2,4-dimethyl-5-(p-tolylthio)cyclohex-2-en-1-one (3.80): 
 
Quinol 3.72 (1.538 g, 10.41 mmol, 1 eq.) and quinine (170 mg, 0.52 mmol, 0.05 eq.) 
was dissolved in toluene (50 mL) and p-toluenethiol (1.357 g, 10.93 mmol,1.05 eq.) 
was added.  The solution was stirred for8.5 h until all starting material had been 
consumed.  The toluene was removed and the crude material was purified directly by 
f.c.c. (1:4 to 1:2 EtOAc:Hexane) to give compound 3.80 as a yellow oil which solidified 
upon standing (1.851 g, 64%).  
 
IR (thin film) 3446, 3019, 2975, 2922, 1677, 1492, 1360, 1118 cm-1. 
1H NMR (500 MHz, CDCl3) δ7.34-7.37 (m, 2H), 7.10-7.13 (m, 2H), 3.51-3.52 m, 1H), 
3.51 (ddd, J=0.7, 5.3, 8.0 Hz, 1H), 3.10 (s, 1H), 2.93 (dd, J=8.1, 17.0 Hz, 1H), 2.81 (dd, 
J=4.5, 16.8 Hz, 1H), 2.32 (s, 3H), 1.76 (d, J=1.5 Hz, 3H), 1.55 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 196.94 (C), 148.57 (CH), 138.45 (C), 135.35 
(C), 133.46 (C), 130.28 (CH), 130.21 (CH), 70.36 (C), 59.07 (CH), 42.31 (CH2), 27.30 
(CH3), 21.24 (CH3), 15.57 (CH3). 
HRMS (ESI+) 285.0920 calc’d for C15H18O2SNa, found 285.0907. 
 
 
 
4-hydroxy-2,4-dimethyl-3,5-bis(p-tolylthio)cyclohexan-1-one (3.81): 
 
Obtained as a side-product from previous reaction when NEt3 was used as a base. 
1H NMR (500 MHz, CDCl3) δ 7.36-7.34 (m, 2H), 7.29-7.27 (m, 2H), 7.13 (d, J = 7.9 
Hz, 2H), 7.08 (d, J = 7.9 Hz, 2H), 3.73 (dd, J = 5.5, 12.9 Hz, 1H), 3.63-3.58 (m, 1H), 
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3.44 (d, J = 4.7 Hz, 1H), 2.69 (t, J = 13.6 Hz, 1H), 2.60 (dd, J = 5.5, 14.5 Hz, 1H), 2.49-
2.49 (m, 1H), 2.34 (s, 3H), 2.31 (s, 3H), 1.62 (s, 3H), 1.17 (d, J = 6.5 Hz, 3H). 
 
General Procedure for Sulfide Kinetic Resolution: 
 
Quinol 3.72 and the catalyst (0.1 eq) were dissolved in toluene and cooled to 0 °C.  p-
Toluenethiol (0.4 eq.) was added and the mixture was stirred until the reaction had 
reached approximately 40% conversion (as determined by 1H NMR spectroscopy of the 
reaction mixture).  The mixture was quenched with 10% aq. HCl and extracted with 
EtOAc.  The combined organic fractions were concentrated.  The conversion was 
determined by 1H NMR spectroscopy.  The ee values were determined using chiral 
HPLC (CHIRALPAK AS, 7% EtOH in i-PrOH, 0.75 mL/min).  The starting material 
eluted at 8.24 and 9.79 min.  The sulfide product eluted at 8.95 and 10.51 min. 
 
 
(1R*,6S*)-1,3-dimethyl-4-oxo-6-(p-tolylthio)cyclohex-2-en-1-yl ethyl malonate 
(3.90): 
Monoethyl malonate (562 mg, 4.26 mmol, 3 eq.) was dissolved in freshly distilled 
TFAA (2.8 mL, 2 mL/mmol substrate).  The reaction was stirred for 30 min.  Excess 
TFAA was removed under high-vacuum.  The resulting residue was dissolved in DME 
(7mL) and sulfide 3.80 (353.4 mg, 1.27 mmol, 1 eq.) was added.  The reaction was 
stirred at rt for 24h.  The reaction was quenched with 25 mL saturated NaHCO3.  The 
aqueous layer was extracted with 3 x 10 mL EtOAc.  The combined organic extracts 
were washed with brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:4 
EtOAc:Hexane) gave the product as a colorless or yellow oil (338.8 mg, 71% yield). 
 
IR (thin film) 2982, 1732, 1683, 1148 cm-1. 
1H NMR (500 MHz, CDCl3) δ 7.36-7.34 (m, 2H), 7.12-7.10 (m, 2H), 7.01 (d, J = 1.5 
Hz, 1H), 4.20 (dq, J = 1.7, 7.2 Hz, 2H), 3.49 (dd, J = 4.4, 11.1 Hz, 1H), 3.33 (d, J = 1.3 
Hz, 2H), 2.91 (dd, J = 11.1, 17.2 Hz, 1H), 2.76 (dd, J = 4.4, 17.2 Hz, 1H), 2.33 (s, 3H), 
1.93 (s, 3H), 1.78 (d, J = 1.5 Hz, 3H) 1.27 (t, J = 7.2 Hz, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 197.35 (C), 166.35 (C), 165.51 (C), 144.55 
(CH), 138.52 (C), 136.74 (C), 134.00 (CH), 130.14 (C), 130.12 (CH), 80.41 (C), 61.82 
(CH2), 55.77 (CH), 42.18 (CH2), 41.59 (CH2), 24.01 (CH3), 21.25 (CH3), 15.54 (CH3), 
14.22 (CH3). 
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HRMS (ESI+) 399.1237 calc’d for C20H24O5SNa+, 399.1236 found. 
 
 
ethyl (3aS*,7aS*)-4,7a-dimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydrobenzofuran-3-
carboxylate (3.91): 
Sulfide 3.90 (1256 mg, 0.33 mmol, 1 eq.) and K2CO3 (138.2 mg, 1.0 mmol, 3 eq.) were 
suspended in MeCN (1.7 mL).  The solution was heated to 50 °C for 7h.  The mixture 
was filtered through a plug of florisil (1:4 EtOAc :Hexane) to give the product (55.1 
mg, 66%). 
 
1H NMR (500 MHz, CDCl3) δ 6.58 (dd, J = 2.0, 10.3 Hz, 1H), 6.04 (d, J = 10.3 Hz, 
1H), 4.26-4.21 (m, 3H), 3.40 (ddd, J = 2.0, 5.0, 12.1 Hz, 1H), 3.27 (d, J = 12.2 Hz, 1H), 
2.81 (dq, J = 5.0, 6.9 Hz, 1H), 1.73 (s, 3H), 1.27 (t, J = 7.1 Hz, 3H), 1.07 (d, J = 69 Hz, 
3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 197.04 (C), 169.54 (C), 167.53 (C), 145.68 
(CH), 129.16 (CH), 81.77 (C), 62.59 (CH2), 51.44 (CH), 50.22 (CH), 40.33 (CH), 23.72 
(CH3), 14.04 (CH3), 12.53 (CH3). 
 
 
ethyl 2-(3-hydroxy-2,6-dimethylphenyl)acetate (xx): 
Lactone 3.91 (20 mg, 0.08 mmol, 1 eq.) and LiBr (35 mg, 0.4 mmol, 5 eq.) were 
dissolved in DMF (0.4 mL) under N2.  The solution was heated to 150 °C for 1h.  The 
reaction was quenched with 5 mL H2O and extracted with 3 x 1 mL EtOAc.  The 
combined organic layers were washed with brine, dried with Na2SO4 and concentrated.  
Purification by f.c.c. (1:4 to 1:2 EtOAc:Hexane) to give phenol 3.94 (9.8 mg, 57%). 
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1H NMR (500 MHz, CDCl3) δ 6.88 (d, J = 8.1 Hz, 1H), 6.59 (d, J = 81 Hz, 1H), 4.82 
(s, 1H), 4.15 (q, J = 7.1 Hz, 2H), 3.68 (s, 2H), 2.25 (s, 3H), 2.20 (s, 3H), 1.25 (t, J = 7.1 
Hz, 3H). 
 
benzyl ((1R*,6S*)-1,3-dimethyl-4-oxo-6-(p-tolylthio)cyclohex-2-en-1-yl) malonate 
(3.96): 
Compound 3.96 was synthesized using the same procedure as that which was used to 
synthesize xx.  The reaction was performed with 250 mg sulfide 3.80 (0.90 mmol).  The 
product was isolated by f.c.c. (1:6 to 1:4 EtOAc:Hexane) to give product 3.96 (390.78 
mg, 99%). 
 
1H NMR (500 MHz, CDCl3) δ 7.37-7.33 (m, 7H), 7.10 (d, J = 7.9 Hz, 2H), 6.97 (d, J 
= 1.4 Hz, 1H), 5.19 (s, 2H), 3.51-3.48 (m, 1H), 3.39 (s, 2H), 3.89 (dd, J = 11.0, 17.2 
Hz, 1H), 2.74 (dd, J = 4.4, 17.2 Hz, 1H), 2.32 (s, 3H), 1.90 (s, 3H), 1.76 (d, J = 1.4 Hz, 
3H). 
 
 
benzyl (3aS*,7aS*)-4,7a-dimethyl-2,5-dioxo-2,3,3a,4,5,7a-hexahydrobenzofuran-
3-carboxylate (3.97): 
Sulfide 3.96 (259 mg, 0.59 mmol, 1 eq.) and Cs2CO3 (576.7 mg, 1.77 mmol, 3 eq.) were 
suspended in MeCN (2.3 mL).  The suspension was stirred at rt for 24h at which point 
the reaction was heated to 50 °C for 1.5 h.  The reaction was cooled to rt and quenched 
with 10 mL H2O.  The solution was extracted with 3 x 5 mL EtOAc.  The combined 
organic layers were washed with brine, dried with Na2SO4, and concentrated.  The crude 
material was purified by f.c.c. (1:4 to 1:1 EtOAc:Hexane) to give the product (128.5 
mg, 69%) as a 1:1.1 mixture of diastereomers. 
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1H NMR (500 MHz, CDCl3) δ 7.38-7.33 (m, 10H), 6.66 (dd, J = 1.7, 10.3 Hz, 1H), 
6.60 (dd, J = 2.0, 10.3 Hz, 1H), 6.07-6.04 (m, 2H), 529-5.20 (m, 4H), 3.48 (d, J = 11.2 
Hz, 1H), 3.43 (ddd, J = 1.8, 2.7, 11.2 Hz, 1H), 2.80 (dq, J = 4.9, 69 Hz, 1H), 2.36 (dq, 
J = 2.7, 7.6 Hz, 1H), 1.75 (s, 2H), 1.74 (s, 3H), 1.32 (d, J = 7.6 Hz, 3H), 1.00 (d, J = 6.9 
Hz, 3H). 
 
tert-butyl ((1R*,6S*)-1,3-dimethyl-4-oxo-6-(p-tolylthio)cyclohex-2-en-1-yl) 
malonate (3.99): 
 
t-Butyl malonate half ester (8.3 g (84 wt %), 43.4 mmol, 3 eq.) was dissolved in 
trifluoroacetic anhydride (TFAA) (29 mL, 2 mmol/mmol substrate).  The solution was 
stirred for 45 minutes and excess TFAA and trifluoroacetic acid were distilled off under 
high vacuum.  Compound 3.80 (4.00 g, 14.47 mmol, 1 eq.) was dissolved in ethylene 
glycol dimethyl ether (30 mL) and added to the solution at rt, and the solution was 
stirred for 18 h.  The reaction was quenched with saturated, aqueous NaHCO3 (50 mL) 
and extracted with 3 x 30 mL EtOAc.  The combined organic layers were washed with 
brine, dried with Na2SO4, and concentrated.  The compound was purified by f.c.c. (1:6 
to 1:4 EtOAc:Hexane) to give compound 3.99 as a white solid. (4.177 g, 71%). 
 
IR (thin film) 2979, 2925, 1728, 1684, 1368, 1331, 1145 cm-1-. 
1H NMR (500 MHz, CDCl3) δ 7.36 (app d, J=8.1 Hz, 2H), 7.11 (app. D, J=7.9 Hz, 
2H), 7.03 (app d, J=1.3 Hz, 1H), 3.49 (dd, J=4.4, 11.1 Hz, 1H), 3.25 (s, 2H), 2.92 (dd, 
J=11.1, 17.1 Hz, 1H), 2.75 (dd, J=4.3, 17.3 Hz, 1H), 2.33 (s, 3H), 1.94 (s, 3H), 1.78 (s, 
9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 197.34(C), 165.79(X), 165.39(C), 144.73(CH), 
138.42(C), 136.53(C), 133.98(CH), 130.14(C), 130.05(CH), 82.36(C), 80.09(C), 
43.44(CH2), 41.54(CH2), 28.07(CH3), 23.96(CH3), 21.20(CH3), 15.46(CH3). 
HRMS (ESI+) 427.1550 calc’d for C22H28O5SNa+, 427.1456 found. 
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tert-butyl (3aS*,7aS*)-4,7a-dimethyl-2,5-dioxo-2,3,3a,4,5,7a-
hexahydrobenzofuran-3-carboxylate (3.71): 
 
Compound 3.99 (1.00 g, 2.47 mmol, 1 eq.) was dissolved in MeCN (25 mL)and Cs2CO3 
(2.41 g, 7.41 mmol, 3 eq.) was added.  The reaction was stirred for 24 h until all starting 
material had been consumed.  The flask was then fitted with a reflux condenser and 
heated to 50 °C for 1 h until all sulfide elimination was complete by TLC.  The reaction 
was cooled to rt and quenched with saturated, aq. NH4Cl (30 mL).  The aqueous layer 
was extracted with 3 x 20 mL EtOAc.  The combined organic layers were washed with 
brine and dried with Na2SO4.  The solution was concentrated and the compound was 
purified by f.c.c. (1:6 to 1:4 EtOAc:Hexane) to give compound xx as an oil which 
solidified upon standing as a 1:1 mixture of diastereomers that was 93% pure by 1H 
NMR spectroscopy (623.8 mg, 84%). 
 
IR (thin film) 2978, 2935, 1783, 1728, 1685, 1150 cm-1. 
1H NMR (500 MHz, CDCl3) δ 6.64 (dd, J=1.8, 10.3 Hz, 1H), 6.58 (dd, J=2.1, 10.2 
Hz, 1H), 3.36 (ddd, J=2.0, 5.0, 12.1 Hz, 1H), 3.31 (d, J=11.1 Hz, 1H), 3.18 (d, J=12.1 
Hz, 1H), 3.04 (ddd, J=1.8, 2.7, 11.1 Hz, 1H), 2.81 (dq, J=5.3, 7.0 Hz, 1H), 2.61 (dq, 
J=2.9, 7.8 Hz, 1H), 1.72 (2 x s, 3H each), 1.48 (s, 9H), 1.47 (s, 9H), 1.32 (d, J=7.4 Hz, 
3H), 1.11 (d, J=7.0 Hz, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 198.56 (C), 197.32 (C), 169.96 (C), 169.08 
(C), 166.54 (C), 165.56 (C), 145.93 (CH), 145.78 (CH), 129.14 (CH), 128.04 (CH), 
83.79 (C), 83.43, (C), 81.50 (C), 79.77 (C), 54.04 (CH), 51.29 (CH), 51.14 (CH), 49.97 
(CH), 42.15 (CH), 40.40 (CH), 28.01 (CH3), 27.85 (CH3), 27.01 (CH3), 23.80 (CH3), 
18.32 (CH3), 12.64 (CH3).  
HRMS (ESI+) 303.1203 calc’d for C15H20O5Na+, 303.1215 found. 
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(3aR*,7aS*)-4,7a-dimethyltetrahydrobenzofuran-2,5(3H,4H)-dione (3.95): 
Lactone 3.70 (403 mg, 1.44 mmol, 1 eq.) and 10 wt. % Pd/C (Aldrich, 100 mg, 25 wt% 
was suspended in ethyl acetate (15 mL) and placed under a H2 atmosphere (balloon).  
The reaction was stirred for 1h (on some runs, additional Pd/C needed to be added to 
achieve complete reaction).  The mixture was filtered through celite and concentrated.  
The resulting material was dissolved in TFA (10 mL) and stirred for 45 min.  When the 
reaction was complete by TLC, the TFA was removed under vacuum and dissolved in 
THF (10 mL).  NEt3  (728 mg, 7.2 mmol, 5 eq.) was added and the reaction was heated 
to 60 oC for 2h.  The solution was cooled to room temperature and quenched with 25 
mL 10% HCl.  The organic layer was extracted with 3 x 10 mL EtOAc.  The combined 
organic extracts were washed with brine, dried with Na2SO4, and concentrated.  The 
residue was purified by f.c.c. (1:1 EtOAc:Hexane) as a tan solid (153 mg, 58%, mixture 
of diastereomers). 
 
IR (thin film) 2973.70, 2935.35, 1766.23, 1715.42 cm-1. 
1H NMR (500 MHz, CDCl3) δ 3.02(dd, J=8.9, 18.3 Hz, 1H), 2.67-2.76(m, 4.4H), 
2.56(ddd, J=5.2, 6.2, 17.1 Hz, 1H), 2.49 (dd, J= 3.0, 18.3 Hz, 1H), 2.34-2.45(m, 4H), 
2.06-2.30(m, 9H), 1.62(s, 4.3H), 1.43(s, 3H), 1.07(d, J=6.5 Hz, 3H), 1.04(d, J=6.4 Hz, 
4.3 H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 210.84(C), 210.59(C), 175.28(C), 175.28(C), 
174.75(C), 85.16(C), 84.51(C), 47.06(CH), 45.34(CH), 45.27(CH), 43.07(CH), 
35.70(CH2), 35.25(CH2), 34.76(CH2), 33.36(CH2), 32.99(CH2), 32.07(CH2), 
28.28(CH3), 26.80(CH3), 12.57(CH3), 12.23(CH3). 
HRMS (ESI+) 205.0835 calc’d for C10H14O3Na+, 205.0834 found. 
 
 
(3aR*,7aS*)-4,7a-dimethyl-5-((trimethylsilyl)oxy)-3a,6,7,7a-
tetrahydrobenzofuran-2(3H)-one (3.69): 
Lactone 3.95 (364 mg, 1.94 mmol, 1 eq.) was dissolved in anhydrous MeCN (8 mL) 
along with NaI (350 mg, 2.33 mmol, 1.2 eq.), which had been dried overnight at 110 
oC.  NEt3 (236 mg, 2.33 mmol, 1.2 eq.) was added followed by TMS-Cl (253 mg, 2.33 
mmol, 1.2 eq.).  The mixture was stirred at rt for 2.5 h and was quenched with saturated 
NH4Cl (25 mL) and extracted with 3 x 10 mL EtOAc.  The combined organic fractions 
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were dried with Na2SO4, filtered, and concentrated to give a brown solid (405 mg, 82%) 
which was used without further purification. 
 
IR (thin film) 2958, 2933, 1776, 1718, 1683, 1182, 1147, 846 cm-1. 
1H NMR (500 MHz, CDCl3) δ 5.30 (s, 1H), 2.87 (dd, J=8.5, 17.4 Hz, 1H), 2.61 (t, J= 
7.5 Hz, 1H), 6.71 (dd, J=6.4, 17.5 Hz, 1H), 2.18-2.42 (m, 1H), 1.95-2.01 (m, 1H), 1.76-
1.81 (m, 1H), 1.55-1.56 (m, 3H), 1.43 (s, 3H), 0.17 (s, 9H). 
13C NMR (500 MHz, CDCl3, DEPT) δ 174.50 (C), 144.19 (C), 110.29 (C), 82.81 (C), 
45.69 (CH), 35.56 (CH2), 32.38 (CH2), 27.15 (CH2), 25.21 (CH3), 14.58 (CH3), 0.57 
(CH3). 
HRMS (ESI+) 277.1230 calc’d for C13H22O3SiNa+ 277.1159 found. 
 
 
 
 
 
(3aS*,7aS*)-4-bromo-4,7a-dimethyltetrahydrobenzofuran-2,5(3H,4H)-dione 
(3.69): 
The silyl-enol ether 3.68 (167 mg, 0.65 mmol, 1 eq.) was dissolved in anhydrous THF 
(6.5 mL) which was cooled to 0 °C.  NBS (178 mg, 0.68 mmol, 1.05 eq.) was added.  
The mixture was stirred for 15 minutes and quenched with 15 mL of a 1:1 mixture of 
saturated NaHCO3 and Na2S2O3.  The aqueous layer was extracted with 3 x 10 mL 
EtOAc.  The combined organic layers were washed with brine, dried with Na2SO4, 
filtered, and concentrated to give the product (96 mg, 56%) as a white solid. 
 
IR (thin film) 2978, 2953, 1768, 1718, 1271, 1093, 957 cm-1. 
1H NMR (500 MHz, CDCl3) δ 3.21 (t, J=10.4 Hz, 1H), 2.81-2.90 (m, 2H), 2.71 (ddd, 
J=4.6, 11.4, 14.8 Hz, 1H), 2.29 (ddd, J=5.4, 11.6, 18.4 Hz, 1H), 2.16-2.24 (m, 2H), 1.82 
(s, 3H), 1.77 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 201.21 (C), 172.30 (C), 84.63 (C), 58.76 (C), 
52.82 (CH), 34.24 (CH2), 32.85 (CH2), 32.63 (CH2), 29.19 (CH3), 26.47 (CH3). 
HRMS (ESI+) 282.9940 calc’d for C10H13BrO3Na+, 282.9935. 
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Chapter 4 Experimental 
 
 
4-methoxy-4-methylcyclohexa-2,5-dien-1-one (4.9b): 
p-Cresol (1.00 g, 9.25 mmol, 1 eq.) was dissolved in MeOH (46 mL).  PIDA (3.13 g, 
9.7 mmol, 1.05 eq.) was added.  The reaction was stirred at rt for 1.5 h.  The reaction 
mixture was concentrated and quenched with 100 mL saturated NaHCO3.  The mixture 
was extracted with 3 x 50 mL EtOAc, washed with brine, dried with Na2SO4, and 
concentrated.  The crude material was purified by f.c.c. (1:4 EtOAc:Hexane) to give the 
product as a yellow oil that solidified upon standing (729.2 mg, 64%) 
1H NMR (500 MHz, CDCl3) δ 6.76 (d, J = 8.4 Hz, 2H), 6.31 (d, J = 8.1 Hz, 2H), 3.19 
(s, 3H), 1.42 (s, 3H). 
 
 
1-allyl-4-methoxy-4-methylcyclohexa-2,5-dien-1-ol (4.10): 
Cyclohexadienone 4.9b (722.3 mg, 5.22 mmol, 1 eq.) was dissolved in Et2O and cooled 
to ‒78 °C.  Allylmagnesium bromide was added dropwise and stirred at ‒78 °C for 1h.  
The reaction was quenched with 100 mL saturated NH4Cl.  The system was extracted 
with 3 x 30 mL EtOAc.  The combined organic layers were washed with brine, dried 
with Na2SO4 and concentrated.  The product was isolated as a 1:1 mixture of 
diastereomers (704.1 mg, 75%). 
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1H NMR (500 MHz, CDCl3) δ 5.98-5.96 (m, 2H), 5.92-5.89 (m, 2H), 5.83-5.77 (m, 
1H), 5.70-5.66 (m, 5H), 5.13-5.06 (m, 4H), 3.12 (s, 3H), 3.05 (s, 3H), 2.38 (td, J = 1.1, 
7.4 H, 2H), 2.34 (td, J = 1.1, 7.4 Hz, 2H), 1.79 (s, 1H), 1.70 (s, 1H), 1.31 (s, 3H), 1.24 
(s, 3H). 
 
 
5-allyl-4-methoxy-4-methylcyclohex-2-en-1-one (xx): 
Alcohol 4.10 (25 mg, 0.14 mmol, 1 eq.) and 18-crown-6 (45 mg, 0.17 mmol, 1.2 eq.) 
were dissolved in THF (1.4 mL).  KH (38 mg, 0.28 mmol, 2 eq.) was added and the 
reaction was stirred at rt for 8 h.  The reaction was quenched with H2O (5 mL) and 
extracted with 3 x 2 mL EtOAc.  The combined organic layers were dried with Na2SO4 
and concentrated.  The reaction was found to have proceeded to only 54% conversion 
by 1H NMR spectroscopy.  Purification by f.c.c (1:10 to 1:4 EtOAc:Hexane) gave the 
product in a 1:4 dr (2.5 mg, 10%). 
1H NMR (major isomer) (500 MHz, CDCl3) δ 6.85 (d, J = 10.3 Hz, 1H), 6.01 Hz, dd, 
J = 1.2, 10.3 Hz, 1H), 5.79-5.68 (m, 1H), 5.10-5.08 (m, 1H), 5.07-5.06 (m, 1H), 3.25 
(s, 3H), 2.65 (ddd, J = 1.2, 4.2, 17.1 Hz, 1H), 2.52 (dd, J = 9.1, 17.2 Hz, 1H), 2.50-2.41 
(m, 2H), 2.09 (dd, J = 13.2, 17.1 Hz, 1H), 1.87-1.80 (m, 1H), 1.25 (s, 3H).  
 
 
4-hydroxy-4-methylcyclohexa-2,5-dien-1-one (4.9a): 
p-Cresol (3.00g, 27.7 mmol, 1 eq.) was dissolved in 140 mL of a mixture of MeCN:H2O 
(3:1).  PIDA (9.4g, 29.1 mmol, 1.05 eq.) was added and the reaction was stirred for 1h.  
When the reaction was complete by TLC, the mixture was partially concentrated by 
rotary evaporation and quenched with 50 mL 10 wt.% Na2S2O3 solution and 200 mL of 
H2O.  The aqueous layer was extracted with 3 x 100 mL EtOAc.  The combined organic 
  
Appendix 1  253 
layers were washed with brine, dried with Na2SO4, filtered, and concentrated.  
Purification by f.c.c. (1:4 to 1:1 EtOAc:Hexane) gave a yellow solid (1.49g, 39%). 
1H NMR (500 MHz, CDCl3) δ 6.90-6.86 (m, 2H), 6.14-6.11 (m, 2H), 2.23 (s, 1H), 1.48 
(s, 3H). 
 
(4S*,5S*)-4-hydroxy-4-methyl-5-((trimethylsilyl)ethynyl)cyclohex-2-en-1-one 
(4.12): 
TMS acetylene (2.13 g, 21.7 mmol, 3 eq.) was dissolved in 50 mL of anhydrous THF 
and cooled to 0 °C.  EtMgBr (7.23 mL of a 3M sol’n, 21.7 mmol, 3 eq.) was added.  
The solution was stirred for 1 h and cooled to −78 °C.  In a separate flask, quinol 4.12 
(1.00 g, 7.24 mmol, 1 eq.) was dissolved in 25 mL of anhydrous THF.  The quinol 
solution was added to the cold acetylide solution via cannula and stirred at −78 °C for 
15 min.  The solution was then warmed to rt for 2 h.  The reaction was quenched by 
adding 100 mL of a saturated NH4Cl solution to the reaction mixture.  The organic layer 
was extracted with 3 x 50 mL EtOAc.  The combined organic layers were washed with 
brine, dried with Na2SO4, filtered, and concentrated.  The product was purified by f.c.c. 
(1:4 EtOAc:Hexane) to give the product (1.17 g, 72%). 
IR (thin film) 3455, 2961, 2899, 2175, 1681, 1250, 1129, 843 cm-1. 
1H NMR δ 6.67 (dd, J=0.6, 10.2 H, 1H), 5.92(d, J=10.2 Hz, 1H), 3.08(ddd, J=0.3, 4.6, 
8.0 Hz, 1H), 2.75(dd, J=8.1, 16.7 Hz, 1H), 2.61(bs, 1H), 2.59(dd, J=4.7, 16.8Hz, 1H), 
1.50(s, 3H), 0.14(s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 196.64(C), 152.18(CH), 128.48(CH), 
103.46(C), 90.85(C), 68.38(C), 40.70(CH), 39.84(CH2), 26.64(CH3), 0.03(CH3). 
HRMS (ESI+) 245.0968 calc’d for C12H18O2SiNa+, 245.0987 found. 
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(4S*,5S*)-4-methyl-5-((trimethylsilyl)ethynyl)-4-((trimethylsilyl)oxy)cyclohex-2-
en-1-one (4.13): 
Alkyne 4.12 (376.7 mg, 1.69 mmol, 1 eq.) and imidazole (460 mg, 6.76 mmol, 4 eq.) 
were dissolved in DMF (5.6 mL).  TMS-Cl (367.2 mg, 3.38 mmol, 2 eq.) was added 
and the solution was stirred at rt for 30 min.  The reaction was quenched with 50 mL 
H2O and extracted with 3 x 20 mL EtOAc.  The combined organic fractions were 
washed with brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:10 
EtOAc:Hexane) gave compound 4.13 as an off-white solid (374.2 mg, 75%). 
1H NMR (500 MHz, CDCl3) δ 6.70 (d, J = 10.1 Hz, 1H), 5.86 (dd, J = 0.9, 10.1 Hz, 
1H), 2.89 (dd, J = 3.0, 11.4 Hz, 1H), 2.84 (dd, J = 11.4, 15.8 Hz, 1H), 2.52 (ddd, J = 
0.9, 3.0, 15.8 Hz, 1H), 1.55 (s, 3H), 0.15 (s, 18H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 198.24 (C), 152.81 (CH), 127.80 (CH), 105.22 
(C), 87.84 (C), 70.52 (C), 41.06 (CH), 39.83 (CH2), 27.86 (CH3), 2.51 (CH3), 0.17 
(CH3). 
 
 
(4S*, 5S*, 6S*)-4,6-dimethyl-5-((trimethylsilyl)ethynyl)-4-
((trimethylsilyl)oxy)cyclohex-2-en-1-one (4.14): 
Enone 4.13 (25 mg, 0.085 mmol, 1 eq.) was dissolved in THF:HMPA (0.9 mL, 10:1 
THF:HMPA) and cooled to ‒78 °C.  Freshly-prepared LDA (1M in THF, 0.1 mL, 0.1 
mmol, 1.25 eq.) was added.  The solution was stirred for 1h at ‒78 °C and MeI (18 mg, 
0.13 mmol, 1.5 eq.) was added.  The reaction was allowed to warm to rt for 3.5 h.  The 
reaction was quenched with 5 mL saturated NH4Cl and extracted with 3 x 2 mL EtOAc.  
The combined organic fractions were washed with brine, dried with Na2SO4 and 
concentrated.  Purification by f.c.c. (1:10 EtOAc:Hexane) gave the product, which 
contained ~10% starting material (16.7 mg, 57%) 
  
Appendix 1  255 
1H NMR (500 MHz, CDCl3) δ 6.64 (dd, J = 1.7, 10.3 Hz, 1H), 5.84 (d, J = 10.3 Hz, 
1H), 3.03 (dd, J = 1.7, 4.4 Hz, 1H), 2.61 (dq, J = 4.4, 6.8 Hz, 1H), 1.53 (s, 3H), 1.26 (d, 
J = 6.8 Hz, 3H), 0.20 (s, 9H), 0.10 (s, 9H). 
 
 
(4S*,5S*)-4-methyl-4-((triethylsilyl)oxy)-5-((trimethylsilyl)ethynyl)cyclohex-2-en-
1-one (S1): 
Enone 4.12 (1.19 g, 5.37 mmol, 1 eq.) and imidazole (1.46 g, 21.48 mmol, 4 eq.) were 
dissolved in DMF (18 mL).  TES-Cl (1.62 g, 10.74 mmol, 2 eq.) was added and the 
solution was stirred at rt for 3 h.  The reaction mixture was quenched with water (100 
mL) and extracted with 3 x 20 mL EtOAc.  The combined organic layers were washed 
with brine, dried with Na2SO4, and concentrated.  The residue was purified by f.c.c. 
(1:20 EtOAc:Hexane) to give the product (1.25 g, 66%) as a colorless oil. 
IR (thin film) 2958, 2912, 2877, 2178, 1693, 1458, 1412, 1249, 1116, 1013, 842,  
728 cm-1. 
1H NMR (500 MHz, CDCl3) δ 6.71 (d, J=10.1 Hz, 1H), 5.86 (d, J=10.1 Hz, 1H), 2.86-
2.93 (m, 2H), 2.51-2.57 (m, 1H), 1.55 (s, 3H), 0.96 (t, J=7.9 Hz, 9H), 0.57-0.66 (m, 
6H), 0.15 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 198.30 (C), 152.80 (CH), 127.95 (CH), 105.09 
(C), 87.87 (C), 69.87 (C), 41.76 (CH), 39.82 (CH2), 28.01 (CH3), 7.12 (CH3), 6.84 
(CH2), 0.90 (CH3). 
HRMS (ESI+) 359.1833 calc’d for C18H32O2Si2Na+, 359.1840 found. 
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(4S*,5S*,6S*)-4,6-dimethyl-4-((triethylsilyl)oxy)-5-
((trimethylsilyl)ethynyl)cyclohex-2-en-1-one (4.17): 
Enone S1 (200 mg, 0.59 mmol, 1 eq.) was dissolved in 6 mL of a 10:1 THF:HMPA 
solution.  The solution was cooled to −78 °C and 0.76 mL of a 1M solution of LDA 
(freshly prepared in THF, 0.71 mmol, 1.2 eq.) was added.  The solution was stirred at 
−78 °C for 1 h and MeI (419 mg, 2.95 mmol, 5 eq.) was added.  The reaction was 
allowed to warm to room temperature and stirred for 2 h at which time it was quenched 
with 25 mL of a saturated NH4Cl solution.  The organic layer was extracted with 3 x 10 
mL EtOAc.  The combined organic extracts were washed with brine, dried with Na2SO3, 
and concentrated.  Purification by f.c.c. (1:10 EtOAc:Hexane) gave the product as a 
colorless oil (129 mg, 63%). 
IR (Thin Film) 2957.64, 2788, 2176, 1690, 1249, 1106 cm-1. 
1H NMR (500 MHz, CDCl3) δ 6.62 (dd, J=1.6, 10.3 Hz, 1H), 5.83 (d, J=10.3 Hz, 1H), 
3.00 (dd, J=1.6, 4.4 Hz, 1H), 2.61(dq, J=4.4, 6.7 Hz, 1H), 1.52 (s, 3H), 1.27 (d, J=6.8 
Hz, 3H), 0.99 (t, J=7.9 Hz, 9H), 0.66 (q, J=7.9 Hz, 6H), 0.09 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 199.58 (C), 153.13 (CH), 126.59 (CH), 103.84 
(C), 89.61 (C), 73.36 (C), 49.14 (CH), 43.60 (C), 27.74 (CH3), 13.82 (CH3), 7.26 (CH3), 
6.95 (CH2), 0.06 (CH3). 
HRMS (ESI+) 373.1990 calc’d for C19H34O2Si2Na+, 373.1993 found. 
 
 
(4S*,5S*,6R*)-6-(1-hydroxybutyl)-4,6-dimethyl-4-((triethylsilyl)oxy)-5-
((trimethylsilyl)ethynyl)cyclohex-2-en-1-one (4.18): 
Compound 4.17 (20 mg, 0.057 mmol, 1 eq.) was dissolved in 0.6 mL of DCM.  NEt3 
(17 mg, 0.17 mmol, 3 eq.) was added.  The solution was cooled to −78 °C and Bu2BOTf 
(70 μL of a 1M sol’n in DCM, 0.07 mmol, 1.2 eq.) was added.  The solution was 
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warmed to 0 °C for 30 min and cooled to −78 °C.  Butanal (21 mg, 0.29 mmol, 5 eq.) 
was added.  The solution was stirred at −78 °C for 1.5 h and quenched with 1 mL 
saturated NaHCO3.   The organic layer was extracted with 3 x 1 mL DCM.  The 
combined organic layers were dried with Na2SO4 and concentrated.  The residue was 
purified by f.c.c. (1:4 EtOAc:Hexane) to give the product as a colorless oil (16.1 mg, 
67%). 
1H NMR (500 MHz, CDCl3) δ 6.51 (d, J=10.2 Hz, 1H), 6.00 (d, J=10.2 Hz, 1H), 4.72 
(t, J=2.32 Hz, 1H), 4.08 (td, J=2.2, 10.5 Hz, 1H), 2.92 (s, 1H), 1.63 (s, 3H), 1.27-1.59 
(m, 8H), 1.17 (s, 3H), 1.01 (t, J=7.0 Hz, 9H), 0.89-0.96 (m, 3H), 0.70-0.79 (m, 6H), 
0.19 (s, 9H). 
13C NMR (500 MHz, CDCl3) δ 200.74, 147.63, 129.99, 102.32, 91.41, 72.86, 70.43, 
52.57, 52.27, 33.03, 29.81, 21.28, 19.76, 13.89, 7.03, 6.84, 0.10. 
HRMS (ESI+) 445.2565 calc’d for C23H42O3Si2Na+, 445.2615 found. 
 
 
(4S*,5S*)-6-allyl-4-methyl-5-((trimethylsilyl)ethynyl)-4-
((trimethylsilyl)oxy)cyclohex-2-en-1-one (4.22): 
Enone 4.13 (250 mg, 0.85 mmol, 1 eq.) was dissolved in THF:HMPA (8.5 mL, 10:1 
THF:HMPA).  The solution was cooled to ‒78 °C.  LDA (1M in THF, 1.02 mL, 1.02 
mmol, 1.2 eq.) was added and the solution was stirred at ‒78 °C for 1h.  Allyl iodide 
(285.6 mg, 1.7 mmol, 2 eq.) was added.  The solution was stirred for 15 min. at ‒78 °C 
then warmed to rt for 15 min.  The reaction was quenched with 40 mL saturated NH4Cl.  
The solution was extracted with 4 x 10 mL EtOAc.  The combined organic layers were 
washed with brine, dried with Na2SO4 and concentrated.  Purification by f.c.c. (1:35 
EtOAc:Hexane) gave the product as a colorless oil in a 12:1 dr (184.1 mg, 65%). 
1H NMR (500 MHz, CDCl3) δ 6.65 (d, J = 10.0 Hz, 1H), 5.85 (d, J = 10.0 Hz, 1H), 
5.76-5.68 (m, 1H), 5.16 (dd, J = 1.1, 17.2 Hz, 1H), 5.02 (dd, J = 2.2, 10.2 Hz, 1H), 2.92-
2.85 (m, 2H), 2.70 (d, J = 11.8 Hz, 1H), 2.50-2.45 (m, 1H), 1.56 (s, 3H), 0.18 (s, 9H), 
0.14 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 199.31 (C), 151.39 (CH), 134.72 (CH), 127.93 
(CH), 117.90 (CH2), 104.45 (C), 89.23 (C), 70.62 (C), 45.76 (CH), 44.78 (CH), 30.92 
(CH2), 28.44 (CH3), 2.53 (CH3), 0.20 (CH3). 
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Oxybis(phenyl-l3-iodanediyl) bis(2,2,2-trifluoroacetate) (4.30):  
Iodosobenzene (11.09 g, 50.4 mmol, 1 eq.) was suspended in CHCl3 (390 mL).  TFA 
(5.75 g, 50.4 mmol, 1 eq.) was added and the solution was refluxed for 3 h and cooled 
to room temperature.  Unreacted iodosobenzene was filtered off and the solution was 
concentrated to give a thick oil that solidified upon trituration with hexanes.  The 
compound was recrystallized from CHCl3 and hexane to give a white solid as needlelike 
crystals (9.01 g, 55%).  The 1H NMR spectrum was consistent with previously reported 
values.1 
 
 
2-Hydroxy-5-methylbenzaldehyde (S2):  
p-Cresol (10.0 g, 92.5 mmol, 1 eq.) was dissolved in MeCN (450 mL).  MgCl2 (13.2 g, 
138.7, 1.5 eq.) and NEt3 (35.1 g, 346.9 mmol, 3.75 eq.) were added followed by 
paraformaldehyde (18.75 g, 624.2 mmol, 6.75 eq.).  The mixture was stirred at reflux 
for 4h.  The reaction was cooled to room temperature and quenched with 200 mL 10% 
HCl.  The mixture was partially concentrated under vacuum and the aqueous layer was 
extracted with 3 x 100 mL EtOAc.  The combined organic extracts were washed with 
brine, dried with Na2SO4, and concentrated.  The resulting yellow solid (11.96 g, 95%) 
was sufficiently clean by 1H NMR spectroscopy and was used without further 
purification. 
1H NMR (500 MHz, CDCl3) δ 10.83 (s, 1H), 9.85 (s, 1H), 7.35-7.32 (m, 2H), 6.89 (d, 
J = 9.2 Hz, 1H), 2.33 (s, 3H). 
 
                                                          
1 Saltzman, H.; Sharefkin, J. G. Org. Synth. 1963, 43, 60. 
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Methyl 2-hydroxy-5-methylbenzoate (4.27):  
Aldehyde S2 (5.00 g, 36.7 mmol, 1 eq.) was dissolved in DMSO (100 mL) and cooled 
to 0 °C.  A solution of NaClO2 (10.37 g, 91.75 mmol, 2.5 eq.) and NaH2PO4·H2O (12.70 
g, 91.75 mmol, 2.5 eq.) in 100 mL H2O was added dropwise.  The reaction mixture was 
warmed to room temperature and stirred for 30 min.  The reaction was quenched with 
3 eq. Na2SO3 (13.80 g) and stirred for 15 min.  The solution was acidified with HCl and 
diluted with 400 mL H2O.  The aqueous layer was extracted with 4 x 100 mL EtOAc.  
The combined organic layers were dried with Na2SO4 and concentrated.  The crude acid 
was taken forward directly into the next step. 
The acid was dissolved in 100 mL MeOH.  Concentrated H2SO4 was added (1.1 mL) 
and the reaction was refluxed for 18 h.  The mixture was cooled to rt, concentrated, and 
quenched with 100 mL of saturated, aqueous NaHCO3.  The aqueous layer was 
extracted with 3 x 30 mL EtOAc.  The combined organic layers were washed with brine, 
dried with Na2SO4 and concentrated.  The resulting brown oil (4.34 g, 71% over 2 steps) 
was sufficiently pure by 1H NMR spectroscopy for the next step without further 
purification. 
 
1H NMR (500 MHz, CDCl3) δ 10.55 (s, 1H), 7.62 (d, J = 1.9 Hz, 1H), 7.26 (dd, J = 
2.3, 8.4 Hz, 1H), 6.88 (d, J = 8.5 Hz, 1H), 3.94 (s, 3H), 2.99 (s, 1H), 2.28 (s, 3H). 
 
 
Methyl 3-methoxy-3-methyl-6-oxocyclohexa-1,4-diene-1-carboxylate (4.26):  
Ester 4.27 (2.00 g, 12.0 mmol, 1 eq.) was dissolved in MeOH (60 mL) and cooled to 0 
°C.  Oxidant 4.30 (7.82 g, 12.0 mmol, 1 eq.) was added in one portion and the solution 
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was stirred at 0 °C for 30 min.  The reaction mixture was partially concentrated under 
vacuum and quenched with a 100 mL of a 1:1 mixture of 10% Na2S2O3 and saturated 
NaHCO3.  The aqueous layer was washed with 3 x 30 mL EtOAc.  The combined 
organic layers were washed with brine, dried with Na2SO4, and concentrated.  The crude 
product was purified by flash chromatography (1:2 EtOAc:Hexane) to give an orange 
oil (1.44 g, 61%).  On some runs, the product was contaminated with an unidentified 
side-product which co-eluted with the material.  The presence of this side product did 
not interfere with the subsequent reactions. 
IR (thin film) 2985, 2952, 2827, 1745, 1675, 1642, 1585, 1436, 1272, 1129, 1040 cm-
1. 
1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 3.1 Hz, 1H), 6.77 (dd, J = 3.1, 10.2 Hz, 1H), 
6.35 (d, J = 10.2 Hz, 1H), 3.86 (s, 3H), 3.22 (s, 3H), 1.47 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 180.80 (C), 164.39 (C), 156.49 (CH), 150.44 
(CH), 133.25 (C), 131.05 (CH), 72.88 (C), 53.97 (CH3), 52.67 (CH3), 26.32 (CH3). 
HRMS (ESI+) 219.0628 calc’d for C10H12O4Na+, 219.0670 found. 
 
 
Methyl (1R*,5S*,6S*)-5-methoxy-1,5-dimethyl-2-oxo-6-
((trimethylsilyl)ethynyl)cyclohex-3-ene-1-carboxylate (4.25):  
TMS-acetylene (2.18 g, 22.2 mmol, 3.5 eq.) was dissolved in Et2O (6.4 mL) and cooled 
to −78 °C.  n-BuLi (9.25 mL of a 2.4 M sol’n, 22.2 mmol, 3.5 eq.) was added and the 
solution was stirred for 30 min.  Et2AlCl (22.2 mL of a 1M solution in hexane, 22.2 
mmol, 3.5 eq.) was added and the mixture was stirred at 0 °C for 4 h.  The solution was 
diluted with 36 mL toluene and allowed to cool to 0 °C.  The cyclohexadienone 4.26 
(1.25 g, 6.35 mmol, 1 eq.) was added in 40 mL of toluene and stirred for 15 min.  The 
reaction was quenched with 100 mL of a saturated solution of Rochelle’s salt.  The 
mixture was stirred vigorously for 30 min and transferred to a separatory funnel.  About 
10 mL of 10% HCl was added to the funnel.  The aqueous layer was extracted with 4 x 
50 mL EtOAc.  The combined organic extracts were washed with brine, dried with 
Na2SO4, and concentrated.  Due to the presumed instability of the product, the crude 
material was immediately carried forward into the next step. 
The crude material (1.51 g, 5.14 mmol, 1 eq.) and 18-crown-6 (134 mg, 0.51 mmol, 0.1 
eq.) were dissolved in toluene (26 mL).  MeI (7.29 g, 51.4 mmol, 10 eq.) was added 
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followed by K2CO3 (1.06 g, 7.71 mmol, 1.5 eq.).  The mixture was stirred at room 
temperature for 18 h.  The reaction mixture was filtered through a plug of florisil and 
concentrated.  Purification by flash chromatography (1:4 EtOAc:Hexane) gave the 
product as a colorless oil (836 mg, 43% over 2 steps).  On some runs, the product was 
contaminated with an unidentified side-product which could not be removed. 
 
IR (thin film) 2954, 2174, 1740, 1686, 1123 cm-1. 
1H NMR (500 MHz, CDCl3) δ 6.76 (d, J = 10.4 Hz, 1H), 5.99 (d, J = 10.3 Hz, 1H), 
3.73 (s, 3H), 3.63 (s, 1H), 3.38 (s, 3H), 1.63 (s, 3H), 1.52 (s, 3H), 0.14 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 197.21 (C), 172.02 (C), 150.22 (CH), 127.11 
(CH), 101.38 (C), 91.13 (C), 71.64 (C), 57.74 (C), 52.80 (CH3), 50.98 (CH3), 45.45 
(CH), 23.30 (CH3), 18.66 (CH3), 0.03 (CH3). 
HRMS (ESI+) 331.1336 calc’d for C16H24O4SiNa+, 331.1339 found. 
 
 
 
Methyl (1R*,2S*)-1,3-dimethyl-6-oxo-2-((trimethylsilyl)ethynyl)cyclohex-3-ene-1-
carboxylate (4.29):  
Enone 4.25 (836 mg, 2.71 mmol, 1 eq.) was dissolved in AcOH (10 mL).  HCl-washed 
Zn (1.77 g, 27.1 mmol, 10 eq.) was added and the reaction was stirred at room 
temperature for 1 h.  The mixture was diluted with EtOAc, filtered through a plug of 
celite, and concentrated.  The crude mixture was purified by flash chromatography (1:6 
EtOAc:Hexane) to give the product as a colorless oil (536 mg, 71%). 
IR (thin film) 2958, 2171, 1723, 1250, 845 cm-1. 
1H NMR (500 MHz, CDCl3) δ 5.42 (tq, J = 1.5, 3.0 Hz, 1H), 3.68 (s, 3H), 3.65 (s, 1H), 
3.02 (qdd, J = 2.0, 4.2, 22.3 Hz, 1H), 2.87 (quintd, J = 2.5, 22.3 Hz, 1H), 1.87 (q, J = 
2.0 Hz, 3H), 1.42 (s, 3H), 0.10 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 204.38 (C), 172.18 (C), 136.02 (C), 119.36 
(CH), 101.64 (C), 89.60 (C), 58.62 (C), 52.83 (CH3), 42.58 (CH), 38.26 (CH2), 22.49 
(CH3), 17.89 (CH3), 0.04 (CH3). 
HRMS (ESI+) 301.1230 calc’d for C15H22O3SiNa+, 301.1229 found. 
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Methyl (1R*,2S*,6S*)-6-hydroxy-1,3-dimethyl-2-
((trimethylsilyl)ethynyl)cyclohex-3-ene-1-carboxylate (4.32a):  
Ester 4.29  (250 mg, 0.90 mmol, 1 eq.) was dissolved in MeOH (6 mL) and Y(OTf)3 
(964 mg, 1.80 mmol, 2 eq.) was added.  The solution was stirred for 30 min. at room 
temperature and NaBH4 (43 mg, 1.13 mmol, 1.25 eq.) was added portion-wise.  The 
reaction was stirred for 5 min. and quenched with 20 mL 10% NaHSO4.  The aqueous 
layer was extracted with 3 x 10 mL EtOAc.  The combined organic layers were 
combined and washed with brine, dried with Na2SO4 and concentrated. Flash 
chromatography (1:10 to 1:2 EtOAc:Hexane) gave the product (69.5 mg, 27%) along 
with its epimer (89.2 mg, 35 %). 
IR (thin film) 3527, 2957, 2916, 2170, 1728, 1451, 1249, 843 cm -1. 
1H NMR (500 MHz, CDCl3) δ 5.27 (t, J = 3.5 Hz, 1H), 3.97 (ddd, J = 5.9, 8.1, 9.7 Hz, 
1H), 3.71 (s, 3H), 3.55 (s, 1H), 3.00 (d, J = 9.8 Hz, 1H), 2.47 (tddd, J = 1.9, 3.8, 5.7, 
18.1 Hz, 1H), 2.08 (tddd, J = 1.9, 3.4, 7.8, 18.1 Hz, 1H), 1.79 (d, J = 1.6 Hz, 3H), 1.44 
(s, 3H), 0.14 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 176.89 (C), 133.05 (C), 120.13 (CH), 104.42 
(C), 88.53 (C), 69.94 (CH), 52.29 (CH3), 49.13 (C), 40.60 (CH), 32.81 (CH2), 22.32 
(CH3), 20.18 (CH3), 0.18 (CH3). 
HRMS (ESI+) 303.1387 calc’d for C15H24O3SiNa+, 303.1382 found. 
 
Analytical data for Epimer 4.32b: 
IR (thin film) 3469, 2955, 2171, 1726, 1435, 1280, 1330, 1019 cm-1. 
1H NMR (500 MHz, CDCl3) δ 5.32-5.34 (m, 1H), 4.11 (td, J = 6.2, 8.2 Hz, 1H), 3.74 
(s, 3H), 3.61 (t, J = 1.0 Hz, 1H), 2.28-2.35 (m, 1H), 2.19 (d, J = 6.7 Hz, 1H), 
2.05(sextetdd, J = 2.7, 8.2, 17.8 H, 1H), 1.81 (s, 3H), 1.30 (s, 3H), 0.14 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 176.11 (C), 131.20 (C), 119.10 (CH), 103.75 
(C), 89.30 (C), 70.87 (CH), 52.40 (CH3), 50.73 (C), 41.06 (CH), 31.29 (CH2), 22.06 
(CH3), 12.60 (CH3), 0.10 (CH3). 
HRMS (ESI+) 303.1387 calc’d for C15H24O3SiNa+, 303.1383 found. 
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Trimethyl(((4aS*,5S*,8aS*)-2,2,4a,6-tetramethyl-4a,5,8,8a-tetrahydro-4H-
benzo[d][1,3]dioxin-5-yl)ethynyl)silane (4.33a):  
LiAlH4 (5.6 mg, 0.15 mmol, 2 eq.) was suspended in 0.3mL Et2O and cooled to 0 °C.  
Ester 4.32a (20.7 mg, 0.074 mmol, 1 eq.) in 0.1 mL Et2 O was added and the solution 
was stirred for 30 min.  The reaction was quenched by adding 1 mL 10% aq. HCl.  The 
aqueous layer was extracted with 3 x 1 mL EtOAc, dried with Na2SO4 and concentrated.  
The crude diol was dissolved in acetone (3 mL) and 2,2-dimethoxypropane (77.1 mg, 
0.74 mmol, 10 eq) was added along with 2 mg PPTS (0.0074 mmol, 0.1 eq.).  The 
solution was stirred at room temperature overnight and concentrated.  The residue was 
dissolved in 1 mL DCM and quenched with 2 mL saturated NaHCO3.  The organic layer 
was separated and the aqueous layer was extracted with 2 x 1 mL DCM.  The combined 
organic fractions were dried with Na2SO4 and concentrated.  The compound was 
purified by flash chromatography (1:20 EtOAc:Hexane) to give acetonide 4.33a as a 
colorless oil (4.1 mg, 20%). 
IR (thin film) 2994, 2964, 2893, 2169, 1380, 1250, 1075, 858, 839 cm-1. 
1H NMR (500 MHz, CDCl3) δ 5.32 (d, J = 2.0 Hz, 1H), 3.86-3.88 (m, 2H), 3.79 (d, J 
= 11.6 Hz, 1H), 3.55 (d, J = 11.6 H, 1H), 2.36-2.44 (m, 1H), 1.91-1.96 (m, 1H), 1.86 
(dd, J = 1.4, 2.4 Hz, 3H), 1.46 (s, 3H), 1.40 (s, 3H), 0.80 (s, 3H), 0.14 (s, 9H).  
13C NMR (125 MHz, CDCl3, DEPT) δ 130.37 (C), 117.04 (CH), 105.53 (C), 99.03 (C), 
87.97 (C), 70.88 (CH), 68.03 (CH2), 35.22 (C), 34.58 (CH), 30.21 (CH3), 28.84 (CH2), 
22.82 (CH3), 18.96 (CH3), 16.06 (CH3), 0.30 (CH3) 
HRMS (ESI+) 315.1751 calc’d for C17H28O2SiNa+, 315.1758 found. 
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Trimethyl(((4aS*,5S*,8aR*)-2,2,4a,6-tetramethyl-4a,5,8,8a-tetrahydro-4H-
benzo[d][1,3]dioxin-5-yl)ethynyl)silane (4.33b): 
Compound 4.32b was synthesized in the same manner as 4.32a starting with 20 mg 
ester 4.32b.  Compound 4.33b was obtained as a colorless oil (6.5 mg, 31%). 
IR (thin film) 2990, 2961, 2855, 2172, 1382, 1250, 879 cm-1. 
1H NMR (500 MHz, CDCl3) δ 5.36 (dt, J = 1.4, 2.7 Hz, 1H), 3.80 (dd, J = 6.0, 10.4 Hz, 
1H), 3.75 (d, J = 11.3 Hz, 1H), 3.68 (d, J = 11.3 Hz, 1H), 2.86 (t, J = 1.1 Hz, 1H), 2.03-
2.10 (m, 1H), 1.93-2.00 (m, 1H), 1.78 (qd, J = 1.4, 2.6 Hz, 3H), 1.45 (s, 3H), 1.43 (s, 
3H), 1.13 (s, 3H), 0.14 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 130.73 (C), 119.57 (CH), 103.31 (C), 99.03 (C), 
88.90 (C), 71.55 (CH), 71.06 (CH2), 41.13 (CH), 35.61 (C), 29.95 (CH3), 28.29 (CH2), 
22.06 (CH3), 18.97 (CH3), 11.70 (CH3), 0.19 (CH3) 
HRMS (ESI+) 315.1751 calc’d for C17H28O2SiNa+, 315.1751 found. 
 
 
(1R*,2S*,6S*)-6-Hydroxy-1,3-dimethyl-2-((trimethylsilyl)ethynyl)cyclohex-3-ene-
1-carbaldehyde (4.24):  
LiAlH4 (13.5 mg, 0.36 mmol, 2 eq.) was suspended in Et2O (0.72 mL) and cooled to 0 
°C.  Compound 4.32a (50 mg, 0.18 mL, 1 eq.) in 0.2 mL Et2O was added dropwise and 
stirred for 15 min.  The reaction was quenched with 2 mL 10% aqueous HCl.  The 
aqueous layer was extracted with 3 x 2 mL EtOAc.  The combined organic extracts 
were washed with brine, dried with Na2SO4 and concentrated.  The crude diol was 
carried forward directly. 
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The crude diol (39.5 mg, 0.156 mmol, 1 eq.) and TEMPO (5 mg, 0.03 mmol, 0.2 eq.) 
were dissolved in DCM and PIDA (361 mg, 1.124 mmol, 2 eq.) was added.  The 
solution was stirred for 2 h and silica gel was added to the reaction mixture.  The solvent 
removed and the crude product was loaded directly onto a column.  Flash 
chromatography (1:10 EtOAc:Hexane) gave the product (25.6 mg, 57% over 2 steps) 
as a colorless oil.   
 
IR (thin film) 3442, 2964, 2937, 2915, 2170, 1723, 1448, 1249, 1075, 1048, 843 cm-1. 
1H NMR (500 MHz, C6D6) δ 9.57 (s, 1H), 5.01 (s, 1H), 4.28-4.29 (m, ~0.5 H, 1H), 
3.88-3.89 (m, 1H), 3.45 (s, 1H), 2.05-2.09 (m, 1H), 1.77-1.79 (m, 4H), 1.16 (s, 3H), 
0.14 (s, 9H). 
13C NMR (125 MHz, C6D6, DEPT) δ 204.93 (CH), 131.54 (C), 120.07 (CH), 105.04 
(C), 88.79 (C), 69.12 (CH), 51.79 (C), 37.79 (CH), 32.22 (CH2), 22.21 (CH3), 16.27 
(CH3), 0.12 (CH3). 
HRMS (ESI+) 273.1281 calc’d for C14H22O2Si, 273.1264 found. 
 
 
(1R*,2S*,6S*)-6-hydroxy-1,3-dimethyl-2-((trimethylsilyl)ethynyl)cyclohex-3-ene-
1-carbaldehyde (4.34a): 
Aldehyde 4.24 (14.3 mg, 0.06 mmol, 1 eq.) was dissolved in anhydrous Et2O (0.6 mL) 
and cooled to −78 °C.  Allylmagnesium bromide (0.17 mL of a 1M sol’n, 0.17 mmol, 
3 eq.) was added drop-wise.  The reaction was stirred for 1h and quenched with 2 mL 
saturated NH4Cl.  The aqueous layer was extracted with 3 x 1 mL EtOAc.  The 
combined organic extracts were dried with Na2SO4 and concentrated.  The crude 
material was converted to the acetonide immediately.   
The crude diol (0.06 mmol) was dissolved in acetone (1.2 mL) and 2,2-
dimethoxypropane (63 mg, 0.6 mmol, 10 eq.) was added.  PPTS (1.5 mg, 0.006 mmol, 
0.1 eq.) was added and the solution was stirred at rt for 18 h.  The solution was quenched 
with aqueous NaHCO3 and the aqueous layer was extracted with 3 x 1 mL DCM.  The 
combined organic extracts were dried with Na2SO4 and concentrated.  Purification by 
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flash chromatography (1:10 EtOAc:Hexane) gave the product (5.9 mg, 34% over 2 
steps) as a 3.1:1 ratio of diastereomers (4.1:1 observed in the crude 1H NMR spectrum). 
 
IR (thin film) 2963, 2914, 2170, 1379, 1249, 1221, 1077 cm-1. 
1H NMR (500 MHz, CDCl3, major diastereomer) δ 5.80-5.95 (m, 1H), 5.34 (td, J = 
1.4,2.7 Hz, 1H), 5.08-5.13 (m, 1H), 5.04-5.07 (m, 1H), 3.91 (dd, J = 3.9, 4.1 Hz, 1H), 
3.87 (dd, J = 3.8, 10.6 Hz, 1H), 3.59-3.61 (m, 1H), 2.50 – 2.53 (m, 1H), 2.36 – 2.49 (m, 
3H), 2.00 (ddd, J = 1.9, 6.2, 19.0 Hz, 1H), 1.83 – 1.84 (m, 3H), 1.41 (s, 3H), 1.36 (s, 
3H), 0.88 (s, 3H), 0.15 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT, major diastereomer) δ 136.76 (CH), 130.54 (C), 
117.62 (CH), 116.16 (CH2), 106.09 (C), 100.13 (C), 88.35 (C), 78.25 (C), 67.24 (CH), 
40.57 (C), 39.32 (CH), 35.92 (CH2), 2.36 (CH3), 25.24 (CH3), 22.61 (CH3), 14.81 
(CH3), 0.25 (CH3). 
HRMS (ESI+) 355.2064 calc’d for C20H32O2SiNa+, 355.2034 found. 
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Chapter 5 Experimental 
 
 
(2,6-bis((E)-(benzylimino)methyl)phenyl)palladium(II) bromide (5.128): 
2-bromoisophthalaldehyde (50 mg, 0.23 mmol, 1 eq.), and benzylamine (49.2 mg, 0.46 
mmol, 2 eq.) were dissolved in toluene (2 mL) and 4Å molecular sieves were added.  
The solution was heated to 60 °C for 48 h.  The product was filtered and concentrated.  
The crude material was carried forward directly. 
The crude product and Pd2(dba)3 (65 mg, 0.0714 mmol, 0.51 eq.) were dissolved in 
benzene (14 mL).  The solution was degassed by bubbling N2 through the solution for 
15 min.  The reaction mixture was heated to 60 °C for 18 h.  The mixture was 
concentrated and the crude material was purified by f.c.c. (1:2 to 1:4 EtOAc:Hexane 
followed by flushing the column with EtOAc) to give the product (44.1 mg, 63%). 
1H NMR (500 MHz, CDCl3) δ 7.81 (s, 2H), 7.48 (d, J = 7.4 Hz, 4H), 7.39 (t, J = 7.4 
Hz, 4H), 7.33 (t, J = 7.2 Hz, 2H), 5.17 (s, 4H). 
 
 
(4-tosylmorpholin-2-yl)methyl acetate (5.126): 
Palladium catalyst 5.128 (2.9 mg, 0.0058 mmol, 0.05 eq.) and AgBF4 (1.36 mg, 0.007 
mmol, 1.25 eq.) were dissolved in DCM and stirred for 1h at rt.  The solution was 
filtered through celite and concentrated.  The catalyst was dissolved in AcOH (1 mL).  
Alcohol 5.125 (30 mg, 0.117 mmol, 1 eq.) and PIDA (48.3 mg, 0.15 mmol, 1.25 eq.) 
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were added.  The reaction was stirred at 50 °C for 1.75 h.  The solution was concentrated 
and the product was purified by f.c.c. (1:4 to 1:2 EtOAc:Hexane) to give the product 
(3.8 mg, 10% yield). 
1H NMR (500 MHz, CDCl3) δ 7.64-7.63 (m, 2H), 7.36 (m, 2H), 4.07 (dd, J = 5.9, 11.8 
Hz, 1H), 4.02 (dd, J = 4.7, 11.8 Hz, 1H), 3.94 (ddd, J = 1.6, 3.4, 11.6 Hz, 1H), 3.80 
(dddd, J = 2.6, 4.7, 5.8, 10.4 Hz, 1H), 3.70 (dt, 2.7, 11.5 Hz, 1H), 3.61 (td, J = 3.1, 11.3 
Hz, 1H), 3.53 (tdd, J = 1.5, 2.8, 11.7 Hz, 1H), 2.45 (s, 3H), 2.44 (dd, J = 3.0, 4.0 Hz, 
1H), 2.19-2.16 (m, 1H), 2.08 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 170.75 (C), 144.27 (C), 132.14 (C), 129.98 
(CH), 128.01 (CH), 73.17 (CH), 66.10 (CH2), 64.38 (CH2), 47.53 (CH2), 45.52 (CH2), 
21.71 (CH3), 20.93 (CH3). 
 
General procedure for the synthesis of N-Allylamides: 
 
Procedure A: 
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Allylamine (1.2 eq.), triethylamine (2 eq.) and DMAP (0.1 eq.) were dissolved in DCM 
(0.5 M).  The solution was cooled to 0 °C and the corresponding acid chloride or 
anhydride was added dropwise.  The solution was allowed to warm to room temperature 
and stirred overnight.  The reaction was quenched with saturated, aqueous NaHCO3 and 
extracted with 3 x 20 mL DCM.  The combined organic solution was washed with brine 
and dried with Na2SO4.  The solution was concentrated and purified by f.c.c. to give the 
pure amide. 
 
Procedure B: 
The corresponding carboxylic acid (1 eq.) was suspended in DCM (0.3M) and 
triethylamine (2.0 eq.) was added.  The solution was cooled to 0 °C and ethyl 
chloroformate (1 eq.) was added drop-wise.  The solution was stirred at 0 °C for 30 min.  
Allylamine (1.2 eq.) was added dropwise.  The solution was allowed to warm to room 
temperature and stirred overnight.  The reaction was quenched with saturated aqueous 
NaHCO3 and extracted with 2 x 20 mL DCM.  The combined organic layers were 
washed with brine and dried with Na2SO4.  The solution was concentrated and purified 
by f.c.c. to give the pure amide. 
Procedure C: 
Allylamine (1 eq.) and carboxylic acid (1.25 eq.) were dissolved in DCM (0.2 M) along 
with a catalytic amount of DMAP (0.1 eq.).  To this solution was added DCC (1.25 eq.).  
The mixture was stirred overnight.  The mixture was diluted with EtOAc and filtered.  
The organic layer was washed with saturated, aqueous NaHCO3 followed by brine, 
dried with Na2SO4 and concentrated.  The title compound was purified by f.c.c to give 
the pure amide. 
 
N-allylbenzamide (5.4a):2 
Synthesized by method A.  Purified by f.c.c. (1:2 EtOAc:Hexane) to give a yellow oil ( 
2.21 g, 78%).  
 IR (Thin Film) 3312, 3065, 1640, 1540, 1307, 921 cm-1.   
                                                          
2 J.-F. Soulé, H. Miyamura and S. Kobayashi, Journal of the American Chemical Society, 2011, 133, 
18550-18553. 
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1H NMR (500 MHz, CDCl3) δ  7.79-7.77 (m, 2H), 7.52-7.49 (m, 1H), 7.45-7.42 (m, 
2H), 6.20 (bs, 1H), 5.95 (ddt, J = 5.7, 10.3, 17.1 Hz, 1H), 5.27 (dtd, J = 1.5, 1.5, 17.2 
Hz, 1H), 5.19 (dtd, J = 1.3, 1.3, 10.2 Hz, 1H), 4.10 (ddd, J = 1.5, 1.5, 5.7 Hz, 2H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 167.4 (C), 134.6 (CH), 134.3 (CH), 131.7 (CH), 
128.7 (CH), 127.0 (CH), 116.9 (CH2), 42.6 (CH2). 
 
 
 
 
N-allyl-2-nitrobenzamide (5.4b):3  
Synthesized by method B.  Purified by f.c.c. (2:1 EtOAc:Hexane) to give a white solid 
(211.4 mg, 69%).  
IR (Thin Film) 3272, 1644, 1545, 1527, 1355 cm-1.  
1H NMR  (500 MHz, CDCl3) δ  8.04 (dd, J = 1.2, 8.2 Hz, 1H), 7.66 (ddd, J = 1.2, 7.5, 
Hz, 1H), 7.57 (ddd, J = 1.4, 7.5, 8.2, Hz, 1H), 7.51 (dd, J = 1.4, 7.5 Hz, 1H), 6.00 (bs, 
1H), 5.97-5.91 (m, 1H), 5.30 (dtd, J = 1.4, 1.4, 17.2, Hz, 1H), 5.20 (dtd, J = 1.3, 1.3, 
10.3, Hz, 1H), 4.07 (ddd, J = 1.5, 1.5, 5.8 Hz, 2H).   
13C NMR  (125 MHz, CDCl3, DEPT) δ 166.5 (C), 146.6 (C), 133.8 (CH), 133.5 (CH), 
133.0 (C), 130.6 (CH), 128.9 (CH), 124.7 (CH), 117.4 (CH2), 42.7 (CH2). 
 
 
N-allyl-4-methoxybenzamide (5.4c):4 
Synthesized by method B.  Purified by f.c.c. (1:2 EtOAc:Hexane) to give a white solid 
(87.7 mg, 23% yield).   
IR (Thin Film) 3315, 1633, 1607, 1543, 1504, 1254, 1180, 1031 cm-1.  
                                                          
3 V. C. Agwada, Journal of Chemical & Engineering Data, 1984, 29, 231-235. 
4 D. F. Harvey and D. M. Sigano, The Journal of Organic Chemistry, 1996, 61, 2268-2272. 
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1H NMR  (500 MHz, CDCl3 δ  7.77-7.74 (m, 2H), 6.92-6.89 (m, 2H), 6.22 (bs, 1H), 
5.97-5.89 (m, 1H), 5.24 (dtd, J = 1.5, 1.5, 17.2 Hz, 1H), 5.16 (dd, J = 1.4, 10.2 Hz, 1H), 
4.06 (ddd, J = 1.4, 1.4, 5.7 Hz, 2H), 3.84 (s, 3H).  
13C NMR (125 MHz, CDCl3, DEPT) δ 167.0 (C), 162.3 (C), 134.5 (CH), 128.8 (CH), 
126.9 (C), 116.6 (CH2), 113.9 (CH), 55.5 (CH3), 42.5 (CH2). 
 
 
 
N-allyl-3-chlorobenzamide (5.4d):3  
Synthesized by method B.  Purified by f.c.c. (1:3 EtOAc:Hexane) as a white solid (165.1 
mg, 53%). 
IR (Thin Film) 3309, 3069, 1640, 1570, 1541, 1312, 920 cm-1.   
1H NMR (500 MHz, CDCl3): δ  7.77 (t, J = 1.8 Hz, 1H), 7.65 (d, J = 7.7 Hz, 1H), 7.47 
(ddd, J = 1.0, 8.0, 8.0 Hz, 1H), 7.37 (t, J = 7.9 Hz, 1H), 6.20 (bs, 1H), 5.97-5.89 (m, 
1H), 5.27 (dd, J = 1.4, 17.1 Hz, 1H), 5.20 (dd, J = 1.2, 10.2 Hz, 1H), 4.09-4.07 (m, 2H).  
13C NMR (125 MHz, CDCl3, DEPT) δ 166.1 (C), 136.4 (C), 134.9 (C), 134.0 (CH), 
131.7 (CH), 130.0 (CH), 127.4 (CH), 125.2 (CH), 117.1 (CH2), 42.7 (CH2). 
 
 
N-allyl-4-bromobenzamide (5.4e): 
Synthesized by method A.  Purified by f.c.c. (1:2 EtOAc:Hexane) as a white solid 
(105.1 mg, 38%).   
IR (Thin Film) 3298, 1631, 1536, 931, 844 cm-1.  
1H NMR  (500 MHz, CDCl3) δ  7.66-7.64 (m, 2H), 7.58-7.55 (m, 2H), 6.22 (bs, 1H), 
5.93 (ddt, J = 5.7, 10.3,17.1 Hz, 1H), 5.26 (dtd, J = 1.5, 1.5, 17.1 Hz, 1H), 5.19 (dtd, J 
= 1.3, 1.3, 10.2 Hz, 1H), 4.09-4.06 (m, 2H).  
13C NMR  (125 MHz, CDCl3, DEPT) δ 166.5 (C), 134.0 (CH), 133.4 (C), 131.9 (CH), 
128.7 (CH), 126.3 (CH), 117.0 (CH2), 42.6 (CH2).   
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HRMS (ESI+) 261.9838 calc’d for C10H10BrNONa, found 261.9823. 
 
 
 
 
 
N-allylpicolinamide (5.4f): 
Synthesized by method B.  Purified by f.c.c. (2:1 EtOAc:Hexane) as a yellow oil (251.3 
mg, 76%).   
IR (Thin Film) 3388, 3059, 3012, 2985, 2919, 1668, 1526, 1456, 1434, 1288, 997, 821, 
751 cm-1.   
1H NMR (500 MHz, CDCl3) 8.55-8.54 (m, 1H), 8.20 (dd, J = 0.9, 7.8 Hz, 1H), 8.14 
(bs, 1H), 7.84 (ddd, J = 1.7, 17.7,17.7 Hz, 1H), 7.42 (ddd, J = 1.2, 4.8, 7.6 1H), 5.94 
(ddt, J = 5.5, 10.3, 17.1 Hz, 1H), 5.27 (dtd, J = 1.5, 1.5, 17.1 Hz, 1H), 5.18 (dt, J = 1.4, 
10.2 Hz, 1H), 4.11 (ddd, J = 1.4, 1.4, 5.8 Hz, 2H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 164.3 (C), 150.0 (C), 148.2 (CH), 137.5 (CH), 
134.2 (CH), 126.3 (CH), 122.4 (CH), 116.6 (CH2), 41.9 (CH2).   
HRMS (ESI+) 185.0685 calc’d for C9H10N2ONa, found 185.0670. 
 
 
N-allylfuran-3-carboxamide (5.4g):5 
 
Synthesized by method B.  Purified by f.c.c. (1:2 EtOAc:Hexane) as a white solid (215.7 
mg, 64%).   
                                                          
5 N. Zanatta, D. Faoro, S. C. Silva, H. G. Bonacorso and M. A. P. Martins, Tetrahedron Letters, 2004, 
45, 5689-5691. 
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IR (Thin Film) 3292, 1634, 1589, 1571, 1538, 1201, 1162, 1019, 986, 875 cm-1.  
1H NMR (500 MHz, CDCl3) δ 7.95 (s, 1H), 7.42 (t, J = 1.7 Hz, 1H), 6.64 (dd, J = 0.76, 
2.0 Hz, 1H), 6.17 (bs, 1H), 5.88 (ddt, J = 5.7, 10.2, 17.1 Hz, 1H), 5.22 (dtd (J = 1.5, 
1.5, 17.2 Hz, 1H), 5.15 (dtd, J = 1.5, 1.5, 10.1 Hz, 1H), 4.01 (ddd, J = 1.5, 1.5, 5.7 Hz, 
2H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 162.6 (C), 144.9 (CH), 143.9 (CH), 134.2 (CH), 
122.6 (C), 116.7 (CH2), 108.4 (CH), 42.0 (CH). 
 
 
 
N-allylacrylamide (5.4h): 
Synthesized by method A. Purified by f.c.c (1:1 EtOAc:Hexane) as an orange oil 
(110.1 mg, 36%). 
1H NMR (500 MHz, CDCl3) δ 6.29 (dd, J = 1.4, 17.0 Hz, 1H), 6.11 (dd, J = 10.3, 
17.0 Hz, 1H), 5.86 (tdd, J = 5.7, 10.3, 17.1 Hz, 1H), 5.75 (bs, 1H), 5.65 (dd, J = 1.4, 
10.3 Hz, 1H), 5.23-513 (m, 2H), 3.96 (tt, J = 1.5, 5.8 Hz, 2H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 165.47 (C), 134.09 (CH), 130.82 (CH), 126.75 
(CH2), 116.79 (CH2), 42.12 (CH2). 
 
 
 
N-allylcinnamamide (5.4i):6  
Synthesized by method B.  Purified by f.c.c. (1:2 EtOAc:Hexane) as a white solid (485.9 
mg, 77%).   
IR (Thin Film) 3289, 3066, 1654, 1624, 1547, 1353, 990, 975, 914 cm-1. 
1H NMR (500 MHz, CDCl3) δ 7.64 (d, J = 15.6 Hz, 1H), 7.49 (dd, J = 3.1, 6.5 Hz, 2H), 
7.35 (ddd, J = 1.9, 4.4, 4.4 Hz, 3H), 6.45 (d, J = 15.6 Hz, 1H), 5.98 (bs, 1H), 5.90 (tdd), 
                                                          
6 S. De Sarkar and A. Studer, Organic Letters, 2010, 12, 1992-1995. 
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J = 5.7, 10.2, 17.1 Hz, 1H), 5.24 (dtd, J = 1.5, 1.5, 17.1 Hz, 1H), 5.16 (dtd, J = 1.4, 1.4, 
10.2 Hz, 1H), 4.02 (ddd, J = 1.5, 1.5, 5.8 Hz, 2H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 165.9 (C), 141.3 (CH), 134.9 (C), 134.2 (CH), 
129.8 (CH), 128.9 (CH), 127.9 (CH), 120.7 (CH), 116.7 (CH2), 42.3 (CH2). 
 
 
 
 
 
N-allylacetamide (5.4j):7 
Synthesized by method A.  Purified by f.c.c. (1:20 MeOH:DCM) as a red oil (217.8 
mg, 50%). 
IR (Thin Film) 3290, 3083, 1655, 1552, 1429, 1283, 920 cm-1.   
1H NMR (500 MHz, CDCl3) δ 5.86-5.77 (m, 2H), 5.17 (dt, J = 1.1, 17.2 Hz, 1H), 
5.11 (dt, J = 1.2, 10.2 Hz, 1H), 3.87-3.84 (m, 2H), 1.99 (s, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 170.1 (C), 134.3 (CH), 116.5 (CH2), 42.2 
(CH2), 23.3 (CH3). 
 
 
N-allylpivalamide (5.4k):8 
Synthesized by method A.  Purified by f.c.c. (1:2 EtOAc:Hexane) as a yellow oil which 
gelled upon standing (223.2 mg, 76%). 
IR (Thin Film) 3341, 2965, 1640, 1532, 1211, 985, 914 cm-1.  
1H NMR (500 MHz, CDCl3) δ 5.85 (tdd, J = 5.6, 10.3, 17.2 Hz, 1H), 5.67 (bs, 1H), 
5.17 (dtd, J = 1.6, 1.6, 17.2 Hz, 1H), 5.13 (dtd, J = 1.4, 1.4, 10.2 Hz, 1H), 3.88 (ddd, J 
= 1.6, 1.6, 5.7 Hz, 2H), 1.21 (s, 9H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 178.3 (C), 134.7 (CH), 116.2 (CH2), 42.0 (CH2), 
38.9 (C), 27.8 (CH3). 
                                                          
7 G. C. Tsui, F. Menard and M. Lautens, Organic Letters, 2010, 12, 2456-2459. 
8 E. Alonso, D. J. Ramón and M. Yus, Tetrahedron, 1997, 53, 14355-14368. 
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N-allyl-2,2,2-trifluoroacetamide (5.4l):9 
Synthesized by method A.  Isolated by f.c.c. (1:2 EtOAc:Hexane) as a yellow oil (257.2 
mg, 48%).   
IR (Thin Film) 3310, 3094, 1704, 1557, 1434, 1161, 994, 931, 726 cm-1. 
1H NMR (500 MHz, CDCl3) 6.39 (bs, 1H), 5.89-5.80 (m, 1H), 5.29-5.24 (m, 2H), 3.99 
(t, J = 5.5 Hz, 2H);   
13C NMR (125 MHz, CDCl3, DEPT) 157.4 (q, J = 36.3 Hz, C), 131.9 (CH), 118.2 
(CH2), 116.0 (q, J = 286.3 Hz, CF3), 42.3 (CH2).  
 
 
 
N-allyl-2,2,2-trichloroacetamide (5.4m): 
Synthesized by method A.  Isolated by f.c.c. (1:2 EtOAc:Hexane) (249.1 mg, 90%) 
1H NMR (500 MHz, CDCl3) δ 6.77 (bs, 1H), 5.89 (tdd, J = 5.6, 10.3, 17.1 Hz, 1H), 
5.33-5.23 (m, 2H), 4.00 (tt, J = 1.5, 5.7 Hz, 2H). 
 
                                                          
9 P. C. Prediger, L. s. F. Barbosa, Y. Génisson and C. R. D. Correia, The Journal of Organic Chemistry, 
2011, 76, 7737-7749. 
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ethyl 3-(allylamino)-3-oxopropanoate (5.4n):10  
Synthesized by method C.  Purified by f.c.c. (1:2 EtOAc:Hexane) as a cream solid 
(215.2 mg, 69%).   
IR (Thin Film) 3313, 2984, 1736, 1665, 1554, 1273, 1159, 1032, 927 cm-1.   
1H NMR (500 MHz, CDCl3) 7.23 b(s, 1H), 5.88-5.80 (m, 1H), 5.20 (dd, J = 1.2, 17.2 
Hz, 1H), 5.14 (dd, J = 1.2, 10.3 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 3.92 (t, J = 5.6 Hz, 
2H), 3.32 (s, 2H), 1.28 (t, J = 7.2 Hz, 3H).  
13C NMR (125 MHz, CDCl3, DEPT) δ 169.8 (C), 164.9 (C), 133.9 (CH), 116.5 (CH2), 
61.7 (CH2), 42.0 (CH2), 41.2 (CH2), 14.2 (CH3). 
 
 
 
 
(S)-2-((ethoxycarbonyl)amino)-3-methylbutanoic acid (5.133):11  
L-Valine (1.00g, 8.53 mmol) and NaHCO3 (3g, 37.5 mmol) were suspended in water 
and ethyl chloroformate (1.4 g, 12.8 mmol) was added dropwise.  The mixture was 
stirred at room temperature for 4.5 hours.  The solution was extracted with 2 x 30 mL 
DCM.  The aqueous layer was acidified and extracted with EtOAc (3x50 mL).  The 
combined organic layers were washed with brine and dried with Na2SO4.  The organic 
layer was concentrated and the resulting solid was used without further purification 
(1.51 g, 94%).   
                                                          
10 Y. Nakaike, N. Taba, S. Itoh, Y. Tobe, N. Nishiwaki and M. Ariga, Bulletin of the Chemical Society 
of Japan, 2007, 80, 2413-2417. 
11 K. M. Engle, D.-H. Wang and J.-Q. Yu, Journal of the American Chemical Society, 2010, 132, 
14137-14151. 
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1H NMR (500 MHz, CDCl3) δ 5.11-5.10 (m, 1H), 4.34-4.30 (m, 1H), 4.16-4.10 (m, 
2H), 2.27-2.20 (m, 1H), 1.26 (t, J = 7.1 Hz, 3H), 1.01 (d, J = 6.9 Hz, 3H), 0.94 (d, J = 
6.9 Hz, 3H). 
 
 
(S)-ethyl (1-(allylamino)-3-methyl-1-oxobutan-2-yl)carbamate (5.134): 
Compound S1 (414 mg, 2.19 mmol) and triethylamine (553 mg, 5.47 mmol) were 
dissolved in DCM (6 mL) and the solution was cooled to 0 °C.  Isobutyl chloroformate 
(299.1 mg, 2.19 mmol) was added dropwise and the solution was stirred at 0 °C for 1 
h.  Allylamine (250 mg, 4.38 mmol) was added and the solution was allowed to slowly 
warm to room temperature and stirred for 18 h.  The solution was quenched with 
saturated NaHCO3 solution (10 mL) and extracted with DCM (2 x 10 mL).  The 
combined organic layers were washed with brine and dried with Na2SO4.  The solution 
was concentrated under reduced pressure and recrystallized from EtOH/H2O as fluffy, 
white crystals (154.8 mg, 31%).   
IR (Thin Film) 3298, 1686, 1650 cm-1;   
1H NMR (500 MHz, CDCl3) δ 6.22 (bs, 1H), 5.85-5.78 (m, 1H), 5.28 (d, J = 8.5 Hz, 
1H), 5.18 (dd, J = 1.3, 17.2 Hz, 1H), 5.13 (dd, J = 1.2, 10.3 Hz, 1H), 4.10 (q, J = 6.9 
Hz, 2H), 3.98-3.93 (m, 1H), 3.92-3.83 (m, 2H), 2.13 (dd, J = 6.6, 12.7 Hz, 1H), 1.24 (t, 
J = 7.1 Hz, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.93 (d, J = 6.8 Hz, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 171.4 (C), 156.9 (C), 134.0 (CH), 116.7 (CH2), 
61.4 (CH2), 60.6 (CH), 42.0 (CH2), 31.1 (CH), 19.5 (CH3), 18.0 (CH3), 14.7 (CH3).   
HRMS (ESI+) 251.1366 calc’d for C11H20N2O3Na, found 251.1352.  
[α]D = –13.7 (c = 0.0041, DCM). 
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(S)-N-(4-methylpent-1-en-3-yl)benzamide (5.138) 
L-valinol (500 mg, 4.85 mmol) and triethylamine (540 mg, 5.3 mmol) were dissolved 
in methanol (25 mL) and the solution was cooled to 0 °C.  Benzoyl chloride (745 mg, 
5.3 mmol) was added dropwise and the solution was allowed to slowly reach room 
temperature.  The solution was stirred for 18 h.  The methanol was removed under 
reduced pressure and the resulting product was dissolved in EtOAc (30 mL) and 
extracted with 30 mL H2O.  The aqueous layer was extracted with 2 x 30 mL EtOAc.  
The combined organic layers were washed with brine, dried with Na2SO4, and 
concentrated under reduced pressure.  The product was purified by f.c.c. (1:3 
EtOAc:Hexane) to yield a colorless oil which solidified upon standing (463.6 mg, 46%). 
DMSO (234 mg, 3.0 mmol) was dissolved in 0.75 mL of dry DCM.  The solution was 
cooled to –78 °C and a solution of oxalyl chloride (168 mg, 1.33 mmol) dissolved in 
3.3 mL of dry DCM was added dropwise.  The solution was stirred for 30 min.  The 
amide alcohol prepared above (250 mg, 1.21 mmol) was dissolved in 1.7 mL of dry 
DCM and added drop-wise.  The solution was stirred at –78 °C and triethylamine (612 
mg, 5.0 mmol) was added drop-wise.  The solution was allowed to warm to rt and stirred 
for an additional 30 min.  The reaction was quenched with 20 mL H2O and extracted 
with 3 x 10 mL DCM.  The combined organic layers were washed with 10% aqueous 
HCl.  The organic layer was washed with brine and dried with Na2SO4.  The solvent 
was removed under reduced pressure and the crude aldehyde was used directly in the 
next step. 
PPh3CH3I (848.8 mg, 2.1 mmol) was dissolved in THF (4 mL) and cooled to –78 °C.  
n-BuLi (0.84mL, 2.5M in hexanes, 2.1 mmol) was added dropwise.  The solution was 
warmed to 0 °C for 45 min. and cooled to –78 °C.  The aldehyde from the previous step 
dissolved in 1 mL of THF was added dropwise.  The solution was allowed to warm to 
rt and stirred for 18 h.  The reaction was quenched with 10 mL saturated aqueous 
NH4Cl.  The aqueous layer was extracted with 3 x 10 mL EtOAc.  The combined 
organic layers were washed with brine and dried with Na2SO4.  The compound was 
purified by f.c.c. (1:4 EtOAc:Hexane) to give a yellow solid (35.2 mg, 14 %).   
IR (Thin Film) 3290, 3055, 2955, 2933, 1633, 1530, 1333, 917, 694 cm-1   
1H NMR (500 MHz, CDCl3) δ 7.77-7.79 (m, 2H), 7.47-7.50 (m, 1H), 7.40-7.43 (m, 
1H), 6.16 (d, J = 7.9 Hz, 1H), 5.84 (ddd, J = 5.8, 10.5, 17.2 Hz, 1H), 5.21 (td, J = 1.5, 
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17.2 Hz, 1H), 5.17 (td, J = 1.3, 10.3 Hz, 1H), 4.55 (dtt, J = 9.1, 5.8, 1.5 Hz, 1H), 1.88-
1.97 (m, 1H); 0.97 (dd, J = 6.7, 1.5 Hz, 6H).   
13CNMR (125 MHz, CDCl3, DEPT) δ 167.1 (C), 136.8 (CH), 135.0 (C), 131.5 (CH), 
128.7 (CH), 127.0 (CH), 116.0 (CH2), 57.1 (CH), 32.3 (CH), 18.9 (CH3), 18.4 (CH3).  
[α]D = 56.5 (c = 0.0058, DCM) 
 
 
(E)-hex-2-en-1-aminium 4-methylbenzenesulfonate (5.141a): 
E-hex-2-en-1-ol (500 mg, 5 mmol, 1 eq.) and NEt3 (556 mg, 5.5 mmol, 1.1 eq.) were 
dissolved in benzene (16 mL).  TFAA (1.15 g, 5.5 mmol, 1.1 eq.) was added dropwise 
and stirred for 1.15 h.  NaN3 (650 mg, 10 mmol, 2 eq.) and DMSO (10 mL) were added.  
The reaction was stirred at 40 °C for 6 h.  The solution was cooled to rt and poured into 
H2O (30 mL).  The organic layer was separated.  The aqueous layer was extracted with 
3 x 5 mL benzene.  The combined extracts were dried with Na2SO4 and filtered.  
Triethyl phosphite (913 mg, 5.5 mmol, 1.1 eq.) was added to the benzene extracts and 
the solution was stirred at 30 °C for 18 h.  The solvent was removed and the residue 
was dissolved in EtOH (2.5 mL).  TsOH·H2O (951.1 mg, 5 mmol, 1 eq.) was added and 
the solution was stirred for 6 h.  The solvent was removed and the residue was treated 
with Et2O (9 mL).  The flask was placed in the freezer overnight and filtered to give 
5.141a as a white solid (494.2 mg, 37%). 
1H NMR (300 MHz, DMSO-d6) δ 7.80 (dd, J = 1.8, 8.3 Hz, 2H), 7.47 (d, J = 8.0 Hz, 
2H), 6.07-5.98 (m, 1H), 5.70-5.59 (m, 1H), 3.63 (d, J = 6.7 Hz, 2H), 2.50 (s, 3H), 2.15 
(q, J = 7.0 Hz, 2H), 1.53-1.49 (m, 2H), 0.98 (dt, J = 1.8, 7.4 Hz, 3H). 
 
 
(E)-3-phenylprop-2-en-1-aminium 4-methylbenzenesulfonate (5.141b): 
The same procedure as 5.141a was utilized to synthesize 5.141b.  Compound 5.141b 
was isolated as a white solid (862.9 mg, 56%). 
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1H NMR (300 MHz, DMSO-d6) δ 7.79 (d, J = 8.2 Hz, 2H), 7.63 (dd, J = 2.0, 5.9 Hz, 
2H), 7.57-7.46 (m, 5H), 6.95-6.89 (m, 1H), 6.49-638 (m, 1H), 3.89 (d, J = 6.9 Hz, 2H), 
2.50 (s, 3H). 
 
 
(E)-N-(hex-2-en-1-yl)benzamide (5.412a): 
Tosylate 5.141a (494.2 mg, 1.82 mmol, 1 eq.), DMAP (25 mg, 0.2 mmol, 0.1 eq.) and 
NEt3 (736 mg, 7.28 mmol, 4 eq.) were dissolved in DCM (5 mL) and the solution was 
cooled to 0 °C.  Benzoyl chloride (281 mg, 2 mmol, 1.1 eq.) was added.  The reaction 
was allowed to warm to rt and stirred for 18 h.  The reaction was quenched with 10 mL 
H2O and he organic layer was separated.  The aqueous layer was extracted with 2 x 10 
mL DCM.  The combined organic layers were washed with brine, dried with Na2SO4 
and concentrated.  Purification by f.c.c. (1:4 EtOAc:Hexane) gave the product (210.3 
mg, 57%). 
IR (thin film) 3312, 3063, 2958, 2927, 2871, 1638, 1578, 1310, 968, 695 cm-1. 
1H NMR (500 MHz, CDCl3) δ 7.78-7.76 (m, 2H), 7.51-7.47 (m, 1H), 7.44-7.41 (m, 
2H), 6.11 (bs, 1H), 5.73-5.67 (m, 1H), 5.55 (ttd, J = 1.4, 6.3, 15.3 Hz, 1H), 4.04-4.01 
(m, 2H), 2.02-2.00 (m, 2H), 1.40 (sextet, J = 7.4 Hz, 2H), 0.90 (t, J = 7.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 167.31 (C), 134.82 (C), 134.25 (CH), 131.52 
(CH), 128.69 (CH), 127.02 (CH), 125.77 (CH), 42.16 (CH2), 34.48 (CH2), 22.40 (CH2), 
13.82 (CH3). 
HRMS (ESI+) 226.1202 calc’d for C13H17NONa+, 226.1193 found. 
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N-cinnamylbenzamide (5.142b): 
Compound 5.142a was synthesized from 500 mg (1.67 mmol) of 5.141b using the same 
procedure that was used to synthesize 5.142a.  Amide 5.142b was obtained after 
purification by f.c.c. (1:4 EtOAc:Hexane) (242.7 mg, 62%). 
1H NMR (500 MHz, CDCl3) δ 7.8-7.79 (m, 2H), 7.51-7.48 (m, 1H), 7.44-7.41 (m, 2H), 
7.37-7.35 (m, 2H), 7.32-7.29 (m, 2H), 7.25-7.22 (m, 1H), 6.58 (d, J = 15.6 Hz, 1H), 
6.37 (s, 1H), 6.28 (td, J = 6.4, 15.8 Hz, 1H), 4.24 (dt, J = 1.2, 6.1 Hz, 2H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 167.44 (C), 136.60 (C), 134.56 (C), 132.61 
(CH), 131.65 (CH), 128.73 (2xCH), 127.91 (CH), 127.08 (CH), 126.53 (CH), 125.55 
(CH), 42.25 (CH2). 
 
 
 
General procedure for the cyclization reaction: 
PIDA (1.2 eq.) was added to a flask and dissolved in DCM (0.1M).  Acetic acid (0.11 
mL, 10 equiv.) was added followed by BF3·Et2O (1.2 eq).  The corresponding 
allylamide was added and the solution was stirred at rt until complete by TLC.  The 
reaction was quenched with 1 eq. solid Na2SO3 and 0.2 eq. NaOAc and the mixture was 
stirred for an hour.  The mixture was diluted with DCM to 5 mL and 5 mL 30% aq. 
NH4OH was added.  The organic layer was separated and the aqueous layer was 
extracted with 2 x 5 mL DCM.  The combined organic fractions were dried with Na2SO4 
and concentrated.  The residue was purified by f.c.c to obtain the pure oxazoline.  
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(2-phenyl-4,5-dihydrooxazol-5-yl)methyl acetate (5.127a) 
Isolated by f.c.c. (1:1 EtOAc:Hexane) as a brown solid (35.6 mg, 84%).   
IR (Thin Film) 3062, 2945, 2875, 1743, 1652, 1369, 1233, 1078, 696 cm-1.   
1H NMR (500 MHz, CDCl3) 7.94-7.92 (m, 2H), 7.49-7.46 (m, 1H), 7.40 (t, J = 7.7 Hz, 
2H), 4.93-4.87 (m, 1H), 4.31 (dd, J = 3.5, 12.1 Hz, 1H), 4.18 (dd, J = 6.1, 11.9 Hz, 1H), 
4.14 (dd, J = 9.8, 14.7 Hz, 1H), 3.81 (dd, J = 7.3, 14.9 Hz, 1H), 2.08 (s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 164.1 (C), 131.6 (CH), 128.5 (CH), 
128.3 (CH), 127.5 (C), 77.1 (CH), 65.3 (CH2), 57.1 (CH2), 20.9 (CH3).    
HRMS (ESI+) 272.0788 calc’d for C12H13NO3Na, found 242.0777. 
 
 
(2-(2-nitrophenyl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127b) 
Purified by f.c.c. (1:1 EtOAc:Hexane) as a brown oil (41.1 mg, 77%).   
IR (Thin Film) 3074, 2947, 1743, 1666, 1537, 1367, 1234, 1105, 1050, 975, 786, 721, 
705 cm-1.   
1H NMR (500 MHz, CDCl3) δ 7.86-7.84 (m, 1H), 7.80 (dd, J = 1.6, 7.5 Hz, 1H), 7.66-
7.59 (m, 2H), 4.96-4.91 (m, 1H), 4.30 (dd, J = 3.5, 12.2 Hz, 1H), 4.21 (dd, J = 6.6, 12.5 
Hz, 2H), 4.16 (dd, J = 10.1, 15.0 Hz, 2H), 3.84 (dd, J = 7.3, 14.9 Hz, 1H), 2.11 (s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 161.4 (C), 149.3 (C), 132.6 (CH), 
131.7 (CH), 131.1 (CH), 124.0 (CH), 123.0 (C), 78.1 (CH), 64.8 (CH2), 57.4 (CH2), 
20.9 (CH3).   
HRMS (ESI+) 287.0638 calc’d for C12H12N2O5Na, found 287.0638. 
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(2-(4-methoxyphenyl)-4,5-dihydrooxazol-5-yl)methyl acetate (5127c) 
Purified by f.c.c. (1:1 EtOAc:Hexane) as a clear oil (33.2 mg, 68%).   
IR (Thin Film) 2939, 1742, 1650, 1513, 1369, 1255, 1170, 1072, 1027, 842, 677 cm-1.  
1H NMR (500 MHz, CDCl3) δ 7.88-7.85 (m, 2H), 6.91-6.88 (m, 2H), 4.86 (dddd, J = 
3.6, 6.3, 7.2, 9.9 Hz, 1H), 4.29 (dd, J = 3.6, 12.0 Hz, 1H), 4.16 (dd, J = 6.2, 12.1 Hz, 
1H), 4.10 (dd, J = 10.0, 14.7 Hz, 1H), 3.82 (s, 3H), 3.77 (dd, J = 7.3, 14.7 Hz, 1H), 2.07 
(s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 163.9 (C), 162.2 (C), 130.0 (CH), 
120.0 (C), 113.8 (CH), 76.9 (CH), 65.4 (CH2), 57.1 (CH2), 55.4 (CH3), 20.9 (CH3).   
HRMS (ESI+) 272.0893 calc’d for C13H15NO4Na, found 272.0892. 
 
 
(2-(3-chlorophenyl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127d) 
Isolated by f.c.c. (1:1 EtOAc:Hexane) as a yellow solid (43.3 mg, 85%).   
IR (Thin Film)  3070, 2946, 2875, 1740, 1652, 1573, 1432, 1368, 1234, 1077, 980, 904, 
761, 709, 659 cm-1.   
1H NMR (500 MHz, CDCl3) δ 7.93 (t, J = 1.7 Hz, 1H), 7.82 (dd, J = 7.8, 1.1 Hz, 1H), 
7.45 (ddd, J = 1.0, 2.0, 8.0 Hz, 1H), 7.34 (t, J = 7.9 Hz, 1H), 4.94-4.89 (m, 1H), 4.31 
(dd, J = 3.5, 12.2 Hz, 1H), 4.18 (dd, J = 6.1, 12.2 Hz, 1H), 4.15 (dd, J = 10.1, 15.7 Hz, 
1H), 3.82 (dd, J = 7.4, 15.0 Hz, 1H), 2.09 (s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 163.0 (C), 134.6 (C), 131.6 (CH), 
129.8 (CH), 129.3 (C), 128.4 (CH), 126.4 (CH), 77.4 (CH), 65.2 (CH2), 57.1 (CH2), 
20.9 (CH3).  
HRMS (ESI+)  279.0398 calc’d for C12H12ClNO3Na, found 276.0411. 
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(2-(4-bromophenyl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127e) 
Isolated by f.c.c. (1:1 EtOAc:Hexane) as a white solid (47.7 mg, 80%).   
IR (Thin Film) 2945, 2875, 1743, 1652, 1593, 1486, 1398, 1369,1232, 1050, 1011, 837, 
726, 669 cm-1.  
1H NMR (500 MHz, CDCl3) δ 7.78 (q, J = 4.5 Hz, 2H), 7.53 (q, J = 4.5 Hz, 2H), 4.89 
(dddd, J = 3.6, 6.3, 7.3, 9.9 Hz, 1H), 4.30 (dd, J = 3.5, 12.1 Hz, 1H), 4.17 (dd, J = 6.1, 
12.1 Hz, 1H), 4.12 (dd, J = 10.0, 15.0 Hz, 1H), 3.79 (dd, J = 7.4, 15.0 Hz, 1H), 2.07 (s, 
3H). 
13C NMR (125 MHz, CDCl3, DEPT) 170.8 (C), 163.3 (C), 131.7 (CH), 129.8 (CH), 
126.5 (C), 126.3 (C), 77.3 (CH), 65.2 (CH2), 57.2 (CH2), 20.9 (CH3). 
HRMS (ESI+) 319.9893 calc’d for C12H12BrNO3Na, found 319.9907. 
 
 
(2-(pyridin-2-yl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127f) 
Isolated by f.c.c. on basic alumina using 2.5% MeOH in DCM as elutant) as a brown 
oil (19.0 mg, 44%).   
IR (Thin Film) 3059, 2944, 2876, 1741, 1646, 1371, 1235, 1096, 1043, 677 cm-1.   
1H NMR (500 MHz, CDCl3) 8.70 (ddd, J = 0.8, 4.8, 4.8 Hz, 1H), 8.02-8.01 (m, 1H), 
7.78-7.75 (m, 1H), 7.39-7.37 (m, 1H), 5.02-4.96 (m, 1H), 4.33 (dd, J = 3.5, 12.2 Hz, 
1H), 4.23 (dd, J = 5.8, 12.0 Hz, 1H), 4.20 (dd, J = 10.3, 15.1 Hz, 1H), 3.87 (dd, J = 7.7, 
15.2 Hz, 1H), 2.06 (s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) 170.9 (C), 163.3 (C), 149.9 (CH), 146.5 (C), 136.8 
(CH), 125.8 (CH), 124.0 (CH), 77.8 (CH), 65.1, (CH2), 57.1 (CH2), 20.9 (CH3).   
HRMS (ESI+)  243.0740 calc’d for C11H12N2O3Na, found 243.0730. 
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(2-(furan-3-yl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127g) 
Isolated by f.c.c. (2:1 EtOAc:Hexane) as a colorless oil (32.2 mg, 75%).   
IR (Thin Film) 3146, 2949, 1742, 1674, 1233, 1113, 1009, 874 cm-1.   
1H NMR (500 MHz, CDCl3) δ 7.87 (s, 1H), 7.41 (d, J = 3.4 Hz, 1H), 6.73 (dd, J = 0.5, 
1.8 Hz, 1H), 4.82 (dddd, J = 3.4, 6.5, 7.0, 10.1 Hz, 1H), 4.26 (dd, J = 3.5, 12.1 Hz, 1H), 
4.14 (dd, J = 6.2, 12.1 Hz, 1H), 4.06 (dd, J = 10.0, 14.7 Hz, 1H), 3.72 (dd, J = 7.3, 14.7 
Hz, 1H), 2.07 (s, 3H).   
13C NMR (125 MHz, CDCl3 DEPT) δ 170.9 (C), 159.3 (C), 145.0 (CH), 143.8 (CH), 
115.4 (C), 109.4 (CH), 76.8 (CH), 65.2 (CH2), 56.8 (CH2), 20.9 (CH3).   
HRMS (ESI+) 232.0580 calc’d for C10H11NO4Na, found 232.0578. 
 
 
(E)-(2-styryl-4,5-dihydrooxazol-5-yl)methyl acetate (5.127i) 
Isolated by f.c.c. (1:2 EtOAc:Hexane) as a brown solid (36.4 mg, 74%).   
IR (Thin Film) 3060, 3027. 2944, 1743, 1655, 1449, 1370, 1233, 977, 760 cm-1.  
1H NMR (500 MHz, CDCl3) δ 7.49-7.47 (m, 2H), 7.39-7.33 (m, 4H), 6.61 (d, J = 16.3 
Hz, 1H), 4.84-4.79 (m, 1H), 4.29 (dd, J = 3.5, 12.1 Hz, 1H), 4.14 (dd, J = 6.2, 12.1 Hz, 
1H), 4.08 (dd, J = 10.0, 15.2 Hz, 1H), 3.74 (dd, J = 7.3, 15.2 Hz, 1H), 2.10 (s, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 163.8 (C), 140.3 (CH), 135.2 (C), 
129.6 (CH), 128.9 (CH), 127.5 (CH), 114.9 (CH), 76.7 (CH), 65.3 (CH2), 57.1 (CH2), 
20.9 (CH3).  
HRMS (ESI+) 268.0944 calc’d for C14H15NO3Na, found 268.0935. 
 
 
(2-methyl-4,5-dihydrooxazol-5-yl)methyl acetate (5127j) 
Small amounts of material could be isolated by f.c.c. (5% MeOH in DCM).  Yield was 
determined by 1H NMR using mesitylene as an internal standard by comparison of the 
mesitylene methyl signals at 2.26 ppm and the methyl group at 2.09.  The mesitylene 
(0.2 eq. wrt. starting material) was added after the product had been worked up prior to 
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final concentration.  Addition of the mesitylene prior to performing the reaction led to 
side product formation and incomplete reaction.     
IR (Thin Film) 2936, 1740, 1659, 1556, 1436, 1372, 1232, 1043 cm-1.   
1H NMR (500 MHz, CDCl3) δ 4.70 (dddd, J = 3.3, 6.9, 6.9, 10.2 Hz, 1H), 4.19 (dd, J 
= 3.4, 12.1 Hz, 1H), 4.07 (dd, J = 6.7, 12.1 Hz, 1H), 3.90 (ddd, J = 1.3, 10.1, 14.4 Hz, 
1H), 3.54 (ddd, J = 1.4, 7.3, 14.3 Hz, 1H), 2.09 (s, 3H), 1.98 (t, J = 1.4 Hz, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.9 (C), 165.0 (C), 76.9 (CH), 65.5 (CH2), 
56.8 (CH2), 20.9 (CH3), 14.0 (CH3).   
HRMS (ESI+) 180.0631 calc’d for C7H11NO3Na, found 180.0609. 
 
 
(2-(tert-butyl)-4,5-dihydrooxazol-5-yl)methyl acetate (5.127k) 
Small amounts of material could be isolated by f.c.c. (1:1 EtOAc:Hex).  Yield was 
determined by 1H NMR using mesitylene as an internal standard by comparing the 
mesitylene methyl signals at 2.26 ppm and the methyl group at 2.07 ppm.  The 
mesitylene (0.2 eq. wrt. starting material) was added after the product had been worked 
up prior to final concentration.  Addition of the mesitylene prior to performing the 
reaction led to side product formation and incomplete reaction.   
IR (Thin Film) 2972, 2875, 1732, 1659, 1460, 1368, 1159, 1048, 995 cm-1.   
1H NMR (500 MHz, CDCl3) δ 4.68 (dddd, J = 3.7, 6.2, 6.2, 9.9 Hz, 1H), 4.16 (dd, J = 
3.6, 12.0 Hz, 1H), 4.05 (dd, J = 5.7, 12.0 Hz, 1H), 3.88 (dd, J = 10.0, 14.3 Hz, 1H), 3.57 
(dd, J = 6.7, 14.3 Hz, 1H), 2.07 (s, 3H), 1.20 (s, 9H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 174.3 (C), 170.9 (C), 76.5 (CH), 65.4 (CH2), 
56.6 (CH2), 33.3 (C), 27.7 (CH3), 20.9 (CH3).   
HRMS (ESI+) 222.1101 calc’d for C10H17NO3Na, found 222.1088. 
 
 
(2-((S)-1-((ethoxycarbonyl)amino)-2-methylpropyl)-4,5-dihydrooxazol-5-
yl)methyl acetate (5.143) 
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Isolated by f.c.c. (1:1 EtOAc:Hexane) as a 1:1 inseparable mixture of diastereomers 
(43.1 mg, 75%).   
IR (Thin Film) 2964, 2877, 1744, 1721, 1531, 1372, 1235, 1043, 1022 cm-1.   
1H NMR (500 MHz, CDCl3) δ 5.19, 5.14 (2 x d, J = 7.0 Hz, 1H), 4.82-4.74 (m, 1H), 
4.36 (dt, J = 6.5, 14.5 Hz, 1H), 4.24-4.19 (m, 1H), 4.11 (tt, J = 5.7, 11.8 Hz, 3H), 3.97-
3.91 (m, 1H), 3.64-3.59 (m, 1H), 2.15-2.10 (m, 1H), 2.08, 2.09 (2 x s, 3H), 1.24 (t, J = 
7.1 Hz, 3H), 0.98 (d, J = 6.8 Hz, 3H), 0.91 (dd, J = 1.9, 6.7 Hz, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) δ 170.81 (C), 170.77 (C), 167.0 (C), 166.8 (C), 
156.5 (C), 156.4 (C), 77.6 (CH), 77.5 (CH), 65.0 (CH2), 64.9 (CH2), 61.2 (CH2), 56.1 
(CH), 56.0 (CH2), 54.4 (CH), 54.3 (CH), 31.4 (CH), 21.2 (CH), 20.83 (CH3), 20.81 
(CH3), 19.0 (CH3), 18.9 (CH3), 17.5 (CH3), 17.3 (CH3), 14.6 (CH3).   
HRMS (ESI+) 309.1421 calc’d for C13H22N2O5Na, found 309.1388. 
 
 
((4S,5R)-4-isopropyl-2-phenyl-4,5-dihydrooxazol-5-yl)methyl acetate (5.144a) 
Purified by f.c.c. (1:4 EtOAc:Hexane) as a brown solid (10.2 mg, 32%).   
IR (Thin Film) 3061, 2959, 2873, 1744, 1654, 1580, 1467, 1370, 1229, 1062, 1026, 
695 cm-1.   
1H NMR (500 MHz, CDCl3) δ 7.95 (d, J = 7.6 Hz, 2H), 7.48 (t, J = 7.2 Hz, 1H), 7.41 
(t, J = 7.7 Hz, 2H), 4.56 (ddd, J = 3.5, 6.4, 6.4 Hz, 1H), 4.26 (dd, J = 3.4, 12.0 Hz, 1H), 
4.14 (dd, J = 6.5, 12.0 Hz, 1H), 3.80 (dd, J = 6.2, 6.2 Hz, 1H), 2.09 (s, 3H), 1.91 (qd, J 
= 6.6, 13.2 Hz, 1H), 1.02 (d, J = 6.8 Hz, 3H), 0.95 (d, J = 6.8 Hz, 3H).   
13C NMR (125 MHz, CDCl3, DEPT) 171.0 (C), 162.6 (C), 131.5 (CH), 128.4 (CH), 
127.8 (C), 79.3 (CH), 74.9 (CH), 66.1 (CH2), 32.5 (CH), 21.0 (CH3), 18.7 (CH3), 18.0 
(CH3). 
HRMS (ESI+) 284.1257 calc’d for C15H19NO3Na, found 284.1257.   
[α]D = –46.3 (c = 0.0062, DCM). 
 
The relative configuration was determined to be trans through NOE studies (see 
spectral data).  The diagnostic enhancement was observed for the methine bonded to 
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the oxygen when the isopropyl methyl groups were irradiated.  Coupling constants 
between Ha & Hb was also consistent with reported related results. 
12 
 
 
1-(2-phenyloxazol-5-yl)butyl acetate (5.146): 
The reaction was performed under the general cyclization conditions.  The product was 
isolated by f.c.c. (1:4 to 1:2 EtOAc:Hexane) to give the product (7.3 mg, 15%). 
1H NMR (500 MHz, CDCl3) δ 8.04 (td, J = 2.4, 5.0 Hz, 2H), 7.47-7.45 (m, 3H), 7.12 
(s, 1H), 5.96, t, J = 7.2 Hz, 1H), 2.09 (d, J = 11.9 Hz, 3H), 2.06-1.93 (m, 2H), 1.46-1.32 
(m, 2H), 0.97 (t, J = 7.4 Hz, 3H). 
13C NMR (125 MHz, CDCl3, DEPT) δ 170.30 (C), 161.89 (C), 150.05 (C), 130.64 
(CH), 128.91 (CH), 127.48 (C), 126.82 (CH), 126.56 (CH), 66.68 (CH), 34.49 (CH2), 
21.21 (CH3), 18.79 (CH2), 13.80 (CH3). 
 
(E)-5-(but-1-en-1-yl)-2-phenyl-4,5-dihydrooxazole (5.147): 
Compound 5.147 was also isolated (9 mg, 22%). 
H NMR (500 MHz, CDCl3) δ 7.47 (t, J = 7.3 Hz, 1H), 7.40 (t, J = 7.2 Hz, 2H), 5.88 
(td, J = 6.3, 15.3 Hz, 2H), 5.58 (dd, J = 7.8, 15.3 Hz, 1H), 5.12-5.07 (m, 1H), 4.20 (app. 
s, 1H), 3.77 (app. s, 1H), 2.14-2.08 (m, 2H), 1.03 (t, J = 7.5 Hz, 3H). 
 
                                                          
12 W. R. Roush, J. A. Straub and R. J. Brown, The Journal of Organic Chemistry, 1987, 52, 5127-5136. 
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(2-phenyl-4,5-dihydrooxazol-5-yl)methyl benzoate (5.154): 
The cyclization was performed under the general cyclization procedures, but with 10 
eq. BzOH instead of AcOH.  Compound 5.154 was isolated (22.4 mg, 40%) in addition 
to acetate 5.127a (16.6 mg, 43%) after f.c.c (1:4 EtOAc:Hexane). 
Isolated by f.c.c. (1:4 EtOAc:Hexane) as a yellow oil (22.4 mg, 40% yield).   
IR (Thin Film) 3062, 2945, 2875, 1722, 1651, 1450, 1272, 1122, 1062, 1025, 711,  
695 cm-1;   
1H NMR (500 MHz, CDCl3) δ 8.04-8.02 (m, 2H), 7.97-7.95 (m, 2H), 7.57-7.54 (m, 
1H), 7.50-7.46 (m, 1H), 7.43-7.40 (m, 4H), 5.09-5.04 (m, 1H), 4.57 (dd, J = 3.5, 12.1 
Hz, 1H), 4.45 (dd, J = 5.8, 12.1 Hz, 1H), 4.23 (dd, J = 10.0, 14.8 Hz, 1H), 3.97 (dd, J = 
7.1, 14.9 Hz, 1H).   
13C NMR (125 MHz, CDCl3, DEPT) 166.4 (C), 164.3 (C), 133.4 (CH), 131.6 (CH), 
129.9 (CH), 129.7 (C), 128.6 (CH), 128.5 (CH), 128.3 (CH), 127.6 (C), 77.1 (CH), 65.8 
(CH2), 57.2 (CH2).   
HRMS (ESI+) 304.0944 calc’d for C17H15NO3Na, found 304.0928. 
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(2-phenyl-4,5-dihydrooxazol-5-yl)methyl 4-methylbenzenesulfonate (5.159): 
Koser’s reagent (48 mg, 0.124 mmol) and benzoic acid (75 mg, 0.62 mg) were added 
to a vial fitted with a Teflon cap. The solids were suspended in DCM (2 mL) and the 
amide (10 mg, 0.062 mmol) was added. The solution was stirred for 20 minutes at which 
time all starting material had been consumed. The reaction was quenched with 10% 
Na2S2O3 (0.5 mL) and saturated NaHCO3 (1 mL), which was stirred for 10 minutes. 
The organic layer was separated, and the aqueous layer was extracted with DCM (2 x 1 
mL). The combined organic layers were dried with MgSO4 and concentrated. The 
compound was isolated by f.c.c (1:1 EtOAc:Hexane) as a tan solid (10.1 mg, 49 %).  
IR (Thin Film) 3055, 2953, 2871, 1651, 1449, 1354, 1292, 1271, 1173, 1063, 975, 828, 
812, 790 cm-1 . 1  
1HNMR (500 MHz, CDCl3) δ 7.83-7.82 (m, 2H), 7.78-7.77 (m, 2H), 7.48 (ddd, J = 
1.2, 1.2, 7.5 Hz, 1H), 7.40-7.37 (m, 2H), 7.28 (d, J = 8.3 Hz, 2H), 4.87 (dddd, J = 4.0, 
6.0, 7.0, 10.0 Hz, 1H), 4.19 (dd, J = 4.0, 11.0 Hz, 1H), 4.14 (dd, J = 6.0, 11.0 Hz, 1H), 
4.11 (dd, J = 10.0, 15.6 Hz, 1H), 3.78 (dd, J = 7.1, 15.0 Hz, 1H), 2.40 (s, 3 H).  
13C NMR (125 MHz, CDCl3, DEPT) 163.8 (C), 145.2 (C), 132.7 (C), 131.7 (CH), 
130.1 (CH), 128.4 (CH), 128.35 (CH), 128.1 (CH), 127.2 (C), 76.3 (CH), 70.1 (CH2), 
56.9 (CH2), 21.8 (CH3).  
HRMS (ESI+) 354.0771 calc’d for C17H17NO4SNa, found 354.0768. 
 
 
allyl 2,2,2-trichloroacetimidate (5.169): 
 
Allyl alcohol (500 mg, 8.9 mmol, 1 eq.) was dissolved in DCM (18 mL).  DBU (274 
mg, 1.8 mmol, 0.2 eq.) was added and the solution was cooled to 0 °C.  
Trichloroacetonitrile (2.57 g, 17.8 mmol, 2 eq.) was added dropwise.  The reaction was 
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stirred at 0 °C for 1h.  The solvent was removed and the crude material was purified by 
f.c.c. (1:10 EtOAc:Hexane) to give the product (1.136 g, 63%). 
1H NMR (300 MHz, CDCl3) δ 8.32 (bs, 1H), 6.10-5.97 (m, 1H), 5.44 (dd, J = 1.5, 17.2 
Hz, 1H), 5.31 (dd, J = 1.2, 10.5 Hz, 1H), 4.82-4.80 (m, 2H). 
 
 
N-phenylacrylamide (5.172): 
Aniline (2.05 g, 22 mmol, 2 eq.) and NEt3 (1.7 g, 16.5 mmol, 1.5 eq.) were dissolved in 
THF (40 mL).  The solution was cooled to 0 °C and acryloyl chloride (1.0 g, 11 mmol, 
1 eq.) was added.  The reaction was warmed to rt and stirred for 18 h.  The reaction was 
quenched with 50 mL saturated, aqueous NaHCO3 and extracted with 2 x 20 mL EtOAc.  
The combined organic fractions were washed with brine, dried with Na2SO4 and 
concentrated.  Purification by f.c.c. (1:5 to 1:4 EtOAc:Hexane) gave the product (721.1 
mg, 45%). 
1H NMR (300 MHz, CDCl3) δ 7.59 (d, J = 7.7 Hz, 2H), 7.50 (bs, 1H), 7.33 (t, J = 7.9 
Hz, 2H), 7.12 (t, J = 7.3 Hz, 1H), 6.44 (dd, J = 1.3, 16.8 Hz, 1H), 6.26 (dd, J = 10.1, 
16.8 Hz, 1H), 5.76 (dd, J = 1.3, 10.1 Hz, 1H). 
 
 
N-phenylmethacrylamide (5.174): 
Methacrylic acid (250 mg, 2.9 mmol, 1 eq.) and NEt3 (586 mg, 5.8 mmol, 2 eq.) were 
dissolved in DCM (7 mL) and the solution was cooled to 0 °C.  Ethyl chloroformate 
(314.7 mg, 2.9 mmol, 1 eq.) was added.  The solution was stirred for 30 min. at 0 °C.  
Aniline (324 mg, 3.5 mmol, 1.2 eq.) was added and the solution was allowed to warm 
to rt and stirred for 18 h.  The reaction was quenched with 20 mL saturated, aqueous 
NaHCO3 and the organic layer was separated.  The aqueous layer was washed with 2 x 
20 mL DCM.  The combined organic layers were washed with brine, dried with Na2SO4 
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and concentrated.  The crude material was purified by f.c.c (1:6 EtOAc:Hexane) to give 
the product (214 mg, 46%). 
1H NMR (300 MHz, CDCl3) δ 7.56 (d, J = 7.8 Hz, 2H), 7.33 (t, J = 7.9 Hz, 2H),  
7.12 (t, J = 7.4 Hz, 1H), 5.79 (s, 1H), 5.46 (t, J = 0.7 Hz, 1H), 2.06 (s, 3H). 
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